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A novel model of unilateral, localized adjuvant-induced arthritis in the
rat was assessed for its use in pharmacological studies on the pain
associated with chronic joint inflammation. Levels of inflammation,
changes in behaviour and joint pathology were examined.
Electrophysiological recordings of afferent activity were made in
anaesthetized rats in vivo and in vitro from a fine branch of the medial
plantar nerve innervating the tarsal joint. The effects of various
putative inflammatory mediators on the discharge of articular
nociceptors both in normal and arthritic joints were also examined.
Where possible, selective agonists and antagonists were used to
characterize the pharmacological receptors involved in the actions of
these substances.
Injection of Freunds Complete Adjuvant around the left ankle joint
caused a localized swelling, nociceptive thresholds to mechanical
stimuli were lowered and use of the injected joint was significantly
reduced. Histological studies revealed the presence of an arthritis
which was confined to the injected ankle. Electrophysiological
investigations showed that in arthritic joints there were a larger
number of identifiable receptive fields for articular mechanonociceptors
compared to those found in normal joints. Receptors had lower activation
thresholds, and often displayed a resting discharge not seen in normal
joints.
Intra-arterial (i.a.) injection of 5-hydroxytryptamine (5-HT), excited
articular nociceptors from normal and arthritic joints. Responses
consisted of two components: (a) a fast transient burst of activity
mediated by a 5-HT3-receptor, followed by (b) a delayed, longer-lasting
excitation mediated by a 5-HT2-receptor. These responses were shown to
occur both in vivo and in vitro. 5-HT also increased the mechanical
responsiveness of articular mechanonociceptors via a 5-HT3-receptor.
Sensory receptors in arthritic joints were more sensitive to 5-HT than
those from normal joints. Administration of the 5-HT3- or 5-HT2*
receptor antagonists caused short-lasting reductions in background
activity in arthritic joints, as well as in normal joints in which
activity had increased following administration of 5-HT.
In normal joints, i.a. injection of PGE2, PGI2 or the selective IP-
receptor agonist cicaprost, excited and caused mechanical sensitization
of articular mechanonociceptors. Potentiation of the short-lived
excitatory and sensitizing effects of i.a. injected bradykinin on these
receptors was also shown. Examination of the effects of PGE2, PGI2 and
cicaprost in vivo or PGE2, cicaprost, PGD2, and PGF2 alpha in vitro,
produced a rank order of potency of
PGI2 - cicaprost » PGE2 » PGD2 - PGF2 alpha
In arthritic rats injection of cicaprost, and to a lesser extent PGE2,
was effective in increasing the mechanical responsiveness and resting
discharge of articular mechanonociceptors previously depressed by i.v.
lysine acetylsalicylate. These results provide evidence for the
involvement of IP-receptors, and perhaps EP-receptors, in the excitatory
and sensitizing actions of the prostanoids on articular nociceptors, and
suggest that PGI2 is the major endogenous prostanoid responsible for the
mechanonociceptor sensitization seen in arthritic rat ankle joints.
Overall the results suggest that more than one mediator is required to
produce conditions of mechanonociceptor sensitization seen in arthritic
rat ankle joints. However, as modulators of the responsiveness of
nociceptors to other mediators, and as potent excitants themselves, the
prostanoids, and in particular PGI2, probably play a major role in the
alterations in nociceptor sensitivity seen in arthritic joints.
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cAMP cyclic adenosine monophosphate
CGRP calcitonin gene related peptide
C.N.S. central nervous system
C02 carbon dioxide
delta change in
delta max change in maximum
delta 3c change in the mean, also mean difference
delta 3H! change in mean expressed as a percentage change
delta Ex discharge integrated with respect to control







































w/v weight per volume
x arithmetic mean
Most abbreviations, other than commonly used expressions, are also
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The severe chronic pain experienced by individuals affected by arthritis
or rheumatism is the major clinical symptom associated with this class
of disorders. The most effective treatment available is the
administration of non-steroidal anti-inflammatory drugs (NSAIDS) such as
aspirin (Hart, 1987). However, NSAIDS are known to cause moderate to
severe damage of the gastrointestinal mucosa (Goodwin, 1987), damaging
effects on renal function (Lifschitz, 1983), and a wide range of less
common side effects. In addition, these drugs may potentiate chronic
inflammation (Lewis & Barrett, 1986), and have a harmful effect on
cartilage, especially on that already compromised by disease (Palmoski &
Brandt, 1985). Opioid analgesics are often used in conjunction with
NSAIDS, but are generally of little additional benefit (Cooper & Beaver,
1976; Ehrnebo et al., 1977; Findlay et al., 1978), and at higher doses
cause centrally-mediated side effects such as drowsiness, dizziness,
nausea, and vomiting. In order to develop new drugs for the treatment of
arthritic pain it is essential that we understand the mechanisms
responsible for its production. This requires in depth knowledge of the
physiological systems involved in the processing of stimuli perceived as
painful, and, in addition, it is important that we understand the
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changes which take place during inflammation which cause alterations in
sensory sensitivity. My aim in the General Introduction will be to
outline the physiology of the peripheral origins of pain, and go on to
examine the role played by these mechanisms in the pain associated with
arthritis.
1.2 Pain and nociception
Early observations from the work of Blix (1884) and Von Frey (1895)
provided evidence for the existence of specific receptors in the skin
that were capable of responding to stimuli perceived as painful. By the
turn of the century, researchers encountered the problem of
investigating pain in animals which could not report whether a stimulus
was painful or not. Following the work of Sherrington (1906), the term
nociception was used to describe the sensory sub-modality responding to
those stimuli-defined as "capable of compromising the integrity of the
organism". In animals these stimuli produce reflex responses such as
flexion reflex, increased heart and respiratory rates, and pupilary
dilatation. In awake animals accompanying behavioural responses such as
escape reactions and vocalisation also occur.
The discovery that different classes of nerve fibre exist in the
periphery led to the demonstration, using graded electrical nerve
stimulation, that nociceptive input is transmitted by small myelinated
(A-delta: corresponding to the "B wave" of the compound action
potential) and unmyelinated (C: corresponding to the "C wave") afferent
axons. The classical studies, using partial nerve blocking techniques,
conducted by Gasser & Erlanger (1929) and later by Clark et al. (1935)
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confirmed these findings and further showed that A-delta fibres were
required for sharp, well localised pain sensations, whereas C fibres
were involved in a delayed, more diffuse pain, often of a burning type.
The first electrophysiological recordings of the activity of afferent
nerve fibres indicated that small diameter nerve fibres could be excited
by different types of noxious stimuli (Adrian, 1931; Zotterman, 1939).
However, these and subsequent investigators found fine fibres which were
also activated by a range of innocuous stimuli. It was not until the
late 1960s that enough evidence had been collected to declare the
existence of well-defined specific "nociceptors" in the skin (see
Burgess & Perl, 1973).
Due to the ease of access to the cutaneous tissues in animals and
particularly in man, nociceptors in these tissues have been studied in
greatest detail. Nociceptors present in the skin possess similar
characteristics to those found in other tissues (Besson & Chaouch,
1987), and for this reason, I will devote the next major section to a
description of their identifying features.
1.3 Classification of cutaneous nociceptors
Work carried out mostly during the 1960s in cats, dogs, rats and
primates (Iggo, 1958,1959; Hunt & Maclntyre, 1960; Iruichijima &
Zotterman, 1960; Witt & Griffin, 1962; Burgess & Perl, 1967; Perl, 1968;
Bessou & Perl, 1969) identified two major groups of nociceptors (Burgess
& Perl, 1973).
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C-polymodal nociceptors: activated by strong stimuli, mechanical,
thermal or chemical.
A-delta mechanonociceptors: activated by strong mechanical stimuli but
unresponsive to chemical or thermal
stimuli.
However, this clear distinction between A-delta and C fibre associated
nociceptors was not apparent in subsequent studies using rats (Necker &
Hellon, 1978; Renins, 1981; Lynn & Carpenter, 1982; Fleischer et al.,
1983) cats (Beck et al., 1974; Fitzgerald & Lynn, 1977), monkeys (Iggo &
Ogawa, 1971; Beitel & Dubner, 1976a,b; Croze et al., 1976; Georgopoulos,
1976; Kumazawa & Perl, 1977; Lamotte & Campbell, 1978; Campbell et al.,
1979; Meyer & Campbell, 1981) and humans (Torebjork & Hallin, 1972; Van
Hees & Gybels, 1972; Torebjork, 1974; Torebjork & Hallin, 1974;
Adriaensen et-al., 1980; Konietzny et al., 1981; Adriaensen et al.,
1983; Adriaensen et al., 1984). A great deal of heterogeneity exists
within populations of nociceptors with A-delta or C fibre afferents.
Thus some A-delta fibres in the cat or monkey can be activated by
mechanical nociceptive and thermal nociceptive stimuli (Beck et al.,
1974; Georgopoulos, 1976), and may function as polymodal nociceptors in
man (Adriaensen et al., 1980). Furthermore, following application of a
noxious thermal stimulus, an A-delta mechanoreceptor may respond to
subsequent heat stimuli (Fitzgerald & Lynn, 1977; Campbell et al.,
1979). Not all A-delta and C fibre afferents are nociceptive (Burgess &
Perl, 1973), and conversely some fast conducting myelinated fibres are
(Georgopoulos, 1976; Fitzgerald & Lynn, 1977; Campbell et al., 1979).
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The response characteristics of all cutaneous nociceptors identified at
this time defined a nociceptor as
(i) having response thresholds higher than that of low
threshold mechanoreceptors or thermoceptors
and (ii) possessing the ability to code the intensity of
nociceptive stimuli.
The following is a consideration of the main classes of cutaneous
nociceptors identified and their response characteristics which enabled
the above conclusions to be reached.
1.3.1 Characteristics of cutaneous mechanonociceptors
Cutaneous high threshold mechanoreceptors are mostly associated with A-
delta afferent fibres and are not excited by thermal or chemical stimuli
(Burgess & Perl, 1967). These receptors do not display any spontaneous
activity, their rate of discharge increases with the stimulus amplitude,
and they adapt slowly to a stimulus of constant intensity (Fitzgerald &
Lynn, 1977). Receptive fields are usually made up of several sensitive
zones, and application of repetitive stimuli to the same point in a
receptive field has been reported to result in a characteristic fatigue
in responsiveness (Burgess & Perl, 1967; Perl, 1968; Lynn & Carpenter,
1982).
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1.3.2 Characteristics of cutaneous polymodal nociceptors
The characteristics of C polymodal nociceptors and A-delta polymodal
nociceptors are, generally speaking, very similar (Bessou & Perl, 1969;
Iggo & Ogawa, 1971; Beck et al 1974; Dubner et al., 1976; Georgopoulos,
1976; Price et al., 1977; Adriaensen et al., 1980). Receptive fields are
usually punctate, often less than 0.5 mm diameter, although more
complex receptive fields have also been identified (Beitel & Dubner,
1976a; Croze et al., 1976; Torebjork, 1979; Van Hees & Gybels, 1981),
and a degree of overlap may exist between receptive fields of several
afferent fibres (Torebjork, 1979). Under normal conditions polymodal
nociceptors do not display any spontaneous activity.
Intense mechanical stimuli are required to produce excitation of
polymodal nociceptors, and stimuli applied using pointed objects are the
most effective. Discharge increases with the intensity of the applied
stimulus and adapts slowly during a stimulus of fixed amplitude (Adrian
& Zotterman, 1926). The development of fatigue following repeated
mechanical stimulation is another characteristic of these receptors (Van
Hees & Gybels, 1972; Torebjork & Hallin, 1974; Beitel & Dubner, 1976b;
Kumazawa & Perl, 1977).
Skin temperatures of 40°C and above produce graded increases in the
discharge of cutaneous polymodal nociceptors. The threshold for
activation is generally around 42°C, although some receptors only fire
at much greater temperatures (Bessou & Perl, 1969). Saturation of
receptor discharge has been reported to occur at temperatures above 50°C
(Beitel & Dubner, 1976a,b; Croze et al., 1976).
An outstanding feature of the response of polymodal nociceptors to
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repeated thermal stimuli is the development of a marked sensitization.
This results in several changes including a reduction in threshold to
below 40°C, an increase in the response to a standard thermal stimulus,
a reduction in the response latency and the appearance of spontaneous
activity. (Witt & Griffin, 1962; Bessou & Perl, 1969; Beck et al., 1974;
Beitel & Dubner, 1976a,b; Croze et al., 1976; Kumazawa & Perl, 1977;
Lynn, 1979; Lynn & Carpenter, 1982; Lamotte et al., 1982; Fleischer et
al., 1983) Heat-sensitized receptors have also been shown to have
enhanced responsiveness to mechanical stimuli (Bessou & Perl, 1969). It
should also be noted that exposure to intense heat (greater than 55°C),
or application of repetitive stimuli, produces a marked desensitization
of receptor responsiveness (Bessou & Perl, 1969; Beitel & Dubner, 1976b;
Georgopoulos, 1976).
Although examination of the effects of chemical stimuli on cutaneous
receptors has not been carried out routinely, several studies
considering the responses of A-delta and C polymodal nociceptors to the
cutaneous application of algogenic substances have been carried out in
animals (Bessou & Perl, 1969; Forster & Ramage, 1981; Renins, 1981; Lynn
& Carpenter, 1982) and humans (Torebjork & Hallin, 1974; Adriaensen et
al., 1980; Van Hees & Gybels, 1981; Adriaensen et al., 1983). These
receptors are excited by the application of acids, bradykinin, histamine
and other irritants to their receptive fields, and a good correlation
exists between evoked activity and the reported pain sensation. Much
work has examined the effects of intra-arterial injection of algogenic
substances on cutaneous nociceptor activity. Results from these studies
will be considered in later sections dealing with individual mediators
and their effects on nociceptor function.
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1.4 Cutaneous nociceptors and sensation
In general, cutaneous nociceptors are only activated by stimuli capable
of causing tissue damage and which are perceived as painful when applied
to humans. However, this is not always the case as nociceptors can
respond at lower intensities of stimuli perceived as non-painful (Van
Hees & Gybels, 1972; Torebjork & Hallin, 1974; Beitel & Dubner, 1976a).
Application of mechanical or thermal stimuli which activate polymodal
nociceptors do not always cause painful sensations (Torebjork & Hallin,
1972; Van Hees & Gybels, 1972). However, higher levels of activity from
these same nociceptors produce pain, and there is a good correlation
between the discharge frequency of nociceptors and the sensation of pain
(Torebjork, 1979; Van Hees & Gybels, 1981; Torebjork et al., 1984).
These observations suggest a role for temporal and spatial summation in
coding of nociceptive input from the periphery.
Sensitization of nociceptors in both animals and humans provides an
explanation for the hyperalgesia and hyperesthesia caused by nociceptor
stimulation, and these phenomena have proven to be extremely important,
particulary in relation to the effects of tissue damage and inflammation
on nociceptor function (see Besson & Chaouch, 1987).
1.5 Morphological studies of cutaneous nociceptors
Since the work of Von Frey (1895) the morphological correlate of the
nociceptor has been regarded as the "free nerve ending". The term
originally arose from work carried out during the nineteenth century
leading to the observation that unmyelinated fibres do not acquire a
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corpuscular or specialized encapulated structure at their peripheral
ends, nor are they associated with any cells thought to participate in
sensory processes (eg Merkel cells). Since these unmyelinated free
terminals were often found to be the predominant or only morphological
structure present in areas from which sensations of pain could be
elicited, it was accepted that they were indeed nociceptors. More recent
electronmicroscopic examination of serial sections from cutaneous
tissues containing unmyelinated or fine myelinated terminals have
revealed the more detailed structure of these endings (Cauna, 1973;
Kruger et al., 1981). As they pass through the epidermis, terminals
often remain enclosed within a Schwann cell process after loss of their
myelin sheath. The terminals contain a mixed population of vesicles and
also mitochondria, this arrangement being reminiscent of a synaptic
bouton.
It seems likely that at the morphological level little differentiation
between nociceptive terminals will be achieved. However,
immunohistochemical studies examining predominantly the peptide contents
of sensory terminals have revealed a previously unsuspected diversity
and heterogeneity of the free nerve ending (see Kruger, 1987).
1.6 Nociceptors in tissues other than the skin
Sensory receptors with finely myelinated or unmyelinated afferent fibres
have been identified in many different tissues. These receptors have
been tested using a variety of stimuli, and have been found to possess
similar response characteristics to those of cutaneous nociceptors. In
the following sections, a brief outline of the putative nociceptor
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populations in different tissues will be given. A separate section will
be devoted to sensory receptors associated with articular tissue.
Visceral receptors with nociceptive properties have been identified in
the abdomen (Zimmerman, 1979; Mei, 1983), colon (Blumberg et al., 1983;
Haupt et al., 1983; Longhurst et al., 1984), bile duct (Cervero, 1982),
reproductive system (Floyd & Morrison, 1974; Clifton et al., 1976; Floyd
et al., 1976; Coggeshall & Ito, 1977; Kumazawaa and Mizumura, 1977b;
1980a,b), urinary system (Denny-Brown & Robertson, 1933; Iggo, 1955;
Todd, 1964; Astrom & Crafoord, 1968; Beacham & Kunze, 1969; Niijima,
1971; Clifton et al., 1976; Floyd et.al., 1976), myocardium (White,
1959; Brown, 1967; Uchida & Murao, 1975; Nishi et al., 1977; Barker
et.al., 1980), and respiratory system (Fillenz & Widicombe, 1972;
Paintal, 1973). These receptors respond to a variety of stimuli,
including stretch of the tissues, application of chemical irritants or
tissue ischemia.
Receptors with A-delta afferent fibres which respond to strong torsion
of a tooth have been identified in the periodontium (Mei et al., 1977),
and tooth pulp A-delta and C fibre polymodal nociceptors have also been
characterized (Olgart, 1974; Horiuchi & Mathews, 1976; Kollman et al.,
1982). In the cornea, polymodal nociceptors with finely myelinated axons
have been characterized which respond to corneal stroking, heating,
acids, or cooling (Belmonte & Giraldez, 1981).
Receptors in muscle, with A-delta or C fibre afferents, have long been
known to be excited by a variety of stimuli including strong mechanical
or thermal stimulation and injection of hypertonic saline (Bessou 6c
Laporte, 1958; Paintal, 1960; Bessou 6c Laporte, 1961; Iggo, 1961).
Receptors with A-delta and C fibre afferents have been shown to have
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very similar characteristics (Mense & Meyer, 1985). About half of the
high threshold mechanoreceptors with either A-delta and C fibre
afferents are also excited by bradykinin (Franz & Mense, 1975; Mense,
1977). In addition, a number of C fibre afferents are excited
exclusively by chemical stimulation. Finally noxious thermal stimulation
has been shown to excite a number of A-delta and C fibre associated
receptors, further characterizing them as polymodal nociceptors
(Kumazawa & Mizumura, 1976; 1977a).
1,7 Articular sensory receptors
The tissues of the joints are extensively innervated by both myelinated
and unmyelinated sensory nerves, and the presence of nerve endings in
the joint capsule has been known for over a hundred years.
Investigations carried out mainly during the 1950s and 1960s identified
a number of morphologically distinct sensory endings within the joint
tissues of animals (Samuel, 1952; Andrew & Dodt, 1953; Hromada &
Polacek, 1958; Polacek, 1966; Freeman & Wyke, 1967) and man (Gardner,
1950). On the basis of these studies articular sensory endings have been
classified into four main types (Freeman and Wyke, 1967):
type (i) globular corpuscle: encapsulated arborising terminals
(Ruffini-type corpuscle)
type (ii) cylindrical corpuscle: thick laminated capsule
(Pacinian-type corpuscle)
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type (iii) fusiform corpuscle: thin capsule and densely
arborizing
terminal (Golgi-Mazzoni-type corpuscle)
type (iv) free nerve ending: unmyelinated free terminal.
Ruffini-type endings are normally linked in clusters of three to six
corpuscles, and are associated with small diameter myelinated axons. The
functional receptor unit is formed by the cluster of corpuscles each of
which is innervated by the same afferent nerve fibre. These endings are
found predominantly in the peripheral layers of the joint capsule, with
smaller numbers located on extrinsic ligaments and in para-articular
periosteum and related tendons (see Freeman & Wyke, 1967).
Cylindrical corpuscles of the Pacinian type are innervated by
myelinated afferent axons and are found individually or in clusters of
two to four corpuscles. Receptor units are associated with a single axon
which branches to supply each corpuscle with a single thickened
terminal. Pacinian type corpuscles are found in the capsular tissue,
predominantly in the deeper layers in apposition with the fibro-adipose
subsynovial tissue. The articular fat pads, where they are attached to
the joint capsule, also contain small numbers of these endings (see
Freeman & Wyke, 1967).
The fusiform corpuscles are entirely absent from the joint capsule,
and are found only in the joint ligaments. Innervated by a single large
myelinated axon, each corpuscle contains many densely arborizing
filaments which arise from the main axon within the end-organ itself.
Clusters of two to three corpuscles may occur, these being supplied by
the same axon, and being smaller in size than single corpuscles (see
13
Freeman & Wyke, 1967).
As in other tissues the free nerve endings consist of relatively
undifferentiated non-corpuscular terminations composed of unmyelinated
nerve filaments. They appear to exist as either closely meshed networks
or as isolated nerve endings. Unmyelinated nerve networks are
distributed throughout the fibrous capsule, adjacent periosteum,
articular fat pads and in the adventitial sheaths of the articular blood
vessels. Isolated free nerve endings arise from the terminal branching
of unmyelinated or finely myelinated afferent axons. They are most
numerous in the joint ligaments, in the tendons related to the joint
capsule and in the deeper layers of the capsule. Free nerve endings of
any type are not seen in the synovial tissues or the menisci (see
Freeman & Wyke, 1967).
Until recently, electrophysiological studies examining the response
characteristics of articular sensory receptors have focused mainly on
those receptors with rapidly conducting afferent fibres (Andrew & Dodt,
1953; Boyd & Roberts, 1953; Boyd, 1954; Skoglund, 1956; Eklund and
Skoglund, 1960; Burgess & Clark, 1969; McCall et al., 1974; Clark, 1975;
Clark & Burgess, 1975; Grigg, 1975; Grigg, 1976; Grigg & Greenspan,
1977; Ferrell, 1980; Grigg & Hoffman, 1982; Grigg et al. 1982). The
Ruffini-type endings appear to be excited by flexion, extension, direct
pressure or stretch of the joint capsule, and are slowly-adapting (Boyd,
1954; Eklund & Skoglund, 1960; Burgess 6c Clark, 1969; Grigg 6c Hoffman,
1982). Golgi-Mazzoni endings are activated by flexion or by pressure
applied to the ligaments or inside surface of the capsule and also show
a slowly-adapting response (Burgess 6c Clark, 1969; Grigg 6c Hoffman,
1982). Rapidly adapting responses are displayed by the Pacinian
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corpuscle-like receptors which are excited only during joint movements
(Burgess & Clark, 1969).
From the few units with slowly conducting (A-delta) afferents
described in the studies above, they are stated as being
characteristically insensitive to joint flexion, extension or rotation
and pressure on the capsule. It was thus concluded that the slowly
conducting myelinated fibres were most likely to be associated with
articular nociceptors (Burgess & Clark, 1969).
1.7.1 Articular nociceptors
It is particularly notable that the sensory afferent innervation of the
joints is composed mainly of finely myelinated and unmyelinated nerve
fibres (Langford, 1983; Langford & Schmidt, 1983; Guilbaud et al.f
1985). Identification of the functional role played by the receptors
associated with these afferents is therefore extremely important.
Investigations carried out by Schaible & Schmidt (1983a,b) have resulted
in the identification of a population of A-delta and C fibre units
(termed by these workers as group III and group IV afferents
respectively) which appear to function as nociceptors in the cat knee
joint. The receptive fields for these units are located in the joint
capsule and consist of one, or occasionally up to four, small (< 2 mm
diameter) responsive zones. Both A-delta and C fibre units have high Von
Frey thresholds ranging from 3 to 225 mN, although the latter are
generally less sensitive, and respond in a graded manner over a wide
stimulus range. The majority of these units were only activated by joint
movements outside the normal working range, responses being largest when
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extreme rotations of the tibia are executed. A few units either
responded to nonnoxious movements (21%) or did not repond even to
extreme joint rotation (34%). Finally, resting activity was found to be
present in a number of instances for each of the different receptor
types described above.
In the capsular tissues of the rat ankle joint a population of high
threshold C mechanoreceptors with nociceptive properties have also been
identified by Guilbaud et al. (1985). Slowly adapting mechanoreceptors
with punctate (1 - 3 mm diameter) receptive fields were found to have
Von Frey thresholds from 4.6 to over 80 mN, with over half of the units
having thresholds greater than 80mN. All units possessed similar
characteristics to those of cutaneous nociceptors in that they were able
to code the intensity of the applied stimulus, developed fatigue
following repeated mechanical stimuli, and displayed an absence of any
resting discharge over the normal range of joint position. Light
pressure on the ankle joint or small degrees of flexion or extension
failed to produce activation. An insensitivity to mild thermal stimuli
was also demonstrated for these receptors.
From these studies it is clear that A-delta and C fibre articular
mechanoreceptors are involved in deep pressure sensation and
nociception. Under normal circumstances these receptors signal that the
joint is under damaging or potentially damaging stress.
16
1.8 Mediators of inflammation
The association between inflammation and disease, first described by
Hyppocrates (460 - 377 BC), was accompanied by the assumption that an
irritant (materia peccans) causes local disturbance of the body fluids,
which attracts digestive materials responsible for catabolism and
dissolution of damaged tissue. From the observations of Celsus (30 BC -
30 AD) on the cardinal signs of inflammation, calor (heat), rubor
(redness), tumor (swelling) and dolor (pain), it was realized that these
effects were probably produced by endogenous substances which were
released following injury.
In the early nineteenth century it was suggested that inflammation
resulted from the reflex activation of neuronal elements (Henle, 1846).
This concept was later replaced by a predominantly vascular theory of
inflammation (Cohenheim, 1873). The inflammatory elements were
considered to be blood cells which invaded the tissues following their
passage through a damaged vessel wall (Arnold, 1875; Weigert, 1889).
Not until the introduction of chemical techniques was the importance
of increased concentrations of small molecules considered in
inflammation (Schade, 1923). The discovery that histamine, synthesized
by Windaus and Vogt (1907) or extracted from biological materials
(Ackerman, 1910; Kutscher, 1910) or ergot preparations (Barger & Dale,
1910), could elicit an inflammation-like reaction in human skin
(Eppinger, 1913), led Lewis (1927) to suggest that a group of 'H'-
substances were the ubiquitous mediators of inflammation. However,
potent antihistamines turned out to be of only limited therapeutic value
in the treatment of inflammation (Bovet & Staub, 1937). Following these
discoveries a series of criteria to be fulfilled by any putative
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mediator of inflammation were formulated by Dale (1929):
(i) Reduction in the release of the substance or inactivation of
the substance by known anti-inflammatory drugs
(ii) Induction by the putative mediator of some or all signs of
inflammation
(iii) Release of the proposed mediator during an inflammatory
reaction.
With the definition of these criteria, a more directed and critical
approach to the identification of potential mediators was now possible.
Menkin (1940) was the first to identify a series of polypeptide
mediators, and suggested the existence of substances specific for
eliciting each symptom of inflammation. This new approach, and the
conviction that more than one inflammatory mediator existed, led to the
description of a variety of mediators such as bradykinin (Werle & Berek,
1948; Rocha e Silva et al., 1949) serotonin (Rowly & Benditt, 1956),
complement factors (Bloch et al., 1963), prostaglandins (Horton, 1969)
and other derivatives of polyunsaturated fatty acids (Samuelsson, 1981)
and phospholipids (Vargaftig & Benveniste, 1983).
1.9 Inflammatory mediators and pain
Pain and hyperalgesia are among the principal features of inflammation
whether in its acute or chronic form. Hyperalgesia and inflammatory pain
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are thought to result predominantly from the actions of various chemical
mediators on nociceptive endings within the affected tissues.
One of the first studies suggesting the action of an endogenous
chemical mediator was carried out by Lewis (1942), who examined the
pain-producing effects of ciculatory occlusion on active muscle. This
observation was attributed to the effects of a 'factor P' which was
later shown not to be lactic acid, C02 or acidity (Dorpat and Holmes,
1955). Induction of pain by putative inflammatory mediators has long
been a subject of investigation (Feldberg, 1956), but it was the studies
of Keele & colleagues that thoroughly established their pain producing
properties (Armstrong et al, 1952; Armstrong et al., 1953; Armstrong et
al., 1957; Keele and Armstrong, 1964). Keele and his coworkers
demonstrated that application of algogens to the exposed cantharidin-
induced blister base induced painful sensations in man. Among the
substances found to be specific algogens were acetylcholine, 5-HT,
histamine, substance P and bradykinin.
Hyperalgesia has been considered for some time to result from the
chemically-induced sensitization of nociceptors in the periphery (Lewis
et al., 1931; Deneau et al., 1953; Smith et al., 1968). From early
investigations, subthreshold, non-algogenic doses of bradykinin were
shown to lower pain thresholds in man (Sicuteri, 1965) and dog (Lim and
Guzman, 1968), and synergism between chemical substances was also
demonstrated for histamine (Lewis, 1942; Emmelin and Feldberg, 1947),
acetylcholine (Skouby, 1953), bradykinin (Sonia and Khaitin, 1967) and
5-HT (Sicuteri et al., 1965). The discovery of the hyperalgesic effects
of the prostaglandins by Ferreira (1972) was followed by numerous
investigations which resulted in the E-series prostaglandins being
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considered as the most important endogenous mediators of hyperalgesia
(Moncada et al., 1975).
Many studies have demonstrated the excitatory effects of algogenic
substances on nociceptive sensory receptors. Receptors with A-delta and
C fibre afferents have been examined in a variety of tissues including
the skin (Douglas & Ritchie, 1960; Fjallbrant & Iggo, 1961; Beck &
Handwerker, 1974; Chahl & Iggo, 1977), viscera (Douglas & Ritchie, 1957;
Armett & Ritchie, 1961; Niijima, 1971; Kumazawa & Mizumura, 1980a,b;
Delpierre et al., 1981; Cottrell & Iggo, 1984), muscles (Mense &
Schmidt, 1974, Franz & Mense, 1975; Fock & Mense, 1976; Hiss & Mense,
1976; Kumazawa & Mizumura, 1976; Mense, 1977; Foreman et al., 1979;
Mense, 1982), and joints (Schaible & Schmidt, 1983a,b; Kanaka et al.,
1985). These studies provide valuable information concerning the effects
of algogenic chemicals on the response characteristics of sensory
receptors. However, it is not possible using this approach to study in
detail the ionic mechanismsresponsible for the generation of action
potentials within sensory endings.
Excitatory responses to applications of various algogenic substances
have been demonstrated for sensory neurone somata in the nodose ganglion
(Sampson & Jaffe, 1974; Higashi, 1977; Higashi et al., 1982). It has
also been shown that transport of receptors for various substances from
cell bodies to peripheral nerve terminals occurs in the vagus nerve
(Young et al., 1980). These findings suggest that the somata, axons and
sensory terminals of primary afferent neurones may possess the same
receptors for algogenic substances. Relying on the assumption that these
receptors function in a similar manner and are associated with the same
ionic channels in each location, changes in membrane properties produced
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by various algogens have been investigated in electrophysiological
studies on the axons and cell bodies of sensory neurones.
1.9.1 Bradykinin
The nonapeptide bradykinin is formed in blood and tissue from the
breakdown of high molecular weight precursors, the kininogens, by the
proteolytic actions of the plasma kallikreins (Rocha e Silva, 1964).
Under normal circumstances, blood and tissue levels of bradykinin are
very low, but during inflammation the processes of formation are highly
active and peripheral levels are markedly increased (see Lewis, 1970;
Garcia-Leme, 1978). Tissue damage induces activation of Hageman factor
resulting in the conversion of prekallikreins to their active form and
the subsequent production of bradykinin (see fig. 1.1).
Bradykinin triggers a number of specific pro-inflammatory responses in
different tissue types including fluid secretion by epithelia (Manning
et al., 1982), contraction of venous smooth muscle leading to increased
capillary permeability (Regoli & Barabe, 1980), release of histamine and
eicosanoids from various cells involved in the inflammatory process
(Regoli & Barabe, 1980; Marceau et al., 1983), and stimulation of cell
growth (Rozengurt, 1986).
1.9.1.1 Bradykinin and pain
Bradykinin is generally considered to be the most potent endogenously
ocurring algogenic substance. Original investigations demonstrated that










Fig 1.1 Schematic diagram showing the generation and breakdown of
bradykinin. Solid arrows indicate transformations and dashed arrows










sensation (Keele & Armstrong, 1964), and when injected intra-arterially
in dogs induced strong pseudoaffective responses indicative of pain
(Guzman et al., 1962). In subsequent studies bradykinin injected
intradermally (Lim et al. 1967; Ferreira, 1972) intra-arterially (Burch
and Pasquale, 1962; Coffman, 1966) or intra-abdominally (Cormia &
Dougherty, 1960; Lim et al., 1967) produced pain in humans, or when
injected intra-arterially (Hashimoto et al., 1964; Ferreira et al.,
1973) or intra-articularly (Melmon et al., 1967; Moncada et al., 1975)
in dogs, induced pseudoaffective responses. These potent algesic effects
of bradykinin are not, however, found by all workers. In man, a
sensation of warmth rather than pain may be experienced (Fox et al.,
1961), and bradykinin-induced pain is found to be dependent on the
presence of other inflammatoy mediators such as 5-HT or prostaglandins
(Sicuteri et al., 1965; Ferreira et al., 1973; Moncada et al., 1975).
Bradykinin is in fact one of the most potent endogenous agents in its
ability to release prostaglandins (Juan et al., 1984) via phospholipase
A2 (Juan, 1977). Furthermore, in the blister base preparation, pain
induced by bradykinin is prone to tachyphylaxis (Keele and Armstrong,
1964), whereas no tachyphylaxis occurs in the hand vein following
exposure to 5-HT (Sicuteri et al., 1965) or when bradykinin is injected
intra-arterially in dogs (Guzman et al., 1962).
These observations, together with the low levels of kinins found in
inflammatory exudates and the lack of correlation between pain severity
and kinin concentrations (Melmon et al., 1967) suggest that bradykinin
is not the sole mediator responsible for the pain associated with
inflammation, although it may well play a role.
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1.9.1.2 Bradykinin and nociceptive sensory nerves
It is clear from recordings of afferent activity from cutaneous sensory
receptors that bradykinin, nonselectively excites both nociceptors and
low-threshold slowly adapting mechanoreceptors when injected intra-
arterially (Fjallbrant & Iggo, 1961; Beck & Handwerker, 1974)
Variability in the reported potency of bradykinin on cutaneous C fibre
afferent units has also complicated analysis of its actions (Fjallbrant
& Iggo, 1961; Beck & Handwerker, 1974; Chahl & Iggo, 1977). Bradykinin
excites nociceptive sensory receptors present in visceral tissues
(Kumazawa & Mizumura, 1976; Haupt et al., 1983), skeletal muscle (Mense
& Schmidt, 1974; Franz 6c Mense, 1975; Kumazawa 6c Mizumura, 1976;
Kumazawa 6c Mizumura, 1977a) and joints (Kanaka et al. 1985). In all of
these tissues, tachyphlaxis of responses to bradykinin has been
reported. In contrast to the situation described in the skin, in muscle
and joint tissues bradykinin is reported to excite A-delta and C fibre
afferent units selectively without affecting those with fast conducting
axons (Mense, 1977; Kanaka et al., 1985). Bradykinin-induced
sensitization of A-delta and C fibre muscle nociceptors to mechanical
stimulation has also been demonstrated (Mense and Meyer, 1987).
The excitatory actions of bradykinin on nociceptors in all tissues are
found to be enhanced in the presence of other chemical mediators such as
5-HT (Mense, 1981) and prostaglandins (Chahl 6c Iggo, 1977; Mense, 1981).
Furthermore, bradykinin-induced activation of muscle (Mense, 1982) or
testicular (Kumazawa 6e Mizumura, 1980b) nociceptors is reduced following
administration of aspirin or indomethacin respectively. These results
provide evidence to suggest that the excitatory effects of bradykinin
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are at least partially dependent on the actions of other substances on
nociceptive sensory receptors.
Clues to the mechanisms behind the excitatory effects of bradykinin on
nociceptive nerve terminals are supplied by studies examining the
membrane permeabilty changes evoked by bradykinin in the cell bodies of
sensory neurones (Baccaglini & Hogan, 1983; Higashi et al., 1982;
Lindsay & Rang, 1987; Weinreich, 1986). In dissociated dorsal root
ganglion cells from adult rats, bradykinin produces a long-lasting (1-4
minutes) inward current associated with increased conductance, and a
second inward current, at depolarized membrane potentials associated
with inhibition of a voltage sensitive K+ current (Rang & Lindsay,
1987). A similar effect of bradykinin is seen in a subpopulation of C-
type nodose ganglion cells in the rabbit where inhibition of a slow
spike after-hyperpolarization is produced via blockade of a Ca^+-
dependent K+ conductance (Weinreich 1986).
Bradykinin is known to produce effects in many tissues via the
activation of second messenger systems (Miller, 1987), and recently,
bradykinin has been shown to increase production of inositol 1,4,5-
triphosphate and diacylglycerol in neonatal rat sensory neurones in
culture (Burgess et al., 1987). The use of phorbol esters to mimic the
effects of diacylglycerol depolarizes and increases membrane
permeability of sensory neurones in vitro (Lindsay & Rang, 1987;
Burgess et al. 1989). Furthermore, the effects of bradykinin or phorbol
dibutyrate are blocked by the protein kinase C inhibitor staurosporine.
Densensitization to phorbol dibutyrate abolishes the response to
bradykinin, suggesting a common mechanism of action involving protein
kinase C (Bettaney et al., 1988b). Similar depolarizing effects of
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bradykinin observed in mouse neuroblastoma x rat glioma cell hybrids are
produced via the inhibition of a voltage-dependent K+ current (Brown &
Higashida, 1988a). This response also appears to be mediated via
activation of protein kinase C, as it is closely reproduced by
application of phorbol esters (Brown & Higashida, 1988b). Finally, using
the isolated neonatal spinal cord and tail, Dray et al. (1988) have
demonstrated that bradykinin and phorbol esters stimulate capsaicin
sensitive C fibres by a mechanism involving protein kinase C, suggesting
that the effects observed on sensory neurone somata also operate at the
peripheral terminals of these cells.
1.9.1.3 Receptors for bradykinin
The varied actions of bradykinin in different tissues are mediated
through at least two types of bradykinin receptor which have been named
B1 and B2 receptors (Regoli & Barabe, 1980). This classification was
based on order of agonist potency and on the effects of specific B1
receptor antagonists (Regoli & Barabe, 1980). Original studies were
carried out using various smooth muscle preparations where B1 receptors
are present in rabbit aorta (Regoli et al., 1977) and rabbit mesenteric
veins (Regoli et al., 1978), and B2 receptors are present in rabbit
jugular vein (Regoli et al., 1978), rat uterus (Barabe et al., 1977),
cat ileum (Barabe et al., 1977) and several other tissues. The B1
receptor is particularly interesting as it has been found to be
synthesized de novo in the mesenteric vein, aorta and urinary bladder
during in vitro incubation and during inflammation (Regoli et al., 1978;
Marceau et al., 1980). The development of B2 receptor antagonists by
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Vavrek & Stewart (1985) has been followed by the description of a
complex series of B2 receptor subtypes in a range of tissues (Rifo et
al., 1987; Steranka et al., 1988).
Evidence is accumulating that the effects of bradykinn on nociceptive
sensory nerves are dependent on activation of a B2 receptor. Pain evoked
by application of bradykinin to the blister in man has recently been
shown to be blocked by a B2 receptor antagonist, while a selective B1
receptor agonist had no algesic effect (Whalley et al., 1987).
Bradykinin-induced excitation of canine, testicular polymodal
nociceptors in vitro has recently been found to be B2 receptor mediated
(Mizumura et al., 1990).
In recent studies demonstration of B2 receptor mediated effects on
isolated cells has also been achieved. In C-type rabbit nodose ganglion
cells bradykinin-induced inhibition of the slow after hyperpolarization
has been demonstrated to be B2 receptor mediated (Rang & Heyman, 1990),
and inhibition of the voltage-dependent K+ conductance in mouse
neuroblastoma x neuroma hybrid cells is also mediated through a B2
receptor (Brown & Higashida, 1988a).
1.9.2. 5-Hydroxytryptamine
5-Hydroxtryptamine (5-HT, serotonin) is synthesized in a variety of
tissues, including enterochromaffin cells, neurones and rat mast cells,
via the hydroxylation and deamination of tryptophan. Blood platelets,
although not possessing the capacity for synthesis, actively store 5-HT.
Although circulating levels of free 5-HT in plasma are low (Garattini &
Valzelli, 1965; Franzen & Eysell, 1969), platelets may release their
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contents during immune activation or as a result of tissue damage. 5-HT
may also be released from mast cells by agents such as substance P
(Johnson & Erdos, 1973). Released 5-HT is either taken up again by
platelets, or else metabolized by the enzyme monoamine oxidase.
5-HT is highly vasoactive and causes smooth muscle contraction and
increased capillary, permeabilty (Levy, 1974; Douglas, 1975). Since 5-HT
is not found in mast cells and basophils in man, it has not generally
been considered to be an important mediator of inflammatory reactions in
humans. However, recent investigations have revealed that platelets play
an active part in the progression of a number of inflammatory diseases
(see Page, 1988), suggesting a role for 5-HT in man.
1.9.2.1 5-HT and pain
The algogenic properties of 5-HT were established by Keele and Armstrong
(1964) who demonstrated its ability to induce pain when applied to a
blister base in humans. When injected intra-arterially, 5-HT was also
shown to induce psudoaffective response in dogs (Guzman et al., 1962).
Sicuteri (1965) demonstrated the sensitizing properties of 5-HT on the
pain-inducing effects of bradykinin in man, and later proposed a role
for the amine in the pain of thrombo-embolic disorders and migraine (see
Sicuteri, 1968). Sensitization to bradykinin-induced pseudoaffective
response in animals has also been observed (Ferreira, 1973; Nakano &
Tiara, 1976).
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1.9.2.2 5-HT and nociceptive sensory nerves
Excitation of C fibre visceral afferents following the injection of 5-HT
into the circulatory supply of the visceral organs was shown by Douglas
& Ritchie (1957a). In further experiments, Douglas & Ritchie (1957b)
found that 5-HT was a very potent excitant of cutaneous receptors. This
finding was supported in single unit studies by Fjallbrant & Iggo
(1961), who demonstrated that both high threshold receptors with non¬
myelinated afferents and low-threshold slowly adapting mechnoreceptors
with myelinated axons were excited by 5-HT. This non-specificity of
action on cutaneous receptors was also demonstrated by Beck & Handwerker
(1974).
In contrast to its non-selective effects in skin, 5-HT excites C and
A-delta receptors from cat muscle with no effect on those receptors with
faster conducting afferents (Mense & Schmidt, 1974; Fock & Mense, 1976;
Mense, 1977;). In cat muscle, 5-HT has also been shown to sensitize C
fibre receptors to the excitatory effects of bradykinin (Mense, 1981).
In experiments using sections of rabbit vagus nerve in vitro. Neto
(1978) demonstrated that 5-HT induced a depolarization of non-myelinated
C fibres. Furthermore, the cell bodies of vagal primary afferents in the
nodose ganglion are excited and produce action potentials in response to
application of 5-HT (Sampson & Jaffe, 1974; De Groat & Simonds, 1976). A
direct depolarizing action on these neurones has been demonstrated by
several groups of workers (Higashi, 1977; 1980; Simmonds & De Groat,
1980; Wallis et al., 1982). The majority of C type nodose ganglion
neurones responded to 5-HT with a rapid depolarization, due mainly to
simultaneous increases in Na+ and K+ conductances, followed by a
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hyperpolarization brought about by an increase of K+ conductance
triggered by a voltage-dependent influx of Ca^+ (Higashi & Nishi, 1982).
This after-hyperpolarization was occasionally followed by a long-lasting
depolarization associated with a small, but sustained, increase in Na+
conductance. Appearance of the initial depolarization is dependent on
the method of application of 5-HT, and is susceptible to tachyphylaxis
(Higashi, 1977; Wallis & Dun, 1988). Similar responses to application of
5-HT have been demonstrated in bull frog type C dorsal root ganglion
cells. (Morita & Katayama, 1986). In these cells, a rapid depolarization
was due to an increase in membrane conductance to Na+ and K+, a
hyperpolarization was caused by activation of a Ca^+-dependent K+
conductance, and a depolarization of delayed onset was due to the
inactivation of a K+ conductance.
5-HT has recently been shown to increase the excitability of a sub-
population of C-type nodose ganglion cells from the rabbit via the
blockade of a Ca^*-dependent K+ conductance (Christian et al.t 1989).
1.9.2.3 Receptors for 5-HT
5-HT has a vast range of reported actions, including effects on
vertebrate smooth muscle, neuronal cell bodies, dendrites, nerve fibres,
terminals, blood platelets and glandular function. In the 1950s, Gaddum
& Piccarelli (1957) defined two types of 5-HT receptor in smooth muscle,
the M and the D receptors. Responses mediated by the M receptor could be
blocked by morphine, while those mediated by D receptor could be blocked
by dibenzyline (phenoxybenzamine) and by LSD (d-lysergic acid
diethylamide). It has since been found that the functional antagonism
30
produced by morphine and phenoxybenzamine probably do not occur at the
level of the 5-HT receptor, while that of LSD does (Paton, 1957;
Kosterlitz & Robinson, 1958).
More recently, receptor binding studies using selective agonists and
antagonists have defined three major types of serotonin receptors (see
Bradley et al., 1986; Kilpatrick et al., 1987; Peroutka, 1988).
According to classification based on functional criteria (Bradley et
al., 1986), the three receptor types have been designated 5-HTi-like, 5-
HT2 and 5-HT3. The 5-HT3 receptor has been further subdivided into 5-
HTlA> 5-HT^g, 5-HT^c an<l 5-HT^d mainly on the basis of data from binding
studies, although some functional correlates have also been proposed
(see Peroutka, 1988).
The excitatory action of 5-HT on primary afferent neurones has
invariably been found to be mediated through the 5-HT3 receptor subtype
as defined by Bradley et al. (1986). Thus, 5-HT-induced excitation or
depolarization of sensory neurones can be mimicked by the 5-HT3 receptor
agonist 2-methyl 5-HT, are potently antagonized by selective 5-HT3
receptor antagonists such as MDL 72222 or ICS 205-930, and is not
inhibited by ketanserin which selectively blocks 5-HT2 receptors or
methysergide and methiothepin which block both 5-HT^ and 5-HT2
receptors.
In the blister base preparation, 5-HT-induced pain is mimicked by the
5-HT3 receptor agonists phenyl biguanide (Fastier et al., 1959) or 2-
methyl 5-HT, is potently and competitively blocked by ICS 205-930 and
unaffected by methysergide (Donatsch et al., 1984b; Richardson et al.,
1985).
The rapid depolarization induced by 5-HT in rabbit isolated nodose
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ganglion cells is mimicked by phenyl biguanide (Wallis et al., 1982),
and is competitively blocked by MDL 72222 or ICS 205-930 (Azami et al.,
1985; Round and Wallis, 1985; Round and Wallis, 1986; Christian et al.,
1989). This effect of 5-HT cannot be blocked by methysergide (Higashi
and Nishi, 1982). Similar depolariztion responses to 5-HT have been
reported for the rabbit or rat isolated vagus nerve where the response
is mimicked by phenylbiguanide (Ireland and Tyers, 1987), and can be
blocked by 5-HT3 antagonists (Donatsch et al., 1984a; Richardson et al.,
1985).
Several reports provide evidence to suggest that 5-HT receptors other
than 5-HT3 are responsible for some of its actions on sensory neurones.
5-HT-induced hyperpolarization of the rabbit isolated vagus nerve occurs
as a secondary event to the initial depolarization and as such is
blocked by 5-HT3 antagonists (Ireland, 1987). However, the existence of
independent mechanisms mediating hyperpolarization was demonstrated in
bullfrog type C dorsal root ganglion cells, where methysergide
reversibly blocked the hyperpolarization but had no significant effect
on initial depolarization (Morita and Katayama, 1986). The delayed
onset depolarization induced by 5-HT in bullfrog dorsal root ganglion
cells was blocked by methysergide in type A neurones (Morita and
Katayama, 1986). Finally, in rabbit nodose ganglion cells 5-HT-induced
inhibition of a Ca2+-depedent K+ conductance is resistant to ICS 205-930
but is antagonised by methysergide (Christian et al., 1989).
32
1.9.3. Prostanoids
The prostanoids are a group of polyunsaturated, 20 carbon chain fatty
acids. They are synthesized via the metabolism of polyunsaturated fatty
acid precursors (Van Dorp et al.1964; Bergstom et al., 1964) by the
enzyme fatty acid cyclooxygenase (Hamberg et al., 1974). Cyclooxygenase
is present in most animal cells (Christ & Van Dorp, 1972) where it has
been shown to be associated with the microsomal cell fraction (Nugteren
et al., 1966; Samuelsson 1967; Miyamoto et al., 1974; Rollins & Smith,
1980). The preferred substrate for this enzyme is arachidonic acid, but
dihomo-r-linoleic acid and eicosapentanoic acid can also be converted to
form prostanoid products (Van Dorp, 1967).
Free arachadonic acid can be metabolized to form the unstable
prostaglandin endoperoxides which are in turn enzymatically converted to
form PGE2, PGF2a, PGD2, PGI2 (Moncada et al., 1976), or TXA2 (Hamberg et
al., 1975) (fig 1.2). The metabolite formed varies from cell to cell as
illustrated by the observations that in blood platelets arachidonic
acid is converted to TXA2, whereas vascular enothelium produces mainly
PGI2 (see Samuelsson et al., 1978)
Cyclooxygenase activity is increased by the application of mechanical
or chemical stimuli (Ferreirra & Vane, 1967) or by immunological
challenge (Piper & Vane, 1969). Willis (1978) was the first to discover
prostanoid activity in inflammatory exudate, and subsequently PGE2,
PGF2<*. PGD2, PGI2 and TXA2 (the latter two being measured as their
stable metabolites 6-keto-PGF]^a and TXB2 respectively) were detected in
inflamed tissues both from animals and man (see Higgs et al., 1984).





Fig. 1.2 Schematic diagram showing the major prostanoid products of
arachidonic acid metabolism. Enzymically controlled reactions are shown
as solid line arrows.
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of different cell types including platelets (Willis, 1978), mast cells
(Becker & Henson, 1973; Roberts et al., 1978), neutrophils (Goldstein -
et al., 1977; Zurier, 1976), mononuclear phagocytes (Davies & Allison,
1976) and macrophages (Myatt et al., 1975; Gordon et al. 1976; Humes et
al., 1977). Prostanoids are also produced by inflamed tissues ex vivo
such as cultured human synovium, which produces PGE2 (Robinson et al.,
1975), PGI2 and TXA2 (Salmon et al., 1983).
The four cardinal signs of inflammation are all induced by metabolites
of arachidonic acid. This is due in part to their ability to dilate
blood vessels and increase vascular permeability (Lewis et al. 1977).
PGeI an<l PGI2 produce local vasodilatation and increase vascular
permeability when injected into the skin of animals (Horton, 1963;
Crunkhorn & Willis, 1971a; Kaley & Weiner, 1971 ; Peck & Williams, 1978)
and man (Crunkhorn & Wilis, 1971; Kuehl, 1977). Arachidonic acid
derivatives are poor at eliciting plasma exudation when injected alone
into guinea-pig (Horton 1963, Williams & Morley 1973; Williams, 1976) or
rabbit (Williams 1976) skin, but they do potentiate plasma exudation
produced by other mediators (Moncada et al., 1973; Williams & Morely,
1973; Williams, 1976). PGE2, PGF2C1 and PGI2 also potentiate irritant-
induced oedema in animals (Higgs et al, 1978; Murota et al., 1979;
Williams & Morely, 1973; Williams & Peck 1977).
1.9.3.1 Prostanoids and pain
Horton (1963) found that PGE^ did not produce pain when applied to a
blister base, and similarly Crunkhorn & Willis (1971b) demonstrated that
intradermal injection of microgram doses of the E-series prostanoids
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produced local oedema and erythema but no discomfort or pain. However,
the oedematous area caused by the injection of PGE^ was shown by Solomom
et al. (1968) and Juhlin & Michaelsson (1969) to be hypersensitive to
touch. Larger doses of E-type prostanoids can cause pain when infused
into the human arm vein (Collier et al., 1972), or headache when
injected intravenously (Bergstrom et al., 1959). Intra-articular
injection of PGE^, PGE2 or, to a lesser extent, PGF2Q: induced an
incapacitation in the dog knee joint (Rosenthal et al. 1972), and when
injected intra-peritoneally in mice, PGE^ and PGE2 induced a writhing
response (Collier & Schneider, 1972).
A clear dissociation between the pain-producing effects of PGEi when
administered at high doses and the hyperalgesic effects of low doses was
demonstrated in a series of experiments conducted by Ferreira (1972).
Bolus intradermal injections of a high dose of PGE^ in man produced an
intense and prolonged pain. This was in contrast to the intense, short
lived pain induced by intradermal acetylcholine or bradykinin. Of
particular interest was the observation that intradermal infusions of
lower doses of bradykinin produced only mild pain, while the concurrent
infusion of low dose PGE^ with bradykinin induced strong pain.
The potentiating effects of PGE^ and PGE2 have been reported in a
number of different models including psuedoaffective response induced by
injection of bradykinin into the spleen of the dog or cat (Ferreira,
1972, Tyers & Haywood, 1979), and rat paw hyperalgesia (Willis &
Cornelson, 1972; Ferreira et al., 1978; Tyers & Haywood, 1979).
Comparison of PGE2- and PGI2-induced effects has shown that the two
prostanoids produce similar hyperalgesic effects in the dog knee joint
and in the rat paw (Ferreira et al., 1978). The reflex fall in blood
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pressure produced by intra-arterial injection of bradykinin in the
rabbit ear was used by Juan (1979) to examine the potentiating effects
of PGEi, PGE2 and PGI2. In this model PGE^ and PGI2 were equipotent,
while much larger doses of PGE2 were required to produce an effect.
In a series of experiments in which nociceptive thresholds in rats
were measured, Ferreira and his colleagues (Ferreira & Nakamura, 1979a;
Ferreira & Lorenzetti, 1981) attempted to analyse the biochemical events
causing prostanoid-induced hyperalgesia. Hyperalgesia was induced by
subplantar injections of PGE2, PGI2, Ca^"1", or dibutyryl cAMP. These
hyperalgesic effects were potentiated in the presence of
phosphodiesterase inhibitors and reversal of PGE2-induced hyperalgesia
was produced by Ca^+ channel blockers. These results were interpreted to
to support the idea that prostanoids induce hyperalgesia via a
cAMP/Ca2+-dependent mechanism (Ferrreira 6c Nakamura, 1979).
Evidence supporting a role for the prostanoids in inflammatory pain
was provided by Vane and his colleagues (Vane, 1971; Ferreira et al.,
1971) and Smith 6c Willis (1971) who demonstrated in several systems in
vitro that non-steroidal anti-inflammatory drugs (NSAIDS) inhibit
arachidonic acid metabolism and thus prostanoid production. By reducing
levels of endogenous prostanoids, NSAIDS are effective anlgesics only in
the pain associated with inflammation where prostanoid levels are
elevated.
1.9.3.2 Prostanoids and nociceptive sensory nerves
The potentiating effects of prostanoids on the reponses of nociceptive
sensory receptors to bradykinin has been demonstrated in skin for PGE^
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and PGE2 (Handwerker, 1976; Chahl & Iggo, 1977), in cat muscle for PGE2
(Mense, 1981) in canine testicular tissue for PGE2 and PGI2 (Kumazawa
et al., 1987) and in cat knee joint for PGE2 (Schaible & Schmidt,
1988b).
PGE^- and PGE2-induced sensitization of cutaneous sensory receptors to
mechanical stimuli has been shown for C polymodal nociceptors (Martin et
al., 1987) and A-delta mechanoreceptors (Petromichelakis & Rood, 1982;
Martin et al., 1987). PGE2*induced sensitization to movement of A-delta
mechanoreceptors, and to a lesser extent C fibre mechanoreceptors, has
also been shown in the cat knee joint (Schaible 6c Schmidt, 1988). In
addition to sensitization, excitatory effects of the prostanoids have
been reported for PGEi in rat skin (Chahl and Iggo, 1977) and for PGE2
in the cat knee joint (Schaible 6e Schmidt, 1988). In these studies,
prostanoid-induced excitation was generally found to be longer lasting
than that produced by other excitants such as bradykinin.
Potentiating effects of prostanoids on responses of sensory receptors
and facilitatory effects on primary afferent neurotransmision have been
demonstrated using the neonatal rat in vitro spinal cord-tail
preparation (Yanagisawa et al., 1986). PGE^ or PGE2 applied to the tail
markedly potentiated capsaicin-induced reflex ventral root
depolarization. This effect was not obtained with PGD2 or PGF2<*. In
addition, application of PGE^ or PGE2 to the spinal cord increased the
amplitude and duration of capsaicin-induced dorsal root depolarization.
Electrophysiological studies on rat sensory neurones in culture have
shown that application of PGE2 causes these cells to produce action
potentials (Baccaglini & Hogan, 1983). In rabbit C-type nodose ganglion
neurones PGE^, PGE2, PGD2, but not PGF2a inhibit a slow after-
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hyperpolarization via blockade of a Ca^+-dependent K+ conductance
(Fowler et al., 1985a; Fowler et al., 1985b; Weinreich & Wonderlin,
1987). This effect of the prostanoids on C-type nodose ganglion cells
was mimicked by forskolin suggesting that inhibition of the Ca^+-
dependent K+ conductance is mediated via cAMP (Weinreich & Wonderlin,
1987).
1.9.3.3 Prostanoid receptors
A working classification of receptors has recently been developed based
mainly on functional criteria (Kennedy et al., 1982; Coleman et al.,
1984; Jones et al., 1984; Coleman et al., 1985). Within the
classification there are receptors which are specific for each of the
five naturally occuring prostanoids: PGD2; PGE2; PGF2Ct, PGI2 and TXA2.
Coleman et al. (1984) have developed a system of nonmenclature in which
each of the five basic prostanoid receptors are designated DP, EP, FP,
IP and TP where the letter 'P' stands for prostanoid and the preceding
letters indicate the natural prostanoid to which that particular
receptor is most sensitive.
Despite the proposed existence of specific receptors for each
prostanoid it is important to note that a high degree of cross
reactivity exits beween receptor types. PGF2C1, for example, causes
contraction of guinea-pig trachael smooth muscle not through an action
at FP receptors, but through interaction with EP- and TP-receptors
(Coleman & Kennedy, 1985).
Further subdivision of the five basic prostanoid receptors has also
been suggested based on various lines of evidence. EP receptors are
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comprized of at least three subtypes (Coleman and Kennedy, 1985; coleman
et al., 1987), while DP- and TP-receptors may each be comprized of two
subtypes (Jones et al., 1984). The existence of such receptor subtypes
is indicated by subscript numbers such that EP-receptors are termed EP^-
, EP2 or EP3-receptors.
As outlined above, the receptor classification was developed through
studies on the actions of prostanoids on smooth muscle and blood
platelets (Coleman et al., 1987). On smooth muscle prostanoids may cause
either contraction via EP^-, EP3-, FP- or TP-receptors, or relaxation
via DP-, EP2- or IP-receptors. On blood platelets they may cause
aggregation via TP-receptors or disaggregation DP- or IP-receptors.
Prostanoid effects on other tissues include inhibition of gastric acid
secretion via EP-receptors and luteolysis in a range of animal species
via FP-receptors (Coleman et al., 1985).
Although the link between prostanoids and hyperalgesia is well
established, little work has been carried out to investigate the effects
of more selective prostanoid analogues. The high potency of PGE^ and
PGE2 supports the involvement of EP-receptors, while the reports of high
potency of PGI2 suggest that IP-receptors may also be involved.
1.10 Adjuvant arthritis as a model for the study of the pain associated
with chronic inflammation
1.10.1 Pathology and aetiology
The first report on the appearance of a polyarthritis in rats injected
with spleen extracts emulsified in Freunds complete adjuvant (heat
killedMycobacterium| was made by Stoerk et al. (1954). Pearson (1956)
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extended these observations, and demonstrated that Freunds complete
adjuvant alone was capable of inducing polyarthritis. Adjuvant
polyarthritis has been reviewed by several authors in the past (Swingle,
1974; Rosenthale, 1974; Billingham & Davies, 1979; Rainsford, 1982;
Billingham, 1983).
As originally described by Pearson (1956), adjuvant-induced
polyarthritis is a whole animal disease in which inflammation of
multiple joints develops over a period of about ten days following
injection of adjuvant into the base of the tail. The most severe
inflammation occurs in the distal joints of the hindlimbs where there is
a progressive destruction of bone, damage to tendons, and a loss of
cartilage following prolonged cellular infiltration of the synovium.
Additional observations on the disease include an increase in the size
of the lymph nodes, a marked impairment of liver metabolism and a series
of serum and tissue chemical changes (see Rainsford, 1982).
The inhibitory effects of steroids on adjuvant arthritis were first
described by Pearson & Wood (1959), and the model was developed as a
screening test for anti-arthritic drugs by Newbold (1963). The
shortcomings of studying acute models of inflammation in the testing of
drugs to treat a chronic condition was pointed out at this time
(Newbold, 1963).
When suspended in vegetable or mineral oils, many species of dead
Mycobacterium are capable of inducing adjuvant arthritis in the rat (see
Billingham, 1983). Induction of polyarthritis has also been achieved
using other species of bacteria (Flax & Waxman, 1963; Paronetto, 1970),
water soluble peptidoglycans (Kohashi et al, 1976; 1977) and muramyl
dipeptide derived from Mycobacterium (Kohashi et al. , 1980).
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Many different factors are important for the successful and consistent
induction of adjuvant polyarthritis, including the concentration of
Mycobacterium and its degree of dispersion (Ward & Jones, 1962; Newbold,
1963), the site of adjuvant injection (Winder et al., 1969; Perper et
al., 1971; Koga et al., 1976) and the strain of rat used (Freeman &
West, 1972; Eisen et al., 1973; Zideck & Perlik, 1971).
The development of adjuvant arthritis was originally considered to be
dependent on the involvement of immune mechanisms. Evidence from a
number of workers favoured a delayed-type T-cell mediated
hypersensitivity response to a disseminated antigen (Pearson & Wood,
1959; Waksman et al., 1960; Flax & Waxman, 1963; Waxman & Wennerstein,
1963; Gery & Waksman, 1967). However, immunity to myobacterial
components does not appear to be essential for disease expression as a
non-immunogenic muramyl dipeptide can induce adjuvant polyarthritis
(Kohashi et al., 1980). Furthermore, another non-immunogenic, low
molecular weight material, an interferon inducer (CP 20961) is capable
of initiating an arthritis similar to classical polyarthritis (Chang et
al., 1980). Immunity to the inducing agent, either humoral or cell
mediated, has been shown to have an exacerbatory influence rather than
an initiating role in the development of adjuvant arthritis (Mackenzie
et al., 1978; Smith et al., 1982). Dissemination of the injected
material to various sites, including synovial membranes (Vernon-Roberts
et al., 1976), would determine the site of activity with T-cell
antibody, but this appears to be a separate event to that causing the
degradative bone changes seen in adjuvant arthritis (see Billingham,
1983).
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1.10.2 Studies in the pain associated with chronic inflammation
A large number of researchers have found that the development of
adjuvant arthritis is associated with the a measurable hyperalgesia. A
wide variety of assessment techniques have been used, including the
Randall-Selitto test (Kayser & Guilbaud, 1981; Kayser & Guilbaud, 1983;
Hara et al. 1984; Butler et al., 1985; Calvino & LeBars, 1986; Calvino
et al., 1987), tail-flick test (Colpaert, 1979; Yonehara et al., 1983),
hot-plate test (Hara et al., 1984), rotarod grip strength (Perrine &
Takesue, 1968), squeezing with forceps (Hirose & Jyoyama, 1971), foot-
bend procedure (Kuzuna & Kawai, 1975; Winter et al., 1979; Capetola et
al., 1980; Calvino et al., 1987; Calvino & LeBars, 1988) and
transcutaneous electrical stimulation (Oliveras et al., 1979; Okuyama &
Aihara, 1984).
It has been suggested by Colpaert and his colleagues (see Colpaert,
1987) that the tests mentioned above represent meaurements of
superimposed acute pain rather than chronic pain itself, and a number of
investigations have been undertaken to validate adjuvant arthritis as a
model of chronic pain.
Several approaches have been used in an attempt to relate behaviour to
the presence of chronic pain. It has been shown that arthritic rats
preferentially consume drinking water containing analgesic drugs
(Colpaert et al., 1980), display disturbances in food intake (Colpaert
et al, 1982; Colpaert & Van Den Hoogen, 1983; Calvino et al., 1987),
show signs of irritability (Procacci et al., 1979; Reuler et al., 1980;
Colpaert et al. 1982) and hyperventilate (Colpaert & Van Den Hoogen,
1983) . Increases in breathing follow the same time course as impaired
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weight control and paw swelling and are reduced by administration of
opioids or aspirin-like drugs (Colpaert & Van Den Hoogen, 1983; Colpaert
et al., 1987). Other behavioural parameters that have been used as
representative measures of chronic pain are marked decreases in
locomotion and increases in scratching behaviour (De Castro Costa et
al., 1981; Calvino et al., 1987). Decreased locomotion is responsive to
aspirin-like drugs (Larsen & Arnt, 1985), and increased scratching
behaviour can be reduced by morphine or aspirin-like drugs (De Castro
Costa et al., 1987).
1.10.3 Nociceptor characteristics in adjuvant polyarthritis
The first studies carried out to determine the changes occurring in
nociceptive systems occuring as a result of adjuvant arthritis were
directed towards the central nervous system. These showed that at
various levels of the sensory pathway many neurones had an increased
resposiveness to peripheral stimuli. Neurones from spinal dorsal horn
(Menetrey & Besson , 1982), thalamus (Gautron & Guilbaud, 1982; Kayser &
Guilbaud, 1984) and cortex (Lamour et al., 1983) which normally only
respond to intense noxious stimuli have been shown to respond to mild
mechanical stimuli in arthritic rats. Pressure stimuli in the ankle
joint region of a normal rat induces responses in spinal dorsal horn,
thalamic or cortical neurones which can be activated by gentle cutaneous
mechanical stimuli. In contrast to the situation in normal rats light
pressure stimuli on the ankle joint of an arthritic rat evokes vigorous
and sustained discharge in neurones of the superficial dorsal horn, an
area which contains large numbers of nociceptor-specific neurones
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(Menetrey & Besson, 1982).
It has been suggested that the changes described above could be
related to alterations in the processing of nociceptive information in
the central nervous system occurring as a result of an elevated
peripheral input (Menetrey et al. 1988). However, increased
responsiveness to stimuli given in the periphery may be due to
alterations in sensory receptor responsiveness. The possible involvement
of peripheral nociceptive sensory elements in these effects has been
investigated by Guilbaud and colleagues.
Guilbaud et al. (1985) examined the characteristics of nociceptors
from the tibiotarsal (ankle) joints of rats with established adjuvant-
induced polyarthritis. High-threshold mechanoreceptors with C fibre
afferents were found to have lower mechanical thresholds in arthritic
joints than those in normal joints. High levels of ongoing resting
discharge in these receptors was also a characteristic of arthritic
joints. Large numbers of receptive fields each corresponding to a single
afferent unit could be found and activated by mechanical probing, this
being in contrast to the situation in normal joints where receptive
fields were sparse, and could be found only with great difficulty
applying strong pressure stimuli. The sizes of individual receptive
fields was no different in normal and arthritic joints.
Small movements of the ankle joint evoked a discharge from receptors
in arthritic rats, whereas similar manipulations in normals were
ineffective. Responsiveness of receptors to thermal stimuli in inflamed
joints but not in normals provided evidence of further changes in
receptor characteristics.
Histological studies of the nerve supply to the ankle revealed no
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difference in number or size of axons between normal and arthritic rats.
Any changes in sensitivity of the ankle joint to mechanical stimuli are
not therefore due to change in the total number of afferent fibres
(Guilbaud et al., 1985).
1.10.3.1 Inflammatory mediator involvement
From the evidence discussed in the previous introductory sections
relating to the effects of inflammatory mediators on nociceptive sensory
receptors, the next question to be answered is which of these mediators
are responsible for the sensory changes seen in adjuvant-induced
polyarthritis. In original studies it was demonstrated that intravenous
injection of lysine acetylsalicylate (1-AS) reduced the responsiveness
of ventro-basal thalamic neurones in arthritic rats (Guilbaud et al.,
1982). A peripheral locus of action of this effect was later shown by
Guilbaud & Iggo (1985). Following intravenous injection or topical
application of 1-AS in arthritic rats the responsiveness of articular
high threshold receptors to controlled mechanical stimuli was reduced,
as was any ongoing background discharge. It was concluded from these
results that in arthritic joints the high level of excitability of these
receptors could at least partly be attributed to the actions of
arachidonic acid metabolites of the cyclooxygenase pathway.
1.11 An outline for the present investigation
It is clear that the pain and hyperalgesia of chronic inflammation
results primarily from the actions of chemical mediators on sensory
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receptors in the periphery. Recent investigations into chronic
inflammatory pain have been dominated by the use of the adjuvant
polyarthritic rat. The demonstration that administration of 1-AS reduces
the enhanced sensitivity of articular sensory receptors seen in
arthritic rats suggests that prostanoid products of arachadonic acid
metabolism make a major contribution to the production of this
phenomenon.Among the many putative inflammatory mediators it is not only
the prostanoids that are capable of sensitizing or exciting sensory
receptors with fine afferent fibres. Bradykinin and 5-HT are the most
likely additional candidates for involvement in inflammatory pain.
With these points in mind the aim of the present investigation was to
assess the actions of cetain prostanoids, bradykinin and 5-HT on
articular sensory receptors in normal joints and in those affected by a
localized adjuvant-induced arthritis. Furthermore, where possible the
pharmacological receptors mediating the effects of endogenously produced
and exogenously administered chemicals were to be characterized using







2.1 Induction of localized adjuvant-induced arthritis
Localized adjuvant arthritis was induced in male Wistar rats (200 -
250 g) by the local subdermal injection of Freunds complete adjuvant
around the tibio-tarsal joint of the left hindlimb. Following induction
of anaesthesia using ether or halothane, the left hindlimb was swabbed
with alcohol, and three subdermal injections of a total volume of 0.15
ml Freunds complete adjuvant (1.0 mgml'l heat killed myobacterium
tuberculosis suspended in paraffin oil, Sigma) were made into the
tissues overlying the left ankle joint. Following recovery, the animals
were housed in cages containing up to five rats. The development of
inflammation was followed for up to 35 days during which period the
animals were used for behavioural or neurophysiological experiments.
2.2 Assessment of the arthritic lesion
The development of the arthritic lesion was assessed using two groups of
tests:
(a) Animals used in electrophysiological studies. In the case of these
animals the general condition and activity of the rats was monitored on
a daily basis by observing their behaviour in the cage up to the point
at which they were used for an experiment. Routine measurements of joint
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circumference were made using a measuring tape. Weight gain was
monitored regularly along with visual assessment of secondary
inflammatory lesion in the hind limbs, tail, snout and ears. Behaviour
was assessed in relation to motility, scratching behaviour and stress
during handling (see Colpaert, 1987).
(b) Animals used in behavioural studies. These studies were carried out
to assess behavioural changes associated with the development of
arthritis. Rats were subjected to the following series of observational
and sensory tests involving the quantitative measurement of standing and
walking weight load (Coderre & Wall, 1987), foot withdrawal to pressure
(Randall & Selitto, 1957), foot withdrawal to heat, response to foot
manipulation (Kuzuna & Kawai, 1975) and grading of foot placing reflexes
(Coderre & Wall, 1987).
1. Standing weight load. Rats were placed in a 30 cm x 30 cm x 22 cm
clear perspex box and observed for a period of five minutes. A mirror
was set at an angle below the box to provide a clear view of the base of
the rat's feet. The amount of weight the rat placed on each hindpaw was
evaluated using the following scale:
0 - normal load bearing, paw placed firmly on the
surface of the perspex floor;
1 - slightly reduced load bearing, paw completely in
contact but without the toes being spread;
2 - moderately reduced load bearing, paw curled with
only some parts of the foot lightly touching the
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floor;
3 - severely reduced load bearing, paw lifted from
surface;
2. Walking weight load. Rats were placed in the box, as described
above, to assess any changes in gait or production of limp in the rats
hindpaws caused by the induction of arthritis. Animals were scored as
follows:
0 - normal gait;
1 - slight limp, over-flexion of the affected limb;
2 - moderate limp, paw briefly touches walking
surface;
3 - severe limp, three-legged gait.
3. Foot withdrawal to pressure. Rats were hand-held, and the paws of
the right and left hindlimbs were in turn placed under a metal bar which
was lowered mechanically on to the paw exerting an increasing pressure
(Ugo Basile, Comeria, VA, Italy), thus pushing the ventral aspect of the
paw on to small raised blunt point. The apparatus was calibrated in
grams of force. The force necessary to elicit a withdrawal response was
used as the endpoint for the test. Thresholds were based on the average
of two trials. A cut-off point of 500 g was used in all tests.
4. Foot withdrawal to heat. Rats were hand-held, their right and left
hindpaws being placed in turn over a small hole in the table surface
beneath which was a small projector bulb which acted as a radiant heat
source. The time taken for the rat to withdraw its paw was recorded.
Latencies were based on the average of two trials.
5. Paw withdrawal to mechanical indentation. Rats were hand-held while
resting on the bench and the withdrawal thresholds for both hindpaws
were determined. Mechanical indentation stimuli around the ankle joint
region were determined using calibrated von Frey hairs. Hairs were
calibrated to exert forces of 0.2 - 90 mN at the first sign of bending.
6. Foot manipulation. Rats were hand-held, and their feet were gently
flexed and extended over the normal working range of the ankle joint.
Responses were classified as either noxious or non-noxious based on the
presence or absence of vocalization or withdrawal when the paw was
manipulated.
7. Placing reflex. Rats held by hand in the air were moved towards the
edge of a table so that the dorsal surface of either the right or the
left hindpaw just touched the side of the table. The response was
classified as a placing reflex if the rat lifted its paw to place it on
the top surface of the table. Scores were based on the number of clear
reflexes observed out of five trials for each paw.
2.2.1 Statistical Assessment
Differences between groups were assessed using the Wilcoxon Mann-Whitney
test and the null hypothesis rejected if p < 0.05.
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2.3 Histological methods
Rats were anaesthetized with urethane (25% w/v, 0.6 ml/lOOg, i.p.), and
a midline incision was made in the abdomen. A cannula was carefully
inserted anterogradely into the abdominal aorta, and the abdominal vena
cava was cut to allow the escape of blood and fixative from the
hindquarters. Heparinized saline (500 Units/kg) was injected into the
animal prior to perfusion with formal saline (NaCl, 0.9 g; 40%
formaldehyde, 10 ml; distilled water, 90 ml) via the cannula in the
abdominal aorta.
The hindlimbs were removed and post-fixed in formal saline overnight
before being placed in a modification of Gooding and Stewart's (1932)
decalcifying medium (formic acid 15 ml, 40% formaldehyde 5 ml,
distilled water to 100 ml total volume) for two weeks. After
decalcification, the tissues were trimmed around the tibio-tarsal joint
and placed in 5% gelatin overnight at 37°C. Blocks were made in aqueous
10% gelatin which was allowed to set before being frozen in Arcton 12
(BOC) cooled with liquid nitrogen (~70°C). Sections of 20 um thickness
were cut from each joint at 100 pm intervals using a cryostat (SLEE).
The sections were mounted on glass slides, stained using haematoxylin
and eosin, and sealed under glass coverslips using DPX. Slides were
examined under a microscope, and the extent of joint pathology assessed.
The presence of bone erosion, inflammatory cell infiltration and tissue
fibrosis was determined for both injected and non-injected limbs.
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2.4 Determination of tissue prostanoid levels
Rats were sacrificed by i.v. administration of barbiturate anaesthetic
overdose (Euthetal) and the soft tissues surrounding the tibio-tarsal
joint removed as quickly as possible and placed in 10ml ethanol. The
tissues were stored in ethanol at -20°C for a period of 2 - 10 days at
which time the now dehydrated tissues were blotted dry and weighed. The
tissues were then homogenized with the ethanol in which they had been
placed using a Fisons glass homogenizer. Each homogenate was centrifuged
at 2500 x g for 10 minutes and the supernatant removed. The residue was
washed with 5 ml ethanol and centrifuged again, the washings being
removed and combined with the original supernatant. The ethanol was
evaporated to dryness on a rotary evaporator at 50°C, and the dry
extract dissolved in 10 ml distilled water. The acidity of the aqueous
solution was lowered to pH4 with 0.1 M HC1, and the prostaglandins
were extracted by shaking with ethyl acetate. The ethyl acetate was
separated from the aqueous solution using a glass separator. This
process was repeated with the remaining aqueous solution. The two ethyl
acetate extracts were combined and evaporated to dryness on a rotary
evaporator at 50°C. The dry residue was dissolved in 2 ml ethyl acetate,
and stored at -20°C.
The amounts of PGE2 and 6-keto-PGF^a present in each extract were
measured by radioimmunoassy, using antibodies whose cross reactivities
have been reported previously (Dighe et al., 1975; Poyser, 1980; Poyser
& Scott, 1980; Lytton & Poyser, 1982). The only significant cross-
reactivities are PGFia (100%) with the PGF2a antiserum, and PGE^
(66%), PGA2 (25.5%) and PGB2 (11.8%) with the PGE2 antiserum. The
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inter-assay and intra-assay coefficients of variation for the three
assays were all less than 10%. The limits of detection were PS PGE2
and 30 pg 6-keto-F2a per assay tube for the respective assays.
2.4.1 Statistical assessment
Differences between groups were analysed using the Students T-test due
to the small group numbers, and the null hypothesis rejected if p <
0.05.
2.5 Determination of plasma salicylate and paracetamol levels
Blood samples of 0.7 ml were taken at regular intervals using heparin
coated syringes, and placed in labelled eppendorf tubes. The plasma and
heamatocrit were separated by centifugation (Eppendorf 5414), the plasma
layer being pipetted off and frozen at -20°C.
Total plasma salicylate was determined using a colorimetric kit (Sigma
Diagnostics), and a colorimeter (Whatman DC 100). Determination was
dependent on the reaction of salicylate with Ferric ions (Salicylate
Colour Reagent, Catalogue No. 530-3) which produces a purple colour
measured at 450 nM. Results were compared with those for a Standard
Salicylate Solution (Catalogue No. 530-25) in order to determine levels
of total plasma salicylate.
Plasma levels of paracetamol and its sulphate, glucuronide, cysteine
and mercapturic acid conjugates were determined using high performance
liquid chromatography (Adriaenssens & Prescott, 1978). An Orlita pump
(Model AE 10-4) was used with a Waters model 440 U.V. absorbance
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detector (254 nm filter) and peak areas were measured with a Hewlett
Packard HP 3370A integrator. The columns were internally-po lished
stainless steel tubes 100 mm x 4.9 mm i.d. slurry packed with Hypersil-
ODS (Shandon Southern Products) and fitted with a septum injector. The
mobile phase was 0.1 M potassium dihydrogen phosphate, 98% formic acid
and isopropanol (100:0.1:1.7 v/v/v). Stock solutions of internal
standard/protein precipitant were prepared containing 360 ^g/ml of N-
propionyl-4-aminophenol in 6% aqueous perchloric acid and were stored
deep frozen prior to use. Aliquots of plasma were pipetted into glass
tubes which were then placed in a vortex mixer while an equal volume of
internal standard/perchloric acid solution was addded slowly. The tubes
were centrifuged and up to 5 pi of the clear supernatant injected
directly into the column. The assay was calibrated using plasma
standards containing paracetamol.
2.6 Electrophysiological experiments In vivo
Experiments were performed on male wistar rats (weight range: 200 - 350
g) •
2.6.1 Anaesthesia
Animals were anaesthetized by i.p. injection of urethane (ethyl
carbamate, 25% w/v in distilled water) 0.6 ml/100 g body weight.
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2.6.2 General
A midline incision was made in the ventral aspect of the neck, and a
tracheal cannula was inserted below the level of the larynx. The left
carotid artery was cannulated with a nylon catheter (OD 0.75 mm), and
arterial blood pressure monitored by connection of the catheter to a
pressure transducer (Bell and Howell, 4-442), and the signal
subsequently amplified and displayed on a chart recorder (Devices M4). A
cannula (OD 0.63 mm) was inserted into the right femoral artery for the
injection of drugs at the level of the iliac bifurcation of the
abdominal aorta. In experiments requiring intravenous administration of
substances, a further cannula (OD 0.75 mm) was inserted into the femoral
vein. Body temperature was monitored continuously, and maintained at 37
± 0.5°C by an electronic heating blanket (Harvard apparatus Ltd).
2.6.3 Dissection
The tibial nerve of the left hindlimb was exposed through a longitudinal
incision in the groin and medial aspect of the leg from the pelvis to
the sole of the foot. A free exposure of the nerve was obtained by
removing the semitendinosis, semimembranosis, biceps femoris and medial
gastrocnemius muscles. The tendons of gastrocnemius and flexor digitorum
longus were cut about 5 mm proximal to the calcaneum. The plantar nerves
were then exposed by careful incision and reflexion of the crural fascia
overlying the stumps of the Achilles tendon, and the primary articulo-
cutaneous ramus (PACR) (Guilbaud et al., 1985) identified where it
leaves the medial plantar. The dissection required to expose the nerve
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and to provide sufficient skin flap to form a liquid paraffin pool
adequate to cover the exposed nerve during electrical recording,
inevitably led to rupture of the cutaneous branches of the PACR so that
recording was restricted to activity in nerve fibres innervating the
subcutaneous tissues. Figure 2.1 shows a diagramatic representation of
the recording arrangement together with a photograph of working
preparation.
2.6.4 Recording afferent nerve activity
Electrical activity in afferent nerve fibres was recorded either from
fine filaments split from the PACR close to its origin from the medial
plantar nerve, or from the intact PACR after it had been dissected away
from the adjacent tissues. On a few occasions, recordings were made from
fine nerve filaments dissected from the medial plantar nerve proximal to
the PACR in order to facilitate single unit recording. The tibial nerve
was routinely cut centrally to abolish efferent nerve activity in the
PACR. Electrical activity was recorded extracellularly using bipolar
platinum-iridium wire electrodes mounted on a micromanipulator, and
carefully placed in contact with the lower side of the nerve filament.
The electrical signal was amplified (X 1000), and displayed on a storage
oscilloscope (Tektronix 5113). The signal was then digitized using a
digital audio processor (Sony PCM 701-ES) for storage on a videotape
recorder (Sony Betamax SL-HF100 UB). Figure 2.2 illustrates the
arrangement used for recording and storing data. The neural information
recorded on videotape was monitored by relaying the output signal from
the video recorder to another channel of the oscilloscope. The output
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Fig. 2.1 (A) Schematic diagram showing the PACR as prepared for
recording purposes. The skin has been dissected from the limb to form a
paraffin oil pool, thus exposing the tissues of the ankle joint.
Labelled in the diagram is the PACR and the the medial (mp) and lateral
(lp) plantar nerves. The PACR leaves the medial plantar nerve and passes
under the saphenous nerve to innervate the tissues of the joint. (B)
Enlarged (x4) photograph of the working preparation. The PACR is hooked
up onto a pair of platinum-iridium wire electrodes for recording
afferent nerve activity from the ankle joint.
59
from the amplifier was also passed through a voltage discriminator
(Digitimer), and action potentials of a selected amplitude were counted,
converted to an analogue signal proportional to the frequency of
discharge, and displayed on the chart recorder (Devices M4). Output from
the voltage discriminator was also relayed to a loudspeaker.
Afferent units were found by exploring the exposed medial aspect of
the ankle joint with a glass probe of approximately 1 mm diameter while
recording electrically from the dissected nerve. The thresholds and
properties of the afferent units were determined by using calibrated von
Frey hairs. Quantitative mechanical stimuli were delivered using an
electromechanical indentation generator (Somedic, Sweden). Ramp and
plateau stimulus waveforms were used routinely, with a maximum
displacement of 200 - 600 /an. Indentation stimuli were of 2 seconds
duration, applied at one or two minute intervals in order to minimise
receptor fatigue. The mechanical transducer probe consisted of a silver
wire core isolated from a metal cylinder casing of 1mm external
diameter. The tip was smooth and rounded, being sealed with plastic
resin. The concentric arrangement of the probe allowed its use for
localized electrical stimulation at the level of the receptor for
identification of mechanosensitive units. Conduction velocity (v) was
calculated from the conduction distance (d) measured in situ and the
conduction time (t) for the action potential to travel from the
stimulating to recording electrodes, where v - d/t (ms"l).
It should be noted that the high level of technical ability required
to dissect the PACR for recording purposes resulted in only a proportion
of preparations being functional. On average a successful recording was























Fig. 2.2 Schematic diagram showing the arrangement of apparatus used
for the application of mechanical stimuli, for electrophysiological
recording and in the collection and storage of data.
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2.6.5 Drug administration
Intra-arterial (i.a.) injections were generally made in a volume of 0.1
ml into the bifurcation of the abdominal aorta via the cannula inserted
anterogradely into the right femoral artery, and washed in with 0.2 ml
saline (0.9 % w/v aqueous NaCl). Where combination injections were made
using more than one drug a volume of 0.2 ml was used followed by a 0.2
ml saline wash. Injections were completed within a period of 1 s. At
least ten minutes were allowed to pass between injections, or longer if
the drug under investigation was known to induce tachyphylaxis. Other
drugs were injected i.v. into the femoral vein in an appropriate volume,
and the catheter flushed with 0.2 ml saline.
Control injections of 0.1 ml saline i.a. were made and the catheter
flushed with 0.2 ml saline. These injections were made throughout each
experiment, and served as a control to determine the effect upon
afferent discharge of the drug vehicle and of the injection procedure.
In all cases injection of saline had no effect on the receptors under
study.
2.6.6 Drugs used
Most of the drugs used dissolved in saline, although capsaicin was
dissolved in a solution of 10% tween 80, 10% absolute ethanol and 80%
saline at a concentration of 1 mgml'l, and PGI2 was dissolved in Tris
buffer pH 10 at a concentration of 50 ng/ml. Dilutions prior to
injection were made in saline equilibrated at room temperature or in the
case of PGI2, Tris buffer pH 8.
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The drugs used, their sources, and details of their molecular weights
are to be found in the Appendix I. Doses referred to in the text are
those of the salt where applicable.
2.6.7 Data analysis
The output of the video tape recorder containing the electrical
recording was passed through an amplifier and filter module (band pass
50 - 300 Hz) and fed to a spike processor (Digitimer) permitting the
counting of selected action potentials. Each action potential that fell
within the window generated a pulse of 1 ms duration. The number of
inpulses occurring in 0.1 s intervals was collected and stored by a
personal computer (IBM PC) programmed to collect over a period of up to
900 s (Software written and kindly supplied by Dr M.Dutia, Dept.
Physiology, University of Edinburgh). A marker was used to indicate the
the point at which a drug injection was made. Collected data were stored
on floppy disc, and subsequently analysed using the same programme on
the personal computer (see Figure 2.3).
A computer-drawn plot of the action potential discharge frequency as a
function of time was displayed on the computer monitor, from which
discharge was analysed in the pre-injection control period and,
thereafter during defined intervals following injection of the drug.
When analysing the effects of a drug, the control period was defined as
the 10 - 60 s period immediately prior to injection. Responses to
mechanical stimuli were expressed as the number of action potentials
produced per indentation stimulus.
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The defined time period (t seconds), for which the computer was
required to process discharge frequency, was selected using a moving
cursor which directed the computer to the memory-stored data displayed
on the monitor. Drug effects were quantified either as the peak
discharge obtained over the defined time interval, or, as with prolonged
drug effects, the total number of action potentials produced above the
control rate of discharge. The calculation shown below was used to
determine the number of action potentials evoked following a drug
injection:
i) Ex: the total impulses (number of action potentials) occurring in the
period t seconds, for control and for test periods. Units: impulses.
ii) x i.p.s.: the mean impulses per second occurring in each period t
seconds.
Hence x" (control) - Ex (control)/t (control),
and x (test) - Ex (test)/t (test)
Units: impulses per second (i.p.s.).
iii) delta x: the difference in the mean discharge occurring in test and
control periods.
Thus, deltaic - "x (test) - x" (control). Units: i.p.s.
iv) delta Ex: the absolute difference of discharge from control levels,
given by: delta Ex - Ex (test) - [1c (control) x t (test)].
Units: i.p.s.
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Of the above, iii and iv will have negative values when there is a
depression of discharge, i and ii may be equal to zero. Data integrated
with respect to control ( i.e. delta Ex) take into account the two-
dimensional character of responses, and both the magnitude and the
duration of the induced change in discharge are included in the analysis
of the response (see McQueen, 1977). This parameter measures the
increase or decrease in discharge in the test period relative to the
pre-injection discharge which, it is assumed, would have remained
constant in the absence of any modifying effect of the drug. This
assumption is of course supported by the finding that control injections
of saline had no effect on the receptors under study.
Whenever possible, dose response studies were performed and an
appropriate parameter expressing the response was plotted against log^o
dose.
2.7 Electrophysiological experiments in vitro
Experiments were performed on male wistar rats (weight range 250 -
350g).
2.7.1 General
Rats were anaesthetized with urethane (25 % w/v, 0.6 ml/100 g), and the
femoral artery of the left hindlimb was cannulated anterogradely using a
nylon catheter (0D 0.63 mm). Heparinized saline (500 units/kg in 3ml
saline) was flushed through the limb via the arterial cannula following
section of the femoral vein to allow the escape of blood and perfusate.
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The limb was then perfused with pre-warmed (32°C), oxygenated (95 X 02 /
5 X C02) Krebs solution (NaCl 118.4 nM, KC14.7 mM, MgS04.7H20 1.2mM,
KH2P04 1.2 mM, NaC03 25 mM, CaC12 2H20 2.5 mM, Glucose 11.1 mM) at a
rate of 2 ml/min using a peristaltic pump (Watson Marlow, 101U).
Perfusion pressure was monitored continually by connection of the
catheter to a pressure transducer (Bell and Howell, 4-442) via a T-piece
connector and the subsequent signal displayed on a chart recorder
(Lectromed, MX6).
2.7.2 Dissection
The left hindlimb was surgically removed from the animal by cutting
through the muscle and bone of the upper thigh. The animals were then
killed by cardiac puncture. The isolated limb was placed into a perspex
superfusion bath containing pre-warmed oxygenated Krebs solution
(composition as described above for perfusion fluid). The superfusion
fluid was allowed to flow from the reservoir and through the bath at a
rate of 5 mlmin'l. The paw of the limb was secured in the bath on a
perspex platform, and all skin was carefully removed from the leg to
expose the underlying tissues. Access to the tibial nerve and subsequent
dissection of the PACR for recording purposes were as described above
for the in vivo preparation. The desheathed nerve was cut centrally, and
placed in a small perspex recording chamber filled with liquid paraffin
where recording of afferent nerve activity was achieved using a
monopolar platinum-iridium wire electrode. Figure 2.3 shows a
diagramatic representation of the preparation.
66
platinum-iricfium electrodes
Fig. 2.3 Schematic diagram showing the isolated hind-limb as prepared
for electrophysiological recording from the PACR. (A) The limb has been
removed and placed in a perspex superfusion bath following cannulation
of the femoral artery for perfusion. The limb is secured in the bath by
a perspex clamp over the paw. Electrophysiological recordings are made
using a small bath filled with liquid paraffin and positioned over the
PACR (B) Diagramatic layout of the perfusion/superfusion apparatus.
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2.7.3 Recording afferent nerve activity
Afferent nerve activity was recorded from the desheathed PACR using
monopolar platinum-iridium wire electrodes mounted on a micromanipulator
and placed inside the recording chamber. The proximal, cut end of the
nerve was carefully wound around the electrode to obtain electrical
contact. The original signal was amplified (X 10,000. Digitimer,
Neurolog) and displayed on an oscilloscope (Tektronix 5103N). The
amplified signal was then digitized using a digital audio processor
(Sony PCM 701-ES) for storage on a videotape recorder (Sony Betamax SL-
HF 100 UB). The output from the amplifier was also passed through a
voltage discriminator (WPI model 120).
Action potentials of a selected amplitude were counted and converted
to an analogue signal proportional to the frequency of discharge, which
was displayed on the chart recorder (Lectromed, MX6).
Afferent units were found by exploring the exposed medial aspect of
the ankle joint with a plastic probe of approximately 1 mm diameter
while recording electrically from the dissected nerve. The thresholds
and properties of the afferent units were determined by using calibrated
von Frey hairs. A concentric bipolar electrode was used to produce
localized electrical stimulation at the level of the receptor.
Conduction velocity (v) was measured from the conduction distance (d) in
situ and the conduction time (t) from stimulating to recording
electrodes, where v - d/t (ms'l).
As described for in vivo electrophysiological studies the high level
of technical ability required to dissect the PACR for recording purposes
resulted in only a proportion of preparations being functional. On
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average 64% of the preparations could be used in experiments, in the
remaining preparations a successful recording was not obtained.
2.7.4 Drug administration
Drugs were generally administered intra-arterially (i.a) into the
perfusate as a bolus injection of 0.1 ml followed by a 0.2 ml saline
wash. Combination injections of more than one drug were given in
volumes of 0.2 ml with a 0.2 ml wash. A period of at least ten minutes
was allowed between drug injections, or longer if the drug under
investigation was known to cause tachyphylaxis. Other drugs were added
to the perfusion and superfusion fluid in order to produce a sustained
effect.
In each experiment control injections of 0.1 ml saline, followed by a
further 0.2 ml saline served as a control, to determine the effect of
the drug vehicle on afferent discharge.
2.7.5 Drugs used
Most of the drugs used dissolved in saline, although capsaicin was
dissolved in a solution of 10% tween 80, 10% absolute ethanol and 80%
saline at a concentration of 1 mgml'l, and PGF2Q which was obtained as a
commercial solution (Lutalyse). Dilutions were made in saline
equilibrated to room temperature prior to injection.
The drugs used, their sources and details of molecular weights and
structures are given in Appedix I. Doses stated in the text are
those of the salt where applicable.
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2.7.6. Data analysis
Data analysis was carried out as described previously for the in vivo
electrophysiology.
2.8 Isolated nerve preparations
2.8.1 Preparation of tissues
Adult New Zealand White (NZW) rabbits were killed using a captive bolt
device, and male hooded rats weighing 200-300 g were stunned by a blow
to the head and killed by cardiac puncture. Segments of rabbit cervical
vagus, rat saphenous nerve or a motor branch of sciatic or tibial nerve
approximately 10 - 15 mm in length were dissected out bilaterally and
placed in modified Krebs solution (NaCl 122 mM, KC1 4.4 mM, MgCl 1.2 mM,
CaCl 1.3 mM, NaHC03 15.4 mM, KH2P04 1.2 mM, glucose 5.5 mM) oxygenated
with 95X 02 / 5X C02, and containing 3 /xM indomethacin, at room
temperature. The connective tissue sheath around each isolated vagus
nerve was then carefull y removed using watchmaker forceps.
2.8.2 Extracellular recording
Within one hour of dissection, 10 - 15 mm sections of desheathed nerve
were transferred to two compartment perspex baths to permit
extracellular recording of prostanoid-induced membrane potential changes
(fig. 2.4). Each nerve was positioned so that approximately half of its







Fig. 2.4 Apparatus for recording extracellularly from isolated nerves.
(A) Diagram of the three chambered bath. (B) Layout of recording
apparatus. The continuous chart record displays the whole nerve
polarization when recording differentially from chambers A and B.
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through a greased slot (Dow-Corning high vacuum grease) into the second.
The DC potential between the two compartments was recorded via silver-
silver chloride electrodes connected to the tissue preparation via agar-
saline / filter paper bridges and was displayed on a potentiometric
chart recorder (Rikadenki). Each compartment of the bath was perfused
with oxygenated Krebs solution containing 3 /iM indomethacin to inhibit
endogenous prostanoid production, the perfusate being dripped directly
on to the tissues. Drugs were applied at a known concentration via the
superfusion stream into the first compartment only. The temperature of
each preparation was maintained at 27 ± 1°C. A diagramatic
representation of the preparation is shown in figure 2.4.
2.8.3 Design of experiments
Concentration-response curves were constructed using non-cumulative,
sequential applications. For all of the natural prostanoids, contact
times were of sufficient duration for the evoked potential change to
have stabilized (3 minute contact time). Tissues were allowed to
repolarize fully between application of each concentration of drug. The
maximum and ED50 of each concentration response curve was estimated by
computer-aided fit of a logistic curve to the experimental data (see
Barlow, 1983).
To examine the possibility that the drugs used caused tachyphylaxis,
non-cumulative, sequential concentration-effect curves were
constructed, using graded applications of either low to high
concentrations or high to low concentrations of drug. Using this
protocol, concentration-effect curves were constructed using PGE2, PGEi,
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PGI2 and cicaprost. A significant shift to the right of the
concentration effect curve for a particular agonist when going from high
concentration to low concentration was regarded as an indication of
tachyphylaxis following the application of high doses. Results between
tissues were compared by testing their responsiveness to a standard
supramaximal concentration of PGI2, and expressing responses as a
percentage of the PGI2 maximum. Tissue viability was determined using a
standard depolarizing concentration of carbachol both before and after
construction of prostanoid concentration-effect curves.
Investigations into the role of cyclic AMP in prostanoid-induced
depolarization of the rabbit isolated vagus nerve involved the addition
of forskolin, 8-Bromo cAMP and IBMX to the superfusion medium for
various periods of time and at different concentrations for the
construction of a sequential concentration-response curve.
2.8.4 Drugs and solutions
The naturally-occurring prostanoids, PGD2, PGE2, PGE^, PGF2a, the
selective EP agonists AH13205, rioprostil, and sulprostone, the
synthetic TXA2-mimetic U46619, the synthetic PGF2a mimetic ICI81008,
and the synthetic PGI2 analogues, iloprost and cicaprost, were dissolved
in saline. Dilutions were made using modified Krebs medium to give final
concentrations of 1 x 10"1° to 1 x 10J "• These we*e made immediately
prior to application. PGI2 was dissolved in Tris buffered saline (pH 9)
at 1 x 10M, dilutions in Tris buffer (pH 8) to 1 x 10"-* M, and
further dilutions in modified Krebs medium being made immediately prior
to application. Forskolin, 8-Bromo cAMP and IBMX were dissolved in
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modified Krebs medium, with dilutions being made immediately prior to
use. All drug solutions were kept on ice.
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SECTION III
LOCALIZED ADJUVANT-INDUCED MONOARTHRITIS AS A MODEL FOR THE
NEUROPHARMACOLOGICAL STUDY OF CHRONIC INFLAMMATION IN RATS
3.1 INTRODUCTION
Ajuvant-induced polyarthritis in the rat is the most widely used animal
model for the study of arthritis (see Billingham, 1983) and chronic pain
(see Colpaert, 1987). The pathological characteristics of the disease
have been described extensively (Pearson & Wood, 1959; Ward & Jones,
1962; Jones & Ward, 1963; Pearson, 1963; Rosenthale 6i Capetola, 1982;
Rainsford, 1982), and knowledge of the disease is substantial.
Adjuvant polyarthritis is a whole-animal disease affecting multiple
joints, eyes, ears, nose, tail and penis of the rat. The most severe
inflammation occurs in the distal joints of the hindlimbs where,
following prolonged leukocyte infiltration of the synovium, there is
progressive destruction of the bone, damage to tendons, and loss of
cartilage. The extensive systemic nature of the disease is marked by
enlargement of the lymph nodes, impairment of liver metabolism and
changes in serum and tissue chemistry.
The use of adjuvant polyarthritis in studies examining the
immunopathology of various arthritides is perhaps justified. However,
for the study of nociceptive mechanisms in chronic inflammation the use
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of such a gross disease is unnecessary and may even complicate the
examination of changes in nociceptive systems. It would be of great
advantage, on both scientific and ethical grounds, if new models could
be developed that did not produce severe systemic complications.
This study was undertaken using a novel model of adjuvant-induced
monoarthritis to determine whether this less severe, and more localized
form of adjuvant arthritis could be used as an alternative to adjuvant
polyarthritis for neuropharmacological studies on chronic inflammation
in rats. Examination of electrophysiological, behavioural and
histopathological characteristics were included in the study. The use of
a unilateral model of arthritis further provides the opportunity for
using the contralateral normal joint as a within animal control. In
electrophysiological studies both limbs cannot be studied readily in
vivo. For this reason an in vitro joint preparation was developed and
assessed for its use in studies of this type.
*
3.2 RESULTS
A localized monoarthritis was induced by the injection of low dose
Freunds Complete Adjuvant (F.C.A.) as described in the Methods Section.
3.2.1 Electrophysiology - in vivo
Afferent units in the PACR of the tibial nerve were examined in twenty
six normal and twenty six arthritic rats. High-threshold slowly adapting
mechanoreceptors with receptive fields located in the joint tissues on
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the medial aspect of the ankle were examined for their responsiveness to
mechanical indentation. Responsiveness to joint flexion or extension
could not be examined in the present study as the limb was immobilized
to facilitate neural recording. Afferent units with mechanosensitive
receptive fields on tendons, fascia and blood vessels were not included
in this study.
3.2.1.1 Normal joints
Receptive fields of slowly adapting mechanoreceptors were identified
using a blunt perspex probe with a tip diameter of 1 mm to apply
localized pressure to the joint surface. Repeated application of
pressure stimuli were used to separate true receptive fields from those
afferents being excited by damage to their axon (Guilbaud et al., 1985).
From the twenty six rats, fifty four slowly adapting units with
receptive fields in the joint tissues were identified. Mechanosensitive
receptive fields were punctate, ranging from 1 - 2 mm in diameter.
Individual units were represented by only a single identifiable
receptive field. Mechanical activation thresholds, measured using a
series of calibrated von Frey hairs, were generally high and ranged from
7 mN - >90 mN. Values are illustrated in figure 3.1 together with
measurements made in arthritic joints. The high thresholds of these
receptors often made them difficult to find, compression of the tissues
against the underlying bone being the only effective stimulus.
Measurements of conduction velocities were made for thirty eight units
and ranged from 0.5 - 16.6 ms~l (mean: 3.45 ± 0.7 ms'^). A low level of
spontaneous resting discharge of 0.38 ± 0.06 i.p.s. was present in
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Fig 3.1 Activation thresholds, measured with von Frey hairs, for
mechanical stimulation of joint capsule receptors in normal (open bars,
n-26) and arthritic (filled bars, n-26) rats.
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sixteen (42%) of these units. Mechanical stimuli of ramp and plateau
waveform were applied using an electromechanical indentation generator.
Phases of dynamic and slowly declining discharge were produced.
Repetition of mechanical stimuli led to a steady decline in the unit
response over a period of time proportional to the rate of stimulation.
These response characteristics are similar to those described previously
for this type of receptor by Guilbaud et al. (1985).
As well as mechanosensitive units a low level of background activity
was also seen in units for which no mechanosensitive receptive fields
could be found by probing in the joint tissues. These afferent units had
action potential spike shapes similar to those of identified C fibre
afferents. This similarity is based on criteria of action potential
spike height (Heapy et al., 1987) and spike width. Action potentials
generally had amplitudes of below 30 /iV and spike widths of 2 - 3 ms.
3.2.1.2 Arthritic joints
Rats were used for experiments between 12 and 35 days following the
injection of adjuvant around the left ankle joint. Dissection of the
lower limb for recording purposes revealed the presence of large amounts
of fibrous tissue, which bound together the inflamed muscles, tendons,
fascia and skin. The capsular tissues around the tibio-tarsal joint were
markedly enlarged and thickened.
From twenty six rats a total of two hundred and four slowly adapting
mechanoreceptors with receptive fields in the joint tissue were
identified. This figure is approximately three times greater than that






Fig 3.2 Diagram illustrating the distribution of punctate receptive
fields for slowly adapting mechanoreceptors in capsular tissue of
representative arthritic and normal ankle joints. Each receptive field
corresponds to a single afferent unit. The inset shows a neurogram of a
typical slowly adapting response of an articular high-threshold slowly
adapting mechanoreceptor.
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receptors in the arthritic joints were activated by the application of
light pressure. The mechanical activation thresholds ranged from 0.2 -
>90 mN. The lower threshold units found in inflamed joints were not seen
in those from normal joints (fig. 3.1). Individual units were
represented by only a single receptive field, each being between 1 and 2
mm in daimeter as seen in normal joints.
Measurements of conduction velocity were made for thirty nine units
and ranged from 0.3 - 4.6 ms'l (mean: 1.48 ± 0.3 ms"l). A mean rate of
ongoing discharge equal to 1.5 ± 0.32 i.p.s. was present in thirty two
(82X) of these units. Thus, there were on average twice the number of
active units in arthritic joints, and their mean rate of discharge was
approximately four times greater than that in recordings from normal
joints.
Application of the mechanical probe produced pitting of the tissues,
and generally responses to repeated stimuli were more susceptible to
fatigue than in normal joints, as described previously by Guilbaud et
al. (1985) in rats with adjuvant polyarthritis.
Units for which no mechanosensitive receptive fields could be found
had a high level of resting discharge and were more numerous than in
recordings from normal joints. These units had action potential spike
shape characteristics similar to those of identified C fibre afferents
as described above for normal joints.
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3.2.2 Electrophysiology - in vitro
3.2.2.1 Normal joints
Following surgical removal, the hind limb was simultaneously perfused
and superfused with pre-warmed, oxygenated Kreb's solution as described
in the Methods (Section II). No obvious tissue oedema occurred in the
tissues around the ankle joint for perusion periods of up to eight
hours. Receptive fields of slowly adapting high-threshold
mechanoreceptors were identified as described for in vivo studies. From
eight rats, fourteen units with receptive fields in the joint tissues
were identified. Receptive fields were punctate and of between 1 and 2
mm in diameter. Mechanical activation thresholds were generally high,
and similar to those found in vivo. Values ranged from 10 - > 100 mN as
shown in figure 3.3. Receptive fields were often difficult to find and
activation generally required that the tissues be compressed against the
underlying bone as found in vivo.
Measurements of conduction velocity were made for six units and ranged
from 0.4 - 2 ms"l . A low level of spontaneous resting discharge of 0.6
± 0.1 i.p.s. was present in two (33%) of these units. Using a blunt
tipped perspex probe, manual application of mechanical stimuli evoked
slowly adapting responses similar to those seen in vivo. Mechanical
responsiveness was maintained for the duration of all recordings, which





Fig 3.3 Activation thresholds, measured with von Frey hairs, for
mechanical stimulation of joint capsule receptors in normal (open bars,
n=8) and arthritic (filled bars, n-8) rats in vitro.
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3.2.2.2 Arthritic joints
Rats were used for experiments as described above for in vivo studies.
From eight rats, eighty seven slowly adapting mechanoreceptors with
receptive fields in the joint tissues were identified. This figure is
approximately six times greater than that for normal joints. Receptors
could be activated by the application of light pressure. Mechanical
thresholds ranged from 10 - > 100 mN, with the majority of units having
thresholds of 90mN or below as illustrated in fig 3.3.. Receptive fields
were of similar size to those seen in normal joints, ranging from 1-2
mm in diameter.
Measurements of conduction velocity were not made in these
experiments, all units having action potential spike shape
characteristics similar to those of identified C fibre afferents. A mean
rate of ongoing discharge equal to 1.2 ± 0.2 i.p.s. was present in two
(66%) of three units that were examined in detail. From these figures
there were approximately twice the number of active units in arthritic
joints, and their rate of ongoing discharge was double that seen in
normal joints.
3,2,3 Behaviour and gross pathology
Injection of adjuvant subdermally around the left ankle joint produced
swelling of the tissues within a few hours. The initial swelling and
inflammation continued for four or five days before beginning to
subside. From day eight a secondary inflammation developed and reached a
plateau within two days. This secondary phase continued for the duration
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of the experiment, during which time the right hindlimb was unaffected.
Measurements of ankle circumference illustrated in figure 3.4 show
that a marked swelling of the joint developed from day one post-
injection and increased gradually to reach a stable level from day six
onwards. The circumference of the contralateral joint showed only the
normal increase in size seen in non-injected rats.
The rate of weight gain were slightly reduced in arthritic rats
compared to controls for the first eight days. A normal rate was
achieved from this time onwards although the weights of arthritic rats
never approached those achieved by controls (fig. 3.5).
Standing and walking weight load scores for the injected hindlimb
increased markedly from day one following adjuvant administration. The
scores declined slightly following the initial reaction, but remained
elevated throughout the test period (figs. 3.6 - 3.7). Scores for the
right hindlimb of arthritic animals remained at basal levels as did
those for both hind limbs of control animals.
As illustrated in figure 3.8, pressure thresholds for paw withdrawal
were reduced markedly following injection of adjuvant. Reductions in
thresholds became significant two days after treatment and remained
lowered for the duration of the study. However, withdrawal thresholds
for the uninjected paws displayed similar reductions with the same time
course. Thresholds for control rats also displayed a significant
reduction at one time point during the test period.
Thresholds to mechanical indentation stimuli were reduced from day one
onwards for the arthritic limbs of treated rats (fig. 3.9). No change in
thresholds was observed for uninjected limbs or in either foot of
control animals.
86
0 1 2 4 6 8 12 14
Days post-adjuvant
Arthritic L ill Arthritic R I I Normal L
Fig 3.4 Changes in ankle circumference resulting from injection of
F.C.A. around the left ankle joint on day zero. Bars represent mean
values for measurements from the injected left ankle (L, closed bars,
n—4) , contralateral non-injected ankle (R, shaded bars, n—4), and the
left ankle (L, open bars, n—4) of control rats. The vertical lines above
each bar represent the s.e.m.. Significantly greater mean values are
shown as * when p < 0.05 (Wilcoxon) .
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Fig 3.5 Weight gain over the 14 day period following injection of
F.C.A. on day zero. No significant differences in weight gain were seen




Fig 3.6 Mean standing load scores for the left hindlimb of of arthritic
rats (n=4) for the 14 day period following injection of F.C.A. . Mean
scores which are significantly greater than those for control rats are






Fig 3.7 Mean walking load scores for the left hindlimb of of arthritic
rats (n—4) for the fourteen day period following injection of F.C.A..
Mean scores which are significantly greater than those for control rats
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Fig 3.8 Mean withdrawl thresholds to graded pressure stimuli over the
14 day period following injection of F.C.A. around the left ankle joint.
Bars represent mean values for measurements from the injected left ankle
(L, closed bars, n-4), contralateral non-injected ankle (R, shaded bars,
n-4), and the left ankle (L, open bars, n-4) of control rats. The
vertical lines above each bar represent the s.e.m.. Mean thresholds




Fig 3.9 Mean values for withdrawal thresholds to mechanical stimuli
using von Frey hairs for the left hindlimb of arthritic rats (n-4).
Significantly lower mean thresholds than those for control rats are





Fig 3.10 Percentage of arthritic rats displaying withdrawl to flexion
and extension of the left ankle joint (n-4) over the 14 day period
following injection of F.C.A.. Tests with a significantly greater
numbers of rats displaying withdrawalwhen compared with controls are
shown as * when p < 0.05 (Wilcoxon).
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Fig 3.11 Mean placing reflex scores for the left hindlimb of rats
injected with F.C.A. (n-4). Values significantly lower than those for
control rats are shown as * when p < 0.05 (Wilcoxon).
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Fig 3.12 Mean withdrawl latencies to radiant heat stimuli for the 14
day period following injection of F.C.A. around the left ankle joint on
day zero. Bars represent mean values for measurements from the
injected left ankle (L, closed bars, n-4), contralateral non-injected
ankle (R, shaded bars, n-4), and the left ankle (L, open bars, n-4) of
control rats. The vertical lines above each bar represent the s.e.m..
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Manipulation of the foot did not elicit noxious responses in either
untreated controls or in the right limbs of arthritic animals. For the
injected left ankle, the number of rats displaying withdrawl responses
increased from from day one and remained elevated until day six.
Thereafter there was a decline in the number of withdrawl responses
elicited (fig. 3.10).
The average number of clear placing reflex responses was reduced a day
after injection of adjuvant. This figure increased gradually up to day
six when a steady level was reached (fig. 3.11). For uninjected limbs
and untreated rats clear responses were obtained in all cases.
Withdrawal latencies for the radiant heat test were not significantly
different between control and arthritic rats at any point following
adjuvant injection (fig. 3.12).
3.2.4 Histopathology
The tibiotarsal joints of five normal rats, five rats at 15 days and
five rats at 31 days post-injection were used for examining the
histopathology of localized adjuvant arthritis.
Following the administration of adjuvant all rats developed a severe
swelling around the ankle region of the injected left hindlimb.
Following an initial vigorous swelling, a stable level was reached after
about ten days. This level of inflammation and swelling was maintained
throughout a thirty one day period of observation. Inflammation was
restricted to the ankle joint region with little evidence of swelling in
the paw or further up the leg. Contralateral limbs appeared to be
unaffected by the treatment.
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Histological examination of the ankle joints at fifteen days post-
injection revealed the presence of a severe invasive periarthritis. The
abundance of invading neutrophils and disintegration of the synovial
lining were the most obvious changes seen in these joints. The joint
cavity itself was relatively free from inflammation, although invasion
of outer regions by fibrinoid synovial villi was prominent in all cases.
Active fibrosis was also seen at sites where erosion was taking place
around the margins of articular cartilage (figs. 3.13 - 3.15).
Simultaneous osteoblastic production of new periosteal bone and
osteoclastic erosion of existing bone was observed along some bone
shafts (fig. 3.16).
Ankle joints from contralateral non-injected limbs had a normal
histological appearance. Synovial tissues appeared to be healthy and no
invasive cells could be seen in the surrounding connective tissue (figs.
3.17 - 3.18).
Examinations of bone sections taken from rats thirty one days after
injection of adjuvant revealed that the arthritis had progressed to a
more erosive condition. Osteoclast activity was evident at marginal
cartilage and in subchondral bone (fig. 3.19 - 3.20). In the smaller
tarsal bones of the paw severe erosion was seen in a small number of
joints (fig. 3.23). Non-injected contralateral ankle joints from these rats
were normal in appearance (figs. 3.21 - 3.22).
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Fig 3.13 Micrograph (xlO) of a 20/im thick transverse section through
the tibio-tarsal joint of the arthritic left hind limb 15 days post-
injection of F.C.A.. Marked cellular infiltration of and fibrin
deposition in the synovium (S) is clealy present. Proliferation of the
synovial tissue has led to the formation of an adhesive pannus (P) which
has invaded the joint space. The initial stages of bone (B) erosion are
occurring at the margins of the articular cartilage (C).
Fig 3.14 Micrograph (xlO) of 20pm thick transverse section through the
tibio-tarsal joint of the left hindlimb of an arthritic rat 15 days
post-injection of F.C.A.. Severe periarticular invasion of neutrophils
and breakdown of the synovial (S) lining are in evidence. Fibrin can be
seen in the peripheral margins of the joint space (JS). Adhesion of




Fig 3.15 Micrograph (x40) of a 20/im thick transverse section through
the left tibio-tarsal joint of an arthritic rat 15 days post-injection
showing detail of the marginal cartilage. Adhesion of pannus (P) can be
seen on the surface of the joint cartilage (C). Marginal cartilage
breakdown is occurring beneath the adhesive layer. Subchondral bone is
also labeled (B).
Fig 3.16 Micrograph (x20) of a 20/im thick transverse section through
the distal shaft of the tibia from the left hindlimb of an arthritic rat
15 days post-injection of F.C.A.. Osteoclastic erosion (0 of existing
bone and simultaneous osteoblastic production of new bone occurring
along the shaft of the tibia (T). The connective tissue (CT) contains
large numbers of invasive cells.
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Fig 3.17 Micrograph (x20) of a 20/jm thick transverse section through
the uninjected right tibio-tarsal joint of an arthritic rat 15 days
post-injection of F.C.A.. The synovium (S) and synovial lining cells (SL) are
healthy in appearance, and clear from any fibrin or invasive cells. The
marginal zones of cartilage are intact and joint space (JS) is
totally clear.
Fig 3.18 Micrograph (xlO) of a 20fim thick transverse section through
the uninjected right tibio-tarsal joint of an arthritic rat 15 days
post-injection of F.C.A.. The synovial tissue (S) is normal in
appearance and free from invasive cells. Apposing cartilage and
underlying bone are healthy in appearance.
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Fig 3.19 Micrograph (x40) of a 20pm thick transverse section through
the arthritic left tibio-tarsal joint 31 days post-injection of F.C.A.,
showing detail of the marginal cartilage. Severe cellular infiltration
of synovium (S), marginal erosion of articular cartilage (MC), and
evidence of osteoclast activity in subchondral bone.
Fig 3.20 Micrograph (xlO) of a 20pm thick transverse section through an
arthritic left tibio-tarsal joint 31 days post-injection of F.C.A.. The
synovium (S) contains large numbers of invasive cells, and a fibrinoid
synovial villus can be seen at the margin of the joint space .
Marginal erosion of cartilage can be seen, but the apposing
cartilage (C) is otherwise quite healthy in appearance.
104
105
Fig 3.21 Micrograph (xlO) of a 20/im thick transverse section through
the uninjected right tibio-tarsal joint 31 days post-injection of F.C.A.
The synovium (S), synovial lining cells and marginal zones (M of
attachment are normal in appearance and free from fibrin or invasive
cells. The apposing articular cartilage (C) and underlying bone (B) are
also normal and healthy.
Fig 3.2 2 Micrograph (x20) of a 20/ira thick transverse section through
the noninjected right tibio-tarsal joint 31 days post-injection of
F.C.A.. Normal synovial lining and synovium (S). Articular cartilage (C)
is normal and healthy in appearance.
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Fig 3.23 Micrograph (xlO) of a 20/an thick transverse section through
the arthritic left hind paw 31 days post-injection of F.C.A, showing
detail of the small tarsal bones. Complete disintegration of synovium





3.3.1 Electrophysiology - in vivo
The high-threshold slowly adapting mechanoreceptors described above had
response characteristics comparable to those of previously identified
articular nociceptors in the rat ankle joint (Guilbaud et al., 1985).
Afferent fibre conduction velocities were in the A-delta or C fibre
range, and fatigue developed following repeated mechanical stimuli.
Afferent units had either a low level of backround discharge or had none
at all. Nociceptors from the cat knee joint have also been reported to
have similar characteristics, responding mainly to intense mechanical
stimuli, to extreme flexion or extension, or to rotations of the joint.
(Schaible & Schmidt, 1983a,b). These units in the cat had either a low
background discharge or were silent.
Slowly adapting mechanoreceptors with receptive fields in the tissues
of the arthritic rat ankle joint had lower activation thresholds and
higher levels of ongoing activity than those from normal joints. These
results are in agreement with those obtained by Guilbaud et al. (1985)
from the ankle joints of rats with adjuvant-induced polyarthritis.
Similar findings have also been reported for cat knee joints acutely
inflamed using intra-articular injection of kaolin and carrageenan
(Coggeshall et al., 1983). In the acutely inflamed cat knee joint
articular receptors with A-delta and C fibre afferents had a heightened
sensitivity to joint movements, and a previously absent background
discharge (Coggeshall et al. 1983; Grigg et al., 1986; Schaible &
Schmidt, 1985; 1988a).
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In both the present study and that of Guilbaud et al. (1985) a larger
number of receptors could be identified in arthritic tissues by probing
mechanically on the joint surface, with individual receptive fields
corresponding to single afferent units. This finding is in contrast to
the situation in the cat where multiple receptive fields for single
units are quite commonly found in the inflamed joint (Schaible &
Schmidt, 1985).
Direct comparison of receptor characteristics both before and after
the development of an acute inflammation was achieved in the cat knee
joint (Schaible & Schmidt, 1988a). Inflammation led to sensitization of
C and A-delta high-threshold units and induction of mechanosensitivity
in units which were unresponsive to mechanical stimuli in the normal
joint. Resting activity consisting of irregular discharges was also
induced.
More recently studies on the effects of inflammation on sensory
receptors from other tissues have been reported. Sensitization of C
fibre polymodal nociceptors to both mechanical and thermal stimuli has
been described following induction of carrageenan inflammation in the
skin of the rat (Kocher et al., 1987). Only those units developing
ongoing activity were sensitized by the inflammation. Cutaneous C-
polymodal nociceptors in the rabbit ear have been shown to develop
background discharge following ultraviolet irradiation sufficient to
produce evidence of delayed inflammation (Szolcsanyi, 1987). In the
muscle of the cat, carrageenan-induced inflammation sensitized C and A-
delta nociceptors, and caused increases in background activity
(Berberich et al., 1988). There was no apparent correlation between the
mechanical threshold of a receptor and its level of background activity
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in inflamed muscle. Finally, in studies on the urinary bladder, mustard
oil-induced acute inflammation caused the development of ongoing
activity and sensitization to bladder distension for receptors with
unmyelinated afferent axons (Habler et al., 1990). These receptors were
previously insensitive to mechanical stimuli.
The results described above suggest that the sensitization of C and A-
delta nociceptors is probably crucial for the development of
inflammatory pain and hyperalgesia. During inflammation the recruitment
of receptors which in normal tissues are non-responsive to mechanical
stimuli will lead to an enhancement of nociceptive input to the spinal
cord and higher perceptual centres. A number of different terms have
been used to describe this type of receptor which becomes sensitive to
perturbation following tissue damage. Schmidt and colleagues have used
the term 'sleeping nociceptor', and along similar lines Handwerker and
his colleagues have called them 'silent nociceptors' (personal
communication). These descriptors do not, however, attempt to ascribe a
biological function to these sensory elements. Perhaps the best way to
describe them is as 'inflammation receptors', a term first used by Iggo
(1988), to identify their key involvement in inflammation.
From a review of the present literature it would seem that the changes
in receptor characteristics seen in acutely inflamed tissues are
superficially the same as those observed in the chronic inflammation of
adjuvant polyarthritis and localized adjuvant arthritis. It seems likely
that alterations in nociceptor function, occurring as a result of
chronic inflammation, may only be revealed using pharmacological
techniques, and as such investigations of this type are of great
interest.
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3.3.2 Electrophyslology - In vitro
Articular sensory receptor populations identified in vitro were similar
to those found in rat ankle joints from in vivo electrophysiological
studies. Furthermore, receptive fields, mechanical activation
thresholds, and response characteristics to mechanical stimuli did not
differ from those seen in vivo. Time-related changes in receptor
behaviour did not occur in these experiments, and no obvious soft tissue
pathology was observed for periods of up to eight hours after removal of
the limb. The long-term maintenance of receptor responsiveness in vitro
indicates that any biochemical factors essential for normal receptor
excitability have not been washed out of the receptor environment.
Articular sensory receptors from arthritic joints studied in vitro
displayed essentially the same characteristics as those seen in vivo.
Thus, compared to the situation in normal joints, arthritic joints had
an increased number of mechanosensitive receptive fields. These
receptors had a lower mean mechanical activation threshold, and a higher
level of spontaneous resting discharge than those found in normal
joints. The similarity between the situation found here in vitro and
that seen in vivo suggests that the heightened sensitivity of these
receptors in arthritic joints is not dependent on the continued presence
of blood borne components, or on influences from the central nervous
system. These results support the idea that an in vitro joint
preparation could be used to examine the effects of chronic inflammation
on the sensitivity of articular sensory receptors. The use of a
unilateral arthritis provides the opportunity to examine both the
arthritic and non-arthritic, contralateral joints from the same animal.
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3.3.3 Behaviour and gross pathology
The time course of development of localized adjuvant-induced arthritis
compares well with that seen in polyarthritis. An initial swelling at
the site of injection was followed by a secondary inflammation of the
ankle joint which persisted for the duration of the experiment. The
major difference seen in the present condition is its highly localized
nature, and lack of whole body effects. The localized nature of the
disease is most likely to be a result of the comparatively low dose of
adjuvant used (Ward & Jones, 1962) and the subdermal site of injection
around the ankle joint (see Billingham, 1983). In a similar model of
localized adjuvant-induced arthritis, injection of the same dose of
adjuvant into the foot pad produced contralateral inflammation after a
period of fourteen to thirty six days in 10% of rats (Stein et al.,
1988). Results from recent studies using adjuvant-induced inflammation
of one hindpaw (Stein et al., 1988) compare well with those described in
the present investigation. Patterns of weight gain, tissue swelling and
development of hyperalgesia all follow a similar time course in both
studies.
Tests for hyperalgesia have been performed extensively in rats with
adjuvant polyarthritis (see Rosenthale 6c Capetola, 1982). Responses
indicative of pain such as vocalization and struggling can readily be
elicited in polyarthritic rats by a variety of stimuli including direct
pressure on the paw as in the Randall-Selitto test (Butler et al.f 1985;
Calvino 6c le Bars, 1986; Hara et al., 1984; Hirose 6c Jyoyama, 1975;
Kayser 6c Guilbaud, 1981; Kayser 6c Guilbaud, 1983; Winter et al., 1979)
or flexion of the ankle joint (Capetola et al., 1978;1980; Kuzuna 6c
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Kawai, 1975).
In the present study the use of these tests revealed a rapid onset of
hyperalgesia in the treated paw which was maintained for the two weeks
post injection over which measurements were carried out. A reduction in
withdrawal threshold to pressure produced by a graded series of von Frey
hairs also demonstrated development of hyperalgesia in the injected paw.
Reduction in nociceptive thresholds were restricted to the injected limb
for flexion-extension and von Frey hair tests. However, a reduction in
the withdrawal threshold for application of gradually increasing
pressure was seen for both inflamed and non-inflamed joints. It is most
likely that this effect was produced as a result of rats associating the
test with a painful experience. Avoidance behaviour of this type is also
evident in the responses of uninjected control rats where withdrawal
thresholds were also significantly reduced after a delayed period.
The most obvious effect of joint inflammation was a reluctance to
place any great weight on the paw of the inflamed ankle. In many cases
an obvious limp was present for short periods, with animals displaying
distinct guarding behaviour. The subjective measure of weight bearing
scores used here shows that a clear reduction in the use of the inflamed
limb for walking and standing occurs throughout the test period. These
results compare well with those obtained in similar studies where other
forms of inflammation affecting only one limb were examined (Coderre &
Wall, 1987; Okuda et al., 1984; Otsuki et al., 1986). This type of test
has an advantage over measurements using a force transducer (Van Arman
et al, 1970; Otsuki et al., 1984) as no prior training is required, and
stress caused by restraint of the animal is considerably reduced
(Coderre & Wall, 1987). Examination of placing reflexes also indicated a
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reluctance of the animals to move their inflamed joint. Results from
these tests suggest that animals with chronically inflamed ankle joints
experience a sustained level of discomfort which restricts their use of
the affected limb, however, this probably also reflect the animals
reluctance to experience acute pain when the joint is moved or allowed
to participate in any load bearing.
The finding that withdrawal latencies to noxious heat stimuli were not
significantly different between treated and non-treated paws or control
animals suggests that lowered thresholds to mechanical stimuli are not
accompanied by reductions in thresholds to thermal stimuli. However, it
is possible that the test was not sensitive enough to detect any changes
in threshold that may have occured as a result of tissue inflammation.
Weight loss and retardation of growth were seen during the initial
stages of inflammation. Although less severe, this pattern is similar to
that reported for studies on rats with polyarthritis (Hathur et al.,
1977; Newbold, 1969; Walz, 1971). The reasons for retarded weight gain
in arthritic rats are not entirely clear. It has been suggested that
reduced motor activity related to the severity of pain is responsible
for a reduction in feeding and thus weight loss (Chudler & Dong, 1983;
Morton & Griffiths, 1985). However, in studies where food was made
available so that no locomotion was required for the animals to consume
it, the same pattern of weight loss was seen (Colpaert & Van den Hoogen,
1983). Other factors may be involved in reduced eating and weight loss,




Examination of sections of tibiotarsal joint from rats with localized
adjuvant-induced arthritis revealed the presence of a chronic invasive
periarthritis combined with a proliferative synovitis. In comparison
with adjuvant-induced polyarthritis (Pearson & Wood, 1959), the present
condition is substantially less severe in terms of bone erosion, and
very little degradation of marginal and sub-chondral bone occurs. Bony
ankylosis, a common feature of polyarthritis, is rarely seen in this
disease. The most important difference seen in the present model is its
localized nature, with the contralateral, non-injected tibio tarsal
joint having a normal histological appearance.
As in adjuvant polyarthritis the fibrin-like material seen early on ir
the disease at the margins of the articular cavity probably comes from
the exudation of blood (Pearson & Wood, 1963; Mohr & Wild, 1976). This
material appears to induce rapid proliferation of the synovium (Pearson
& Wood, 1963; Mohr & Wild, 1976). The presence of invasive cells around
the synovium, tendon sheaths, bursae and periosteal surfaces by
inflammatory cells seen at day fifteen represent signs of the local
inflammatory process. Identification of different cell types is
difficult using the present staining techniques. However, at this stage
of polyarthritis various cell types have been identified around the
synovium including mast cells (Van Arman, 1976; Mohr & Wild, 1976)
polymorphs, monocytes and lymphocytes (Pearson & Wood, 1963; Nusbickel &
Troyer, 1976).
A prominent feature of adjuvant polyarthritis, and indeed human
rheumatoid arthritis, is the presence of a granulomatous outgrowth of
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tissue from the synovium known as pannus (Pearson & Wood, 1963; Mohr &
Wild, 1976). This characteristic of the chronic arthritic lesion is also
seen in the the present condition where invasion of the joint cavity by
fibrinoid synovial villi is clearly present by day fifteen. As in
polyarthritis, erosion of marginal cartilage can be seen at day fifteen
and to a greater extent at day thirty one where contact is made with
fibrinoid synovial villi.
Histological examination of the tibio-tarsal joint in localized
adjuvant arthritis has revealed a pathology that can probably be
described most accurately as a chronic proliferative synovitis. Although
the appearance of the periarticular tissues are similar to that seen in
adjuvant polyarthritis, the limited nature of the bone and cartilage
destruction seen in this model differs conspicuously from the severe
erosicn prevalent in established polyarthritis. In this aspect, the
present model bears a closer resemblance to rheumatiod arthritis in
humans.
3.3.5 Further points for discussion
Levels of neuropeptides involved in nociceptive processes, such as
substance P, CGRP and the opioid, peptides, have been shown to be
increased bilaterally in the dorsal horn of the spinal cord and in
primary afferent neurones of rats with adjuvant polyarthritis (Lembeck
et al., 1981; Chery-Croze et al., 1985; Levine et al., 1985; Millan,
1986; Oku et al., 1987). These changes are thought to occur at least
partly as a result of a sustained high level of nociceptive input.
Similar increases have recently been shown to occur unilaterally in
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localized arthritis (Stein et al., 1987, 1988; Nahin et al.f 1990; Smith
et al., 1990) providing further evidence that this represents a model of
chronic inflammatory pain.
3.4 CONCLUSIONS
The results obtained in this study suggest that localized adjuvant-
induced arthritis represents a suitable model for the study of pain
associated with chronic inflammation. A large number of characteristics
associated with alterations in nociceptive systems in adjuvant
polyarthritis have also been demonstrated in the present model.
Furthermore, that many of the characteristics described above have been
shown to be present only on the side ipsilateral to the inflammation,
provides a within animal experimental control, which is not possible in
adjuvant polyarthritis. It is concluded, therefore, that localized
adjuvant-induced arthritis has considerable scientific and ethical
advantages over adjuvant polyarthritis for the neuropharmacological
study of arthritic pain.
119
SECTION IV
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SECTION IV
EFFECTS OF CAPSAICIN ON ARTICULAR SENSORY
RECEPTORS IN THE RAT ANKLE JOINT
4.1 INTRODUCTION
Cutaneous application of capsaicin, the pungent ingredient of hot
pepper, causes burning pain and flare that spreads beyond the area of
contact (Bernstein et al., 1981; Carpenter & Lynn, 1981). Similar
excitatory actions occur in the airways and in many visceral organs.
Excitation of cutaneous C-polymodal nociceptors is evoked in all
mammalian species tested, including cat (Foster & Ramage, 1981), rabbit
(Szolcsanyi, 1987), rat (Renins, 1982; Szolcsanyi et al., 1988) and man
(Konietzny & Hensel, 1983). Other types of C fibre receptor in the skin,
including high threshold and low threshold mechanoreceptors are reported
not to be excited (Foster & Ramage, 1981; Renins, 1982; Szolcsanyi,
1988). Cutaneous sensory receptors with A-fibre afferents are generally
unaffected by capsaicin, although a small population of A-delta
nociceptors in the rat hairy skin are excited (Szolcsanyi et al., 1988).
The effects of capsaicin have also been examined on axons in nerve
trunks and on neuronal cell bodies. Capsaicin causes depolarization of
the rat isolated sciatic (Hayes et al., 1984) and vagus (Marsh et al.,
1987) nerves, and somata from rat nodose (Marsh et al., 1987) and dorsal
root (Baccaglini & Hogan, 1983; Heyman & Rang, 1985) ganglia.
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Depolarization is only seen in a sub-population of C-type ganglion
cells, suggesting that capsaicin does not affect all C fibre afferents
(Heyman & Rang, 1985; Marsh et al., 1987).
In rat sensory neurones in culture, capsaicin opens cation-selective
channels, which can be observed using patch-clamp recording (Bevan &
Forbes, 1988). The channels are activated in isolated membrane patches
suggesting that they are directly gated by the capsaicin, and no second
messengers are involved. These capsaicin-gated channels appear to differ
from channels described previously in dorsal root ganglion cell
membranes, having high permeability both to sodium and calcium ions, and
unusual rectifying properties.
Examination of the effects of drugs on sensory receptors using intra¬
arterial injection relies on access to receptor terminals via the local
micro vasculature. Thus, if a sensory receptor is not excited, it is
difficult to tell if this is due to the drug being ineffective on that
particular unit, or if there is a problem of access. In order to test
the resposiveness of sensory receptors to drugs injected intra-
arterially a chemical known to produce receptor excitation must be used.
Injection of K+ has previously been used by other workers. However, the
excitatory effect is not selective for receptors with unmyelinated or
finely myelinated afferent fibres. In the present investigation the
effects of capsaicin on articular sensory receptors were examined to
determine whether the drug could be used as a selective pharmacological
probe for the excitation of nociceptive afferents. Experiments were
conducted using normal and arthritic rats, with effects being examined
both in vivo and in vitro.
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4.2 RESULTS
The effects of capsaicin were examined on two types of afferent unit:
high-threshold slowly adapting mechanoreceptors with receptive fields in
the joint capsule, and 'chemosensitive' units which were excited by
capsaicin and other chemicals (i.e. 5-HT, bradykinin or prostanoid
agonists) but for which no receptive fields for mechanical stimuli were
found (table 4.1). Injections of capsaicin were carried out at the end
of experiments in which the effects of other drugs were investigated.
4.2.1 In vivo electrophysiology
4.2.1.1 Excitatory effects on mechanoreceptors
Normal joints
From nine experiments, thirteen high-threshold slowly adapting
mechanoreceptors with a mean afferent fibre conduction velocity of 4.4 ±
1.8 ms"l (range: 0.5 - 16.6 ms'l) were examined. Since the majority of
these units had previously been exposed to other excitatory substances,
they had an enhanced level of ongoing activity of 0.6 ± 0.1 i.p.s.
Capsaicin (1 - 10 fig, i.a.) consistently activated all of the units
tested (table 4.1). An example of the excitatory effect of capsaicin is
illustrated in figure 4.1. In twelve (92%) units injection of capsaicin
evoked responses of short latency (3 ± 0.7 s), short duration (14.3 ±
2.6 s) and high discharge frequency. The mean peak discharge, obtained

















Fig. 4.1 Response of a slowly adapting articular mechanoreceptor (c.v.
" 0.8 ms-1) from an arthritic rat to the injection of 5 ng capsaicin.
(A) Neurogram showing the firing pattern for rapid excitation induced by
capsaicin. The time of injection of 5/ig capsaicin (i.a.) is indicated by
the arrow. (B) Neurogram showing the firing pattern for delayed
excitation caused by capsaicin. (C) Computer-generated plot illustrating
the response of the mechanoreceptor unit to the same injection of
capsaicin (given at arrow) shown in the neurograms. Each collection bin
(bar) represents a 1 s time period. The time periods corresponding to
the neurogram traces are indicated above the graph. Responses to
mechanical stimuli (applied at arrow heads) are also shown, with the
number of evoked action potentials per stimulus given above each
response. The inset traces show (i) 30 superimposed triggered
oscilloscope sweeps of the recorded unit action potential, and (ii) the
slowly adapting response of the unit to the standard mechanical
stimulus. This unit responded with both rapid and delayed excitation.
Mechanical responsiveness was first reduced (40% of control) following





discharge(i.p.s) to o t[i-i
of evoked action potentials above basal discharge (delta Ex) was 35 ± 6.
Unit responses to a standard dose of 10 fig are shown in figure 4.2.
Repeated injections of 1 - 10 fig doses at intervals of 15 minutes evoked
a consistent response. Application at shorter intervals caused a
reduction of the response to develop (fig 4.3). Dose-dependent effects
were observed in four units.
In addition to rapid excitation, capsaicin also evoked a delayed (47 ±
6.3 s), longer lasting (79 ± 10 s) increase in activity in ten (77%)
units (fig. 4.1). The mean peak discharge, obtained over a 15 s time
interval, was 1.8 ± 0.4 i.p.s., and the mean total number of action
potentials evoked above basal discharge (delta Sx) was 72 ± 18. This
response was less consistent than rapid excitation and no dose-
dependency was observed. Unit responses to a standard dose of 10 fig are
shown in figure 4.4. The majority of units displayed both types of
response, with only one unit showing only the delayed effect in response
to a single 10 fig dose.
Arthritic joints
From nine experiments eleven slowly adapting mechanonoreceptors with a
mean afferent fibre conduction velocity of 2.1 ± 1.0 ms~l (range: 0.3 -
7.8 ms'l) were examined. These units had a mean resting discharge of 0.8
±0.2 i.p.s. .
Capsaicin (1 - 10 fig, i.a.) consistently activated all of the units
tested (table 4.1). The responses were of short latency (0.7 ± 0.2 s),
short duration (22 ± 4 s) and high discharge frequency. The mean peak





I I normals n=6 HI arthritics n=5
Fig. 4.2 Mean peak response and duration of rapid excitation evoked by
a standard dose of 10 ng capsaicin (i.a.) in normal and arthritic
joints. Not all units were tested with this dose of capsaicin. (A) The
peak discharge, obtained over a 15 s recording period, was greater,
although not significantly (p < 0.05, Wilcoxon), in arthritic rats
compared with normals. (B) The duration of the rapid excitation was also
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Fig 4.3 Computer-generated plot illustrating the response of a slowly
adapting mechanoreceptor unit from a normal joint to repeated i.a.
injection of 5 fig capsaicin (given at arrow). Each collection bin (bar)
represents a 1 s time period. Responses to mechanical stimuli (applied
at arrow heads) were not increased by capsaicin. This unit had an
afferent fibre conduction velocity of 0.8 ms"l. Consecutively labelled
graphs (A) and (B) represent consecutive injections of capsaicin.
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I I normals n=4 HI arthritics n=3
Fig- 4.4 Mean peak response and duration of delayed excitation evoked
by a standard dose of 10 pg capsaicin (i.a.) in normal and arthritic
joints. Not all units were tested with this dose of capsaicin. (A) The
peak discharge, obtained over a 15 s recording period, was marginally
greater in arthritic rats compared with normals. (B) The duration of the
rapid excitation was also longer, although not significantly (p < 0.05,
Wilcoxon) for arthritics.
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the mean total number of evoked action potentials above basal discharge
(delta Ex) was 106 ± 33. This effect is greater than that seen in
receptors from normal joints for the same dose levels of capsaicin. Unit
responses to a standard dose of 10 fig are shown in figure 4.2. Repeated
injections of 1 - 10 fig doses at intervals of 15 minutes evoked a
consistent response. Application at shorter intervals caused a reduction
of the response to develop. Dose-dependent effects were observed in
three units.
In addition to rapid excitation, capsaicin also evoked a delayed (51 ±
8.6 s), longer lasting (195 ± 67 s) increase in activity in seven (64%)
units. The mean peak discharge, obtained over a 15 s time interval, was
2.4 ± 0.6 i.p.s., and the mean total number of action potentials evoked
above basal discharge (delta Ex) was 195 ± 67. This effect is of greater
amplitude and duration to that seen in normal joints. Unit responses to
a standard dose of 10 fig are shown in figure 4.4. The delayed response
was less consistent than rapid excition and it was not possible to
determine dose-dependency. The rapid excitation was seen for ten (91%)
of eleven units and the delayed response for seven (64%) of eleven
units. One unit gave only the delayed response and four units only the
rapid excitation.
4.2.1.2 Effects on mechanoreceptor responsiveness
Normal joints
From five experiments seven units were examined for the affects of
capsaicin (1 - 10 fig, i.a.) on their responsiveness to a standard
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mechanical stimulus applied once every 2 minutes, responsiveness was
increased (sensitization) in four (57%) (see fig 4.1). Mechanical
sensitization occurred after a delay of 15 seconds in three units and 2
minutes in the fourth, and lasted for one to two stimuli. A summary of
unit responses is shown in figure 4.5. The mean peak response was 162%
of the pre-injection control. Dose-dependency of the effect was seen in
three units.
Arthritic joints
In nine units from six experiments, capsaicin (1 - 10 ng, i.a.) caused a
sensitization to mechanical stimuli in seven (77%) (fig 4.4). A delay of
15 seconds in five units and 2 minutes in two units occurred before the
onset of the response which lasted for one to four stimuli (see fig.
4.1). The mean peak response was 161% of the pre-injection control.
Dose-dependency was not seen in these units. In three of the
mechanoreceptors sensitized by 1 - 5 /ig capsaicin, a subsequent
injection of 10 ng caused a short lived reduction in responsiveness to
mechanical stimuli. A further unit gave only this reduction in
responsiveness following capsaicin injection.
4.2.1.3 Excitation of chemosensitive units
Normal joints
In this study four recordings consisting of between one and three
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Fig. 4.5 Pooled data showing changes in mechanoreceptor responsiveness
caused by the i.a. injection of capsaicin in normal and arthritic
joints. Changes in responsiveness of the four mechanoreceptors from
normal joints and seven mechanoreceptors from arthritic joints that were
briefly sensitized to mechanical stimuli following injection of
capsaicin (at arrow). For these units responses are shown for a median
dose of 5 ng capsaicin for normal and arthritic groups. Each bar
represents the mean response of five units to mechanical stimuli applied
every 2 mins. Sensitization in arthritic joints was of longer duration
than that seen in normals. Significant differences from control pre-
injection responses are shown as * when p < 0.05 (Wilcoxon).
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low level of background activity (mean; 1.2 ± 0.6 i.p.s), for which no
mechanoreceptive fields could be found. Their action potential spike
shape characteristics were similar to those of identified C-fibre
afferents, in terms of spike width and amplitude (see Section III).
Capsaicin (1 - 10 ng, i.a.) consistently activated all of the units
tested (table 4.1). In all recordings injection of capsaicin evoked
responses of short latency (0.8 ± 0.4 s), short duration (22 ± 9.6 s)
and high discharge frequency. The mean peak discharge, obtained over a
15 second time period, was 4.7 ± 2.0 i.p.s.. Capsaicin also evoked a
delayed (33 ± 14 s), longer lasting (79 ± 10 s) increase in activity in
three (75%) recordings. The mean peak discharge of the delayed
excitation, obtained over a 15 s time interval, was 3.2 ± 2.2 i.p.s..
Arthritic joints
Six recordings, consisting of between one and three different action
potential spikes, were obtained from units for which no mechanoreceptive
fields could be found. Their action potential spike shape
characteristics were similar to those of identified C fibre afferents
(see Section III), and their mean rate of resting discharge before the
injection of capsicin was 1.3 ± 0.3 i.p.s..
In all recordings injection of capsaicin (1 - 10 pg, i.a.) evoked
responses of short latency (1.1 ± 0.2 s), short duration (18 ± 3.3 s)
and high discharge frequency (table 4.1). The mean peak discharge,
obtained over a 15 s time period, was 8.3 ± 1.9 i.p.s..
The delayed (44 ± 10 s), longer lasting (149 ± 33 s) increase in
activity was obtained in four (67%) recordings. The mean peak discharge,
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obtained over a 15 s time interval, was 4 ± 0.6 i.p.s..
4.2.1.4 Effects of other algogens on mechanoreceptors excited by
capsaicin
The excitatory effects of capsaicin were examined in experiments in
which other putative mediator substances were also being tested. A
summary of the results obtained is shown in table 4.2. From this
information it can be seen that capsaicin excited all of the units
excited by bradykinin (0.1 - 40 fig, i.a.), 5-HT (1 - 100 fig, i.a.), PGE2
(0.03 - 3 fig, i.a.) and the selective PGI2 (IP-) receptor agonist
cicaprost (0.01 - 5 fig, i.a.). Two units not excited by bradykinin and
three units not excited by PGE2 were sensitive to capsaicin.
4.2.2 In vitro electrophysiology
4.2.2.1 Excitatory effects on mechanoreceptors
From six experiments on normal joints, six high-threshold slowly
adapting mechanoreceptors with action potential spike shape
characteristics similar to those of identified C fibres were examined.
These units had a mean ongoing resting discharge of 0.07 ± 0.05 i.p.s..
Capsaicin (0.01 - 10 fig, i.a.) activated five (83X) of the six units
tested (table 4.3). Injection of capsaicin evoked responses of short
latency (1.8 ± 0.3 s), short duration (25 ± 9.4 s) and high discharge
frequency (see fig. 4.6). The mean peak discharge, obtained over a 15 s
time period, was 2.4 ± 1.0 i.p.s., and the mean total number of evoked
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Fig. 4.6 Response of an articular mechanonociceptor to i.a. injection
of capsaicin in vitro. (A) Neurogram of the discharge pattern of rapid
excitation evoked by injection of capsaicin (0.1 pg, i.a.). (B)
Computer-generated plot of the discharge evoked by the same injection of
capsaicin shown in the neurogram. The time period corresponding to that
in the neurogram is indicated above the graph. Each bin (bar) represents
a 1 s time period. The inset shows thirty superimposed triggered
oscilloscope sweeps of the recorded unit action potential.
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action potentials above basal discharge (delta Ex) was 23 ± 9.
In addition to rapid excitation, capsaicin also evoked a delayed (68 ±
12 s), longer lasting (206 ± 61 s) increase in activity in three (50%)
units (Fig. 4.5). The mean peak discharge, obtained over a 15 s time
interval, was 0.5 ± 0.1 i.p.s., and the mean total number of action
potentials evoked above basal discharge (delta Sx) was 12 ± 2. Three
units displayed both types of response, one unit only the rapid
excitation and one unit only the delayed response (Fig.4.7).
4.2.2.2 Excitation of chemosensitive units
In this series of experiments nine recordings consisting of between one
and three different action potential spikes were obtained from units,
for which no mechanoreceptive fields could be found. Their action
potential spike shape characteristics were similar to those of
identified C-fibre afferents, and they had a resting discharge of 0.6 ±
0.1 i.p.s..
Capsaicin (1 - 10 ng, i.a.) consistently activated all of the units
tested (table 4.3). In all recordings injection of capsaicin evoked
responses of short latency (1.9 ± 0.3 s), short duration (12 ± 2 s) and
high discharge frequency. The mean peak discharge, obtained over a 15 s
time period, was 4.8 ± 1.4 i.p.s.. Capsaicin also evoked a delayed (42 ±
10 s), longer lasting (118 ± 22 s) increase in activity in three (75Z)
recordings. The mean peak discharge, obtained over a 15 s time interval,














Fig. 4.7 Response of an articular mechanonociceptor to i.a. injection
of capsaicin in vitro. (A) Neurogram of the discharge pattern of delayed
excitation evoked by injection of capsaicin (1 fig, i.a.). The inset
trace on the right shows thirty superimposed triggered oscilloscope
sweeps of the recorded unit action potential. (B) Computer-generated
plot of the discharge evoked by the same injection of capsaicin shown in
the neurogram. The time period corresponding to that in the neurogram is
indicated above the graph. Each bin (bar) represents a 1 s time period.
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4.2.2.3 Effects of other algogens on mechanoreceptors excited by
capsaicin
The excitatory effects of capsaicin were examined in experiments in
which other putative mediator substances were also being tested. A
summary of the results is shown in table 4.4. Capsaicin excited all but
one of the units excited by bradykinin (0.1 - 10 fig, i.a.), 5-HT (0.01 -
100 fig, i.a.), PGE2 (0.01 - 10 fig, i.a.) or the selective PGI2 (IP-)
receptor agonist cicaprost (0.01 - 1 fig, i.a.). Three units not excited
by bradykinin, two units not excited by PGE2, and one unit not excited
by 5-HT were sensitive to capsaicin.
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These results show that capsaicin potently excites articular high
threshold mechanoreceptors with afferent fibre conduction velocities in
the C fibre and fine A-delta range. This differs from the situation
reported for skin where only A-delta and C-polymodal nociceptors were
excited, with C and A-delta high threshold mechanoreceptors being
insensitive to the drug (Foster & Ramage, 1981; Renins, 1982;
Szolcsanyi, 1987; Szolcsanyi et al., 1988). The afferent axons of all
the receptors studied here, have previously been reported to be
unmyelinated at their peripheral regions, and as such might be expected
to be equally sensitive to chemical stimuli (Paintal, 1971). Units with
conduction velocities in the C fibre or A-delta range were equally
responsive to capsaicin, suggesting that they do not differ functionally
in this respect. Both types of unit also have similar mechanical
response characteristics (see Section III and Guilbaud et al., 1985).
The sensory receptors examined here are normally insensitive to noxious
thermal stimuli (Guilbaud et al., 1985), and therefore, cannot be
classified as polymodal. Thus, it can be concluded that the receptors
described in the present series of studies constitute a population of C
and fine A-delta articular nociceptors responding selectively, under
non-pathological conditions, to chemical and strong mechanical stimuli.
Capsaicin-evoked responses of rapid onset and with high discharge
rates have been reported by other workers (Foster & Ramage, 1981;
Renins, 1982; Szolcsanyi, 1987), whereas the longer latency response
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observed in the present study have not previously been described. This
response was seen both in vivo and in vitro, eliminating the possibility
of the involvement of second pass effects, systemic release of blood
borne mediators, or reflex effects mediated through the spinal cord. The
minimally effective dose of capsaicin in vitro was at least ten times
lower than that required in vivo. As the mechanonociceptors under study
did not have any greater mechanical sensitivity in vitro (see Section
III), this difference may be due to an improved access of capsaicin to
these receptors via the vasculature. Although no obvoius pathology was
seen in these experiments, damage to the vessel walls or endothelium
caused by the perfusion could be responsible for increasing their
permeability.
Capsaicin-induced sensitization of nociceptors, which follows a
similar time course to the delayed excitation, has not previously been
reported in electrophysiological studies. Capsaicin is known to induce
the release of neuropeptides such as substance P from sensory terminals
in the periphery (Hoover, 1987; Renzi et al., 1988; Manzini et al.,
1989), which may in turn release other mediators such as the prostanoids
or 5-HT (see Holzer, 1988). Thus, it is possible that delayed excitation
or mechanical sensitization occur secondary to the production of other
local effector substances. Alternatively, increased levels of
intracellular Ca^+, resulting from the opening of cation channels in the
cell membrane (Bevan & Forbes, 1988), may result in the activation of
second messenger systems involved in the control of neuronal
excitability. This mechanism could also account for the delayed and
sustained nature of these responses. Further investigations using
selective neuropeptide antagonists, inhibitors of arachidonic acid
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metabolism and manipulations of second messenger mechanisms will be
necessary in order to determine the significance of these systems in the
delayed effects of capsaicin.
Desensitization of nociceptor responses to capsaicin seen in the
present study have also been reported extensively by other workers
(Szolcsanyi, 1987; Belmonte et al., 1988; Bettaney et al., 1988a). In
the rabbit skin (Szolcsanyi, 1987) and cat cornea (Belmonte et al.,
1988), high doses of capsaicin non-selectively abolished the responses
of C-polymodal nociceptors to mechanical, chemical and thermal stimuli.
However, in the neonatal rat spinal cord-tail preparation in vitro,
using lower doses, selective desensitization to capsaicin was achieved,
with responses to mechanical and thermal stimuli, and bradykinin, being
unaffected. This finding is supported by results from the present series
of experiments where single injections of low doses had no affect on
nociceptor reponses to mechanical or further chemical stimuli.
Capsaicin-induced excitation of afferent units for which no
mechanosensitive receptive fields could be found had the same response
pattern as seen for identified mechanoreceptors. These sensory receptors
are also excited by bradykinin, 5-HT and the prostanoids (see Sections
V-VII). Other workers have recently identified mechanically and
thermally insensitive cutaneous C fibre units which are excited by
chemical stimuli (Meyer & Campbell, 1988; Davies et al., 1989). These
specifically 'chemosensitive' sensory receptors may have an important
role to play during inflammation (see Section III).
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4.3.2 Arthritic joints
Both rapid and delayed excitation of receptors was observed in
recordings from arthritic joints. The rapid response was of greater
magnitude and longer duration, suggesting that these receptors had a
higher level of excitability than those in normal joints. Delayed
excitation and capsaicin-induced sensitization to mechanical stimuli
were also of longer duration. Enhanced responsiveness to capsaicin may
result from the actions of various inflammatory mediators on sensory
receptors in the chronically inflamed joint. In the neonatal rat spinal
cord-tail preparation in vitro PGE^ and PGE2 have been shown to markedly
potentiate capsaicin-induced ventral root depolarization via an effect
on peripheral nerve endings (Yanagisawa et al., 1986). PGE2 has also
been shown to potentiate the excitatory effects of capsaicin in skin, as
recorded from thalamic neurones in the cat (Andoh et al., 1982). This
finding suggests that prostanoids may be at least partly responsible for
the enhancement of the effects of capsaicin seen in arthritic joints
(see also Sections VII). If the delayed effects of capsaicin observed in
the present study are produced secondary to the release of other
substances, then their enhancement in chronically inflamed tissues may
occur as a result of increased release of these substances. As discussed
in Section III of this thesis levels of substance P in sensory neurones
are elevated as a result of the arthritic lesion, and therefore, more
will be available for release when the nerve is depolarized by
capsaicin. Furthermore, the greater availability of a variety of cell
types from which other mediators could be released, may add to this
effect.
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Depression of mechanoreceptor responsiveness seen in a small number of
units from arthritic rats may occur as a result of the nonselective
desensitizing effect of capsaicin reported by other workers (Szolcsanyi,
1987; Belmonte et al., 1988; Bettaney et al., 1988a). Mechanoreceptor
desensitization was only observed in units from arthritic joints, and
may be related to the enhanced effect of capsaicin in these tissues.
Desensitization of C-polymodal nociceptors has been shown not to be a
general phenomena. Thus, in the rabbit skin desensitization of a single
nociceptor to all forms of stimuli was not observed (Szolcsanyi, 1987).
This finding suggests that desensitization does not occur as a result of
action potential blockade, a known property of high dose capsaicin
(Petsche et al., 1983; Handwerker et al., 1984; Lynn et al., 1984), but
rather results from effects on the impulse-generating mechanisms for the
different modalities (Szolcsanyi, 1987). Anti-nociceptive effects of
capsaicin, mediated via central and peripheral terminals, have recently
been demonstrated (Dickenson et al., 1990). It has been suggested that
these effects may be mediated via long-lasting inhibition of voltage-
gated Ca^+ channels induced by capsaicin (Bevan & Szolcsanyi, 1990).
4.4 CONCLUSIONS
Results from the present study suggest that capsaicin can be used as a
selective pharmacological probe to test the accessibility of
chemosensitive nociceptors via the blood supply. Its usefulness in
neuropharmacological experiments is supported by the finding that
single, low dose injections do not have any long lasting effect on
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mechanonociceptor responsiveness. The longer duration effects of
capsaicin on mechanonociceptors from arthritic joints, suggests that
these receptors are more sensitive to chemical stimuli than those from
normal joints. This is supported by findings reported in Section VI
showing that 5-HT also has greater effects on mechanonociceptors from
arthritic joints.
Electrophysiological studies in vitro have shown that tarsal joint
mechanonociceptors function normally under conditions of combined
superfusion and slow perfusion, responses to mechanical (see Section
III) and chemical stimuli being maintained for periods of several hours.
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SECTION V
EFFECTS OF BRADYKININ ON ARTICULAR SENSORY RECEPTORS
IN THE RAT ANKLE JOINT
5.1 INTRODUCTION
The generation of plasma kinins is increased markedly during
inflammation (Lewis, 1970). Local production of bradykinin in
inflammatory exudates causes vasodilation and tissue oedema (Regoli &
Barabe, 1980), and bradykinin is also a powerful algesic agent causing
intense, burning pain when applied to the exposed blister base at
concentrations below 0.1 /iM (Keele & Armstrong, 1964). Bradykinin is
also known to cause pain in man when injected intra-arterially (Burch &
Pasquale, 1962; Coffman, 1966;), subdermally (Lim et al., 1967;
Ferreira, 1972) or intra-abdominally (Lim et al., 1967). Furthermore,
pseudoaffective responses in animals are produced by injection of
bradykinin intra-arterially (Guzman et al., 1962; Hashimoto et al.
1964; Ferreira et al., 1973) or intra-articularly (Melmon et al., 1967;
Moncada et al., 1975).
Electrophysiological studies have demonstrated that bradykinin excites
nociceptors from a variety of tissues including the skin (Beck &
Handwerker, 1974; Chahl & Iggo, 1977; Fjallbrant & Iggo, 1961), viscera
(Haupt et al., 1983; Kumazawa & Mizumura, 1976), muscle (Mense 6c
Schmidt, 1974; Kumazawa 6c Mizumura, 1977b) and joints (Kanaka et al.
1985). Bradykinin-induced sensitization of muscular nociceptors to
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mechanical stimuli has also been shown (Mense & Meyer, 1987).
The present study examined the effects of bradykinin on articular
nociceptive sensory receptors in the ankle joint of the rat. Assessment
of bradykinin's actions on sensory receptors in arthritic joints was
also carried out to determine the actions of the peptide on
mechanonociceptors during chronic inflammation.
5.2 RESULTS
5.2,1 Electrophysiology in vivo
The effects of intra-arterial injections of bradykinin on articular
mechanonociceptors were examined in normal and arthritic joints.
Bradykinin excited and sensitized mechanosensitive units from the ankle
joints of both groups of animals (fig. 5.1). No difference in
responsiveness between receptors with C or A-delta afferent fibres was
found. Excitation of units for which no mechanoreceptive fields could be
found was also produced. However, as their response characteristics were
similar to those of the mechanoreceptors which could be identified more
fully, responses of these units were not analysed routinely in this
series of experiments.
Normal joints
In twenty four experiments using normal rats, thirty three high-
threshold slowly adapting mechanoreceptors with A-delta and C fibre
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Fig. 5.1 Computer-generated plots showing bradykinin-induced activation
and increased responsiveness to mechanical stimuli given once every two
minutes. (A) Neurogram showing mechanically evoked activity in the high
threshold mechanoreceptor unit with an afferent fibre conduction
velocity of 0.4 ms-1. Dynamic and slowly adapting responses can be seen.
The inset shows thirty superimposed triggered oscilloscope sweeps of the
action potential generated by stimulation of the mechanoreceptor. (B)
Mechanical sensitization caused by injection of 1 /ig bradykinin (at
arrow). The number of action potentials evoked by each mechanical
stimulus (applied at arrowheads) is given above each response. (C)
Mechanoreceptor excitation evoked by injection of 10 /ig bradykinin (at
arrow). Mechanoreceptor sensitization was not seen with this higher dose





























afferent (mean afferent fibre conduction velocity: 2.0 ± 0.5 ms"^-,
range: 0.38 - 8.5 ms"l) were examined for their responsiveness to
bradykinin. Eleven (33%) of these units had an ongoing spontaneous
discharge of 0.4 ± 0.1 i.p.s. under resting conditions.
Arthritic joints
In ten experiments thirteen slowly adapting mechanoreceptors with C and
A-delta afferent fibres (1.2 ± 0.6 ms"^, range: 0.3 - 4.0 ms~l) were
examined for their responsiveness to bradykinin using arthritic joints.
In contrast to the small number of acive units seen in normal joints
eleven (85%) of these units had a resting discharge of 1.4 ± 0.4 i.p.s..
5.2.1.1 Bradykinin-induced excitation
Normal joints -
Injection of bradykinin (0.1 - 40 ng, i.a.) excited twenty five (76%) of
the thirty three units. The minimal effective dose ranged from 0.1 - 10
Hg for the twenty one units examined to determine this parameter (fig.
5.2). In four units tested with only a single dose of 40 /xg, three (75%)
responded with a prolonged, large increase in discharge. Excitation had
a mean latency to onset of 65 ± 11 seconds and a mean duration of 171 ±
18 seconds.
Examination of dose-dependency (0.1 - 10 /xg, i.a.) was carried out on
nineteen units of which seven (37%) displayed a clear dose-response














Fig. 5.2 Minimal effective doses of bradykinin causing excitation of
high threshold mechanoreceptors from normal (n-21) and arthritic (n-9)
joints. The number of units (n) with minimal effective doses of 0.1, 1.0
and 10 fig are shown. The percentage of excitable units giving an initial
response to each dose is given above the appropriate bar. As can be seen
from the graph, a greater proportion of units from normal joints were
excited by a lower minimal effective dose than were units from arthritic
joints.
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Fig. 5.3 Dose-dependent excitatory effects of bradykinin on high
thresholds mechanoreceptors from normal joints. Clear dose dependent
effects were seen in seven units ( ■ ). These units had a mean afferent
fibre conduction velocity of 1.3 ± 0.4 ms-1. Desensitization occurred at
the highest dose of 10 /ig in six units ( □ ), and further six units no
dose dependent effect was evident (x). These twelve units have a mean
afferent fibre conduction velocity of 2.5 ± 0.7 ms-1.
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discharge alone did not consistently reveal a dose-dependent effect of
bradykinin, as duration of response also increased with the dose
administered. Thus, responses are expressed as the total number of
impulses above basal discharge produced for the duration of the effect
(integrated response given as delta Ex as detailed in Section II). The
dose-response curve for the twelve units not responding in a dose-
dependent manner was flat in appearance with a low maximum (fig. 5.3).
The mean maximal integrated response for units examined for dose-
dependency (0.1 - 10 fig) was 157 ± 48 impulses above basal (delta Ex),
with a mean peak discharge obtained over a fifteen second period of 2.9
± 1.1 i.p.s.. Maximal responses were produced by a median dose of 1.0 fig
(see table 5.1).
The four units tested with only high dose (40 fig) bradykinin gave a
mean maximal response of 238 ± 83 impulses (delta Ex), with a mean peak
discharge of 2.9 ± 0.4 i.p.s. over a 15 s time period. In two units for
which a second injection of 40 fig bradykinin was given, tachyphylaxis of
the response was evident.
Arthritic joints
Injection of bradykinin (0.1 - 40 fig, i.a.) excited ten (77X) of the
thirteen units. The minimal dose for receptor excitation ranged from 0.1
- 10 fig (f^S- 5.2). Excitation had a mean latency to onset of 27 ± 8
seconds and a mean duration of 120 ± 20 seconds.
Maximal responses were evoked by a median dose of 1.0 fig for units
tested with doses of 0.1 - 10 fig. A mean maximal integrated response of
209 ± 85 impulses above basal discharge (Ex) was obtained, the mean peak
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mean unit max 157 ± 48 209 ± 85 **
(delta Zx)
latency (s) 71 ± 24 ** 27 ± 8
duration (s) 256 ± 40 ** 120 ± 20
** significantly greater value (p < 0.01)
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discharge over a 15 s time period being 4.5 ± 1.2 i.p.s. (table 5.1).
Responses to bradykinin were dose-dependent in five of the ten units,
the remaining ten responsive units displaying either an 'all-or-none'
type response or reduced responsiveness with increasing dose.
5.2.1.2 Effects on mechanonociceptor responsiveness
Normal joints
Twenty six mechanonociceptors were examined for the effects of
bradykinin (0.1 - 40 fig, i.a.) on their responsiveness to controlled
mechanical stimuli. Increased responsiveness to mechanical stimuli
(sensitization) following injection of bradykinin was seen for eighteen
(70%) of these units. There was no correlation between units that were
excited by bradykinin and those that were sensitized to mechanical
stimuli. Thus,, four units (15%) which were not excited by bradykinin
were also unaffected in their responsiveness to mechanical stimuli,
another four (15%) units sensitized to mechanical stimuli were not
excited by the drug, and a further four units excited by bradykinin were
not sensitized to mechanical stimuli.
The minimal dose causing receptor sensitization was between 0.1 and 10
fig (fig. 5.4). Bradykinin-induced changes in receptor responsiveness had
a latency to onset of between 15 seconds and 6 minutes (mean: 2.5 ± 0.5
minutes), and lasted for between one and ten mechanical stimuli (mean
duration: 6.5 ± 1.0 minutes).
Thirteen responsive units were examined for the construction of a dose
response curve to bradykinin (0.1 - 10 fig, i.a.), and of these only four














Fig. 5.4 Minimal effective doses of bradykinin causing increased
responsiveness of high threshold mechanoreceptors to mechanical
stimulation in normal (n=-14) and arthritic (n—4) joints. The number of
units (n) responding to minimal effective doses of 0.1, 1.0 and 10 fig
are shown. The percentage of excitable units giving an initial response
to each dose is given above the appropriate bar. No clear difference in
minimal effective dose was seen between units from normal and arthritic
joints.
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nine units a reduction in sensitization response was observed with
increasing doses of bradykinin (Fig 5.6). There was no correlation
between units that were excited and those that were sensitized to
mechanical stimuli in terms of dose-related effects. Thus, three units
which showed reduced responsiveness to mechanical sensitization were
excited in a dose-dependent manner, and four units which were sensitized
by bradykinin in a dose-dependent manner were susceptible to reduced
excitation at higher doses. For doses of 0.1 - 10 fig, maximal unit
responses were produced by the full range of doses (Fig. 5. 8).
Arthritic joints
Nine mechanonociceptors were examined for the effects of bradykinin (0.1
- 40 fig, i.a.) on their responsiveness to mechanical stimuli. Of these
units, four (44%) displayed an increased responsiveness to mechanical
stimuli following injection of bradykinin. The minimal dose for receptor
sensitization was between 0.1 and 5 fig (fig. 5.4). Bradykinin-induced
changes in responsiveness had a mean latency of between 15 seconds and 4
minutes (mean: 2 ± 1 mins), and lasted for between three and ten stimuli
(mean duration: 4.5 ± 0.4 mins).
Of four units which were examined for dose-dependent effects, only two
responded in a dose-dependent manner (Fig 5.7). For the other two units,
desensitization to increasing doses of bradykinin occurred. For doses of
0.1 - 10 fig, maximal unit responses to injections of bradykinin were
produced by the full range of doses (Fig. 5.8).
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Fig. 5.5 Dose-dependent effects of increased responsiveness of
articular mechanonociceptors caused by bradykinin in normal joints. Each
bar represents the mean response of four units to mechanical stimuli
applied every two minutes following injection of bradykinin (upper
panel, 0.1 /xg; middle panel, 1.0 fxg; lower panel, 10 fxg, i.a.).
Significant increases were only seen with the highest dose used of 10
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Fig. 5.6 Desensitization of increased mechanonociceptor responsiveness
to increasing doses of bradykinin. Each bar represents the mean response
of nine units to mechanical stimuli applied every 2 minutes following
injection of bradykinin (upper panel: 0.1 pg, middle panel: 1.0 /xg,
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Fig. 5.7 Dose-dependent effects of bradykinin on increased
responsiveness of mechanonociceptors in arthritic joints. Each bar
represents the mean response of two units to mechanical stimuli applied
at each time point following i.a. injection of bradykinin (upper panel:
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-2 A 0 2 4 6 8 10 12 14 16 18
Time from injection (mins)t
I I normals n=14 arthritics n=4
Fig. 5.8 Maximal bradykinin-induced increases in mechanonociceptor
responsiveness in normal and arthritic rats. Maximal unit responses to
bradykinin are illustrated, with each bar representing the mean value
for responses to mechanical stimuli applied every 2 minutes. Maximal
responses were caused by a median dose of 1.0 pg both in normals and
arthritics. Although the peak effect was greater for units from
arthritic animals, the response was of longer duration in normals. * p <
0.05.
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5.2.2 Electrophysiology in vitro
Responses of articular sensory receptors to bradykinin were examined
using the in vitro isolated hind limb preparation described in detail in
the Section II. In eleven experiments afferent activity was examined
both for units with identified mechanoreceptive fields in the ankle
joint tissues, and units for which no response to mechanical probing was
obtained, but which were activated by injection of bradykinin. All the
units studied had action potential spike shapes similar to those of
identified C fibre afferent units. Identified high threshold slowly
adapting mechanoreceptors had afferent fibre conduction velocities
ranging from 0.4 - 2.0 ms'^.
5.2.2.1 Mechanonocieceptors
Injections of .bradykinin (0.1 - 10 ng, i.a.) into the hind-limb
perfusate produced excitation of only one mechanonociceceptor unit out
of six that were excited by injections of capsaicin or other chemicals
(see Section IV). The highest dose of 10 ng bradykinin was required to
excite this receptor.
5.2.2.2 Chemosensitive units
Injections of bradykinin (0.1 - 10 ng) excited eight (89%) from nine
non-mechanoresponsive units. The minimal effective dose for was between
0.1 and 10 /ig, and for the single mechanosensitive unit was 10 ng (fig.
5.9). The mean latency to onset of the response to bradykinin was 36 ±
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minimal excitatory dose
Fig. 5.9 Minimal effective doses for bradykinin-induced excitation of
high threshold mechanoreceptor and non-mechanoresponsive units.
Mechanoreceptors were relatively insensitive to the excitatory effects
of bradykinin.
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Fig. 5.10 Dose-dependent excitatory effects of bradykinin on articular
sensory receptors. Dose-dependent responses were obtained in seven of
nine units.
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11 seconds, and the mean duration was 228 ± 30 seconds.
Dose-dependent effects of bradykinin were examined in all units for
doses of 0.1 - 10 /ig. From the nine non-mechanosensitive units seven
responded in a dose-dependent manner, with the remaining unit displaying
a reduced response to the highest dose used (fig. 5.10).
5.3 DISCUSSION
In this series of experiments intra-arterial injection of bradykinin
both excited and increased the mechanical responsiveness of articular
high-threshold mechanoreceptors with afferent fibre conduction
velocities in the C and A-delta range. These responses are seen in both
from normal and arthritic joints. Furthermore, demonstration of the
excitatory effects of bradykinin on articular receptors has also been
accomplished in vitro.
5.3,1 In vivo electrophysiology
5.3.1.1 Bradykinin-induced excitation
The doses of bradykinin (i.a.) required for receptor excitation in the
present investigation were in the same order of magnitude as those shown
to excite C or A-delta afferent units from the knee joint of the cat
(Kanaka et al., 1985). In other feline tissues including muscle (Franz &
Mense, 1975), viscera (Haupt et al., 1983) and skin (Beck & Handwerker,
1974) similar doses caused nociceptor excitation following intra-
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arterial bolus injection. Over more prolonged periods of application,
comparable concentrations of bradykinin have been shown to excite canine
muscular (Kumazawa & Mizumura, 1977a) and testicular (Kumazawa &
Mizumura, 1980b) polymodal nociceptors. Bradykinin has also been
reported to excite cutaneous low-threshold slowly adapting
mechanoreceptors (Beck & Handwerker, 1974; Fjallbrant & Iggo, 1961).
In the present study, no separation of effects on articular receptors
with A-delta or C fibre afferents was found. This lack of selectivity
has also been demonstrated for nociceptors from the cat knee joint
(Kanaka et al., 1985), and from muscle (Mense, 1977), where
approximately equal numbers of A-delta and C fibre units are excited by
bradykinin.
Tachyphylaxis of responses to bradykinin, found here in articular
receptors has been reported for nociceptors in many other tissues, and
is a characteristic of bradykinin-evoked pain in the blister base (Keele
& Armstrong, 1964). As in the present study, dose-response curves
constructed for the effects of bradykinin on nociceptors from muscle
(Mense, 1977) were often bell-shaped, or responses were of an all-or-
nothing type.
Bradykinin excited 76% of units examined from the rat ankle joint, a
smaller proportion than that found in studies on cat knee joint
receptors (Kanaka et al., 1985) where thirty seven (92.5%) of forty C
and A-delta afferent units were excited by bradykinin. In other tissues,
similar proportions of responding units to those found in the present
experiments have been reported. These include skin 52% (Beck &
Handwerker, 1974), viscera 80% (Haupt et al., 1983), and muscle 60%
(Mense, 1977; Franz & Mense, 1975). In two studies carried out on
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cutaneous afferents, bradykinin did not produce any significant
activation of C fibre afferents (Chahl & Iggo, 1977; Fjallbrant & Iggo,
1961).
Differences in the proportions of sensitive sensory receptors may
reflect variation in tissue types, or heterogeneity in sensory receptor
populations. Kanaka et al. (1985) favour the idea that poor access to
particular receptors via the blood supply is responsible for this
variation, and in their study only those units initially excited by i.a.
KC1 were included in their final analysis. In the present study
injection of capsaicin (1-10 fig) at the end of the experiment excited
two units which were not previously excited by bradykinin (see Section
IV on capsaicin for further details). Desensitization of sensory units
to bradykinin may also complicate the matter. A further source of
variability arises from the demonstration that the algesic (Ferreira et
al., 1973; Moncada et al., 1975) or excitatory (Chahl & Iggo, 1977)
effects of bradykinin are dependent on the presence of prostanoids. It
has in fact been shown that bradykinin-induced excitation of nociceptors
from muscle or viscera is reduced by the administration of aspirin or
indomethacin (Mense, 1982; Kumazawa et al. 1987). It follows that the
presence of differing levels of prostanoids in tissues surrounding the
receptors under study will produce changes in excitability (also see
Section VII).
Direct excitatory effects of bradykinin on dissociated or cultured
sensory neurones have recently been demonstrated ( Higashi et al., 1982;
Baccaglini & Hogan, 1983; Weinreich, 1986; Lindsay & Rang, 1987) and
provide information regarding the mechanisms by which bradykinin induces
nociceptor activation. Bradykinin causes an increased sodium conductance
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in the soma of sensory neurones (Burgess et al., 1989). This is
associated with activation of phospholipase C, which results in the
generation of the second messengers 1,4,5-inositol triphosphate and
diacylglycerol. Diacylglycerol is known to activate protein kinase C,
and studies with phorbol esters and protein kinase C inhibitors suggest
that this enzyme is important in generating the excitatory inward
current (Burgess et al., 1989). Although the actions of bradykinin are
strongly dependent on the presence of other mediators in vivo, these
findings provide evidence that bradykinin is capable of producing
excitatory effects of its own.
5.3.1.2 Mechanonociceptor sensitization
In the present series of experiments, in addition to activating
articular mechanononociceptors, bradykinin also increased their
responsiveness (sensitization) to mechanical stimuli. Bradykinin-induced
sensitization of nociceptors to mechanical stimuli has been reported
previously in muscle (Mense & Meyer, 1987), where sensitization of 38%
of C and 67% of A-delta nociceptive afferent units was produced
following local intramuscular injection. As demonstrated in cat muscle
(Mense & Meyer, 1987), sensitization of ankle joint receptors shown here
can occur without activation, and vice versa. Furthermore, in the
present study, the two effects show independent desensitization,
suggesting that two different mechanisms may be responsible for
bradykinin-evoked excitation and sensitization.
The mechanism of action of bradykinin induced sensitization may not
involve a direct action on the nerves themselves, but may involve the
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release of other mediators from surrounding tissues. As mentioned above
bradykinin releases prostaglandins from many tissues (Juan et al., 1984)
and therefore sensitization may be produced by the action of the
prostanoids on the sensory receptors (Schaible & Schmidt, 1988b). Other
substance are also released by bradykinin including substance P (Lembeck
& Holzer, 1979) and leukotrienes (Samuelsson, 1983).
Results from electrophysiological studies on isolated sensory neurones
suggest that bradykinin may increase nociceptor excitability by a direct
effect of its own. As well as the protein kinase C mediated
depolarization mentioned above (Burgess et al., 1989), bradykinin also
inhibits a slow after-hyperpolarization in sensory neurones via blockade
of Ca^*-dependent (Weinreich, 1986). Inhibition of the slow after-
hyperpolarization leads to an increased level of excitability and
increases the potential firing rate in C-type nodose ganglion neurones
of the rabbit (Weinreich & Wonderin, 1987). Application of forskolin
mimics this effect of bradykinin, suggesting that it is mediated via
cyclic AMP.
The identification of two distinct mechanisms by which bradykinin may
excite or sensitize nociceptive neurones provides a possible explanation
for the independent occurrence of bradykinin-induced excitation and
sensitization in the present study. The involvement of separate second
messenger systems in the two types of response could also explain the
lack of cross desensitization seen here. Involvement of different
bradykinin receptors is unlikely, since both the excitatory and
sensitizing effects of bradykinin have been reported to be B2 receptor
mediated (Mizumura et al., 1990; Rang & Heyman, 1990).
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Actions of bradykinin in arthritic joints
The ability of bradykinin to excite and sensitize high-threshold
articular mechanoreceptors suggests that endogenous bradykinin could
play a role in the increased responsiveness of these receptors in
chronically inflamed joints. However, the behaviour of C and A-delta
afferent units in the arthritic joint (Guilbaud et al., 1985) differs
from that produced by bradykinin in these experiments. Long-lasting
increases in spontaneous activity were not seen following bradykinin
administration, and receptor sensitization was generally short-lived.
In arthritic joints, bradykinin was less potent than in normal joints
with regard to both excitation and sensitization of receptors. Repeated
administration of bradykinin in arthritic joints resulted in a marked
tachyphylaxis. During inflammation, when endogenous levels of bradykinin
are likely to be elevated (Lewis, 1970), additional application of
exogenous bradykinin will have to act on an elevated baseline. Thus
large increases will not be produced and susceptibility to
desensitization will be greater.
In addition to causing the release of other mediators involved in the
production of inflammatory pain, bradykinin has also been shown to cause
local release of opioid peptides (Kudo et al., 1986a,b). Several lines
of evidence exist to suggest that opioids may exert a peripheral
analgesic effect, particularly during inflammation (Ferreira &
Nakamura, 1979b; Hargreaves et al., 1988; Stein et al., 1988). Opiate-
induced reduction in afferent discharge from the inflamed cat knee joint
has also been described (Russell et al., 1987). It Is possible that in
the inflamed joint, endogenous opioids may be partly responsible for the
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variable responses produced by bradykinin in the present study.
Levels of bradykinin found in inflammatory exudates are generally low
and in man there is no correlation between pain severity and kinin
concentration in chronic arthritis (Melmon et al., 1967). These
findings, together with the results described above, support the idea
that bradykinin is involved in the production of pain when released
acutely. However, suseptibility to tachyphylaxis, and its inability to
cause sustained increases in afferent discharge and nociceptor
excitability, suggest that bradykinin could not be solely responsible
for the changes in nociceptor behaviour seen in chronically inflamed rat
ankle joints. Further investigations using selective bradykinin receptor
antagonists may help to determine the role played by the peptide in
enhanced nociceptor activity in arthritic joints.
5.3.2 In vitro electrophysiology
The demonstration that bradykinin excites articular receptors in vitro
suggests that this effect is not secondary to the systemic release of
other blood-borne mediators or to spinal reflex mechanisms. In the
present experiments, in vitro responses to bradykinin were dose-
dependent, or displayed desensitization with increasing doses, and as
such were essentially the same as those seen in vivo. Identified high
threshold mechanoreceptors were not excited as effectively in vitro,
suggesting that the responses of these units are dependent on certain
conditions present in vivo. This difference in responsiveness may be
partly due to the lower operating temperature in vitro (Kumazawa &
Mizumura, 1983), or may be due to the perfusion fluid washing out other
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substances present in the tissues, such as endogenous prostanoids.
Indeed, results reported in Section VII of this thesis dealing with the
potentiating effects of the prostanoids support this idea. The potent
excitatory effect of bradykinin on non-mechanosensitive fine afferent
units demonstrated in this study, has also been reported by other
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SECTION VI
EFFECTS OF 5-HT ON ARTICULAR SENSORY RECEPTORS
IN THE RAT ANKLE JOINT
6.1 INTRODUCTION
Keele & Armstrong (1964) demonstrated that 5-HT has the ability to cause
pain when applied to a blister base in man, and 5-HT was later shown to
lower thresholds for chemically-induced pain in humans (Sicuteri et al.,
1965), and to enhance pseudoaffective responses to bradykinin in animals
(Nakano & Tiara, 1976). Sensory nerve endings associated with small
myelinated and non-myelinated axons are activated and sensitized by 5-HT
in skin (Fjallbrant & Iggo, 1961; Beck & Handwerker, 1974) and muscle
(Mense, 1981), as are cutaneous slowly adapting type II mechanoreceptors
with rapidly conducting afferent fibres (Fjallbrant & Iggo, 1961).
Although the pain produced by application of 5-HT to a blister base is
antagonized by ICS 205-930, and therefore probably involves a 5-HT3
receptor (Donatsch et al., 1984b; Richardson et al., 1985), in most
cases the pharmacological identity of the 5-HT receptor associated with
nociceptive sensory endings has not been established. The present study
was undertaken to examine the effects of 5-HT on nociceptors in the rat
ankle joint, and to characterize the 5-HT receptors mediating these
effects by the use of selective receptor antagonists (Fozard et al.,
1984; Bradley et al., 1986; Brittain et al., 1987; Butler et al., 1988).
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Rats with localized adjuvant arthritis were used to investigate whether
5-HT plays a role in the increased sensitivity of articular
mechanonociceptors in chronically inflamed arthritic joints.
6.2 RESULTS
Two types of afferent unit activity were investigated: mechano¬
nociceptors for which receptive fields were identified in the joint
capsule; and chemosensitive (see Section IV) afferent units which either
had an ongoing discharge or were excited by 5-HT, but had no
identifiable receptive fields for mechanical stimuli (Table 6.1).
6.2.1 Electrophyslology in vivo
6.2.1.1 Mechanonociceptors
Normal joints
Mechanosensitive units with with receptors in normal ankle joint
capsular tissues were high-threshold, and slowly adapting with punctate
receptive fields of approximately 1mm diameter. Units had afferent fibre
conduction velocities in the range 2.1 - 10.5 ms"^* Only one
mechanosensitive unit had an ongoing discharge (0.2 i.p.s.) before the
addition of 5-HT, the rest were not spontaneously active.
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Arthritic joints
On average approximately three times as many mechanonociceptors were
found in athritic ankle joints compared with normals. The conduction
velocities of their afferent fibres ranged from 0.5 - 7.8 rns"^1
contrast to the lack of ongoing mechanonociceptor activity in normal
rats nine units had an ongoing low level of discharge equal to 1.2 ±
0.35 i.p.s. before the administration of 5-HT.
6.2.1.2 Effects of 5-HT on responsiveness to mechanical stimuli
Normal joints
In the six units examined, injection of 5-HT (1-100 fig, i.a) produced a
dose-dependent increase in responsiveness (sensitization) to the
standard mechanical stimulus (fig. 6.1). The minimal effective dose was
found to be 5 fig, this dose giving reproducible responses in all of the
units examined. As illustrated in figure 6.3 a mean peak increase of 56%
(n-4) was observed in response to subsequent stimuli following injection
of a minimally effective dose of 5^g 5-HT, and this effect lasted for 1
to 2 mechanical stimuli. Individual unit responses are illustrated in
figure 6.2. Larger doses of 5-HT had a more prolonged action as can be
seen in figure 6.1, where the response to a mechanical stimulus was
still elevated three minutes after the injection of 100 fig. Repeated
injections of 5-HT produced a sensitization to the drug in four
mechanonociceptors.
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Fig. 6.1 Effects of 5-HT on the activity of a mechanonociceptor from a
normal animal. (A) Neurogram showing the discharge pattern of the fast
response evoked by i.a. injection of 100 fig 5-HT at the arrow. (B)
Neurogram showing the discharge pattern of the slow response for the
same injection of 5-HT (at arrow) using a slower sweep speed. The line
trace below each neurogram represents the application of the mechanical
stimulus. (C) Computer-generated plot illustrating the fast and slow
responses to the same injection of 5-HT (at arrow) as shown in the
neurograms. Mechanical stimuli (arrowheads) were repeated once every
minute, and it can be seen that mechanical responsiveness was increased
following the injection. The number of action potentials evoked per
stimulus is given above each response. The inset shows 100 superimposed
triggered oscilloscope traces of the single afferent unit whose
discharge was counted. This unit had an afferent fibre conduction
velocity of 4 ms"l.
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Fig 6.2 Summary of the effects of 5-HT on responsiveness to mechanical
stimuli in mechanonociceptors from normal and arthritic joints Each bar
represents the response of a single mechanoreceptor to a mechanical
stimulus of 2 s duration repeated once every 2 mins both before and
after injection of 5-HT (at arrow). Values are expressed as a percentage
of the pre-injection (-2 min) response. Mechanonociceptor responses are
shown for i.a. injection of 5 ng 5-HT in four normal joints, and 1 pg 5-
HT in six arthritic joints. Although the time to peak and duration of
the sensitization evoked by 5-HT differed between units, it can be seen
that both the peak responsiveness and duration of effect were greater in
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Fig. 6.3 Effects of 5-HT on mechanoreceptor responsiveness both in
normal and arthritic joints. (A) Bar graph showing the mean increase in
mechanonociceptor responsiveness at the peak of the response evoked by 5
fig 5-HT (i.a.) in four normal joints (open bar), and by 1 fig 5-HT in six
arthritic joints (filled bar). Values are given as a percentage of the
pre-injection response. (B) Bar graph illustrating the mean duration of
increased responsiveness produced by the same injection of 5-HT (normal
joints, open bar; arthritic joints, filled bar). Error bars represent



























In all ten units examined a dose-dependent increase in responsiveness to
the standard mechanical stimulus was produced following the injection of
5-HT (1-100 fig). In six of these units the minimal effective dose for
production of consistent responses was determined and found to be 1 fig.
A mean increase of 75% (n-6) in response to subsequent mechanical
stimuli was produced following injection of this minimally effective
dose. This lasted for 1 to 3 mechanical stimuli, a duration which is
significantly greater (p < 0.05, Wilcoxon) than that produced by the
minimally effective dose of 5 ng 5-HT in normal rats (fig. 6.2).
Individual unit responses are illustrated in figure 6.2. Sensitization
of mechanonociceptor responses to 5-HT was observed in two units.
6.2.1.3 Excitatory effects of 5-HT on mechanonociceptors
Normal joints
From six mechanonociceptors, i.a. injection of 1 - 100 fig 5-HT evoked a
discharge in three previously silent mechanonociceptors and increased
the discharge of one unit from a very low initial level of discharge.
Thus 66X of the units were excited by 5-HT. The effect was reproducible
in two of these units at the highest dose used (100 fig 5-HT). A two-
component response was observed following injection of 5-HT consisting
of transient burst of activity with rapid onset (<10 s), followed by a
delayed (>20 s), longer lasting increase in discharge (fig 6.1). A
summary of responses evoked by injections of 5-HT can be seen in table
6.1, together with data from arthritc joints.
190
Arthritic joints
Increases in spontaneous activity of six (60X) of ten mechanonociceptors
was seen following injection of 5-HT (1 - 100 fig, i.a.). The biphasic
response seen in normal animals was much less conspicuous, being
obtained in only one recording. One unit gave only the fast response,
and three units responded with only the delayed increase in spontaneous
activity. Using counting periods of 15 s duration, in four units the
slow response consisted of a mean increase of 1.6 ± 0.6 i.p.s. above
basal discharge (1.1 ± 0.7 i.p.s) at the peak of the response. This
response lasted for 185 ± 34 seconds. This effect of 5-HT contrasts
markedly with the small response obtained following injection of 100 fig
5-HT in the normal rat (fig. 6.4). Ongoing activity in a seventh unit
showed only a depression of activity following 5-HT administration.
6.2.1.4 Chemosensitive units
Normal joints
In the twelve normal animals examined in this study sixteen recordings
consisting of between one and three different action potentials were
obtained from units with a low level of activity before the addition of
5-HT. Their action potential spike shape characteristics were similar to
those of identified C fibre afferents (see Section III), and their mean
rate of discharge was 1.4 ± 0.3 i.p.s.
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Table6.1Summaryofthnu berofmechanonociceptorsdchem sensitiveu itsexc ted5- HTandtheminimaleff ctivedosesf rtheseeffects. rapiddelayed NORMALmechanonociceptor64(67X)350%1 0 chemosensitive162(75%) ARTHRITICmechanonociceptor103(3 %)55 chemosensitive127(58%)100%) Thepercentageofu itsrespondingwithchtypeofresponseish wnbrack ts
Fig. 6.4 Comparison of 5-HT-induced slow excitation of mechanosensitive
units in normal and arthritic rats. (A) Bar graph showing the peak
increase in discharge produced by 100 /ig 5-HT (i.a.) in two responding
units of six tested from normal rats (open bars), and the mean increase
produced by 1 pg 5-HT in four of five units from arthritic ankle joints
(filled bar). The mean basal rate of discharge in arthritic rats was 1.1
± 0.8 i.p.s., whereas in control rats no activity was present before the
injection of 5-HT. (B) Bar graph showing the duration of effects for the
same injections shown in A. The vertical lines above each bar represent





















Spontaneously active units without identifiable mechanosensitive
receptive fields were more numerous in arthritic rats than in normals.
In experiments on ten animals the effects of 5-HT on spontaneous
discharge were examined in twelve recordings consisting of between one
and three different action potentials from units with spike shape
characteristics similar to those of identified C fibre afferents. Their
mean rate of spontaneous discharge before the administration of 5-HT was
1.4 ± 0.2 i.p.s.
6.2.1.5 Excitatory effects of 5-HT on chemosensitive units
Normal joints
All the units with an ongoing discharge were excited by an initial or
subsequent injection of 5-HT (1-100 fig, i.a.); a further three units
became active following the administration of the drug. Following the
failure of initial doses of 5-HT to evoke a response, activation of
individual units by 5-HT was seen with subsequent injections.
Two main components could be recognised in the response to 5-HT. An
early, brief burst of activity, which was seen in 75X of active units
followed by a sustained increase in background afferent discharge in 75X
of units. Responses in individual units were either monophasic or
biphasic; fast responses occurred within 10 seconds following injection
of 5-HT and lasted for a maximum of 30 seconds. Desensitization
developed to repeated injections of 5-HT (20-100 fig) at 10 minute
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intervals. However, with lower doses (1-10 fig), and a 15 minute interval
between injections, a relatively consistent response was obtained in
four recordings. The slow response generally took longer than 15 seconds
to develop and lasted for on average 105 ± 11 seconds. Depression of
activity following the initial excitation was also seen in a small
number of units when background activity was elevated.
Arthritic joints
All of the units examined were responsive to injections of 5-HT (1-100
fig). A two component response was seen as normal animals. A fast
excitatory response was seen in 58% of units, and in all the units
studied a delayed, long-lasting (121 ± 17 seconds) increase in discharge
was observed.
6.2.1.6 Effects of 5-HT receptor antagonists in normal and arthritic
joints
The 5-HT receptor antagonists MDL 72222, ICS 205-930 and ketanserin were
administered at 100 /igkg'l, i.a., doses previously found to be active in
abolishing chemoreceptor responses to 5-HT in the cat (Kirby and
McQueen, 1984). The 5-HT3 receptor antagonists MDL 72222 and ICS 205-930
are structurally related to cocaine (Richardson et al., 1985), and may
possess some local anaesthetic properties. While GR38032F has been shown
to be highly selective and specific in its antagonism of 5-HT3 receptors
when administered in vitro at doses up to 1 mgkg'l (Butler et al.,
1988), the 5-HT2 receptor antagonist ketanserin may produce hypotension
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via antagonist activity at a-adrenergic receptors (Vanhoutte, 1985).
Evidence for a selective and specific effect of the antagonists used in
the present experiments is provided by the observation that the 5-HT3
receptor antagonists selectively blocked the 5-HT3 receptor mediated
Bezold-Jarisch-like reflex (bradycardia) evoked by 5-HT, and ketanserin
selectively antagonized a 5-HT-induced hypotension. Furthermore,
capsaicin-induced excitation (see Section IV) was not blocked by either
the 5-HT3 or 5-HT2 antagonists.
Mechanonociceptor responsiveness
The 5-HT3 receptor antagonists MDL 72222, ICS 205-930 and GR38032F
administered intra-arterially, each antagonized the 5-HT-induced
increase in responsiveness of mechanonociceptors both in normal and
arthritic joints. In five units treatment with MDL 72222 (100 /igkg'l)
markedly reduced the increased responsiveness produced by 5-HT;
injection of ICS 205-930 (100 /jgkg'l) produced a clear rightward shift
in the 5-HT dose response curve in one unit; in studies on five units,
GR38032F (100 /igkg'l) abolished the response in one unit and produced a
marked reduction in the response in four units (see Fig.6.5).
The 5-HT2 receptor antagonist, ketanserin (100 /igkg'l), did not affect
the 5-HT evoked increase in mechanonociceptor responsiveness, either in
normal or arthritic joints when tested in six units.
Activity of mechanonociceptors
In spontaneously active mechanonociceptors from arthritic joints the 5-
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Fig. 6.5 Effects of 5-HT3 antagonists GR 38032F (100 /igkg'l, i.a.), MDL
72222 (100 /xgkg"1, i.a.) or ICS 205-930 (100 /igkg"1, i.a.) on 5-HT-
induced enhancement of mechanonociceptor responsiveness both in normal
and arthritic joints. (A) Graph showing a shift to the right in the log
dose-response curve caused by ICS 205-930 (100 /igkg-1, i.a.) on a
mechanoreceptor with afferent fibre conduction velocity of 2.7 ms-1 from
an arthritic joint. Open circles and filled circles represent responses
before and after addition of antagonist respectively. The dose of 5-HT
is shown in /ig with the peak response obtained given as a percentage of
the pre-injection control response. (B) Bar graph illustrating the
effect of GR38032F (n - 5) and MDL 72222 (n - 5) on the mean peak
increase in mechanoreceptor responsiveness produced by an effective
standard dose of 5-HT (1 - 100 /ig, i.a.). Bars represent peak responses
before (open) and after (filled) injection of antagonist. (C) Bar graph
showing the duration of response obtained for the same injections as in
A. Error bars represent s.e. mean. Significantly different values are
shown as * when p < 0.05, and ** when p < 0.01 (Wilcoxon).
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HT3 antagonists MDL 72222 (100 /xgkg'l, n-1) or GR38032F (100 jigkg'l,
n-2) caused reductions in ongoing activity of 70X and 65X (range: 30 -
100%) respectively when injected on their own. Reductions of activity
lasted for no longer than 5 minutes in each case. In two
mechanosensitive units the 5-HT2 receptor antagonist ketanserin (100 jig
kg~^) had no effect on spontaneous activity.
An examination of the effects of the various 5-HT antagonists on the
two components of 5-HT induced increases in spontaneous activity was
complicated by the inconsistent nature of the fast response and its
marked susceptibility to desensitization. The slow response, however,
was observed in all cases, and in arthritic animals neither MDL 72222
(100 /igkg"1, n-1), ICS 205-930 (100 /igkg*1, n-1) or GR38032F (100 /igkg*
1, n-1) had any affect on it. In one of two units ketanserin produced a
marked shift to the right of the 5-HT dose response curve (Fig. 6.6).
Chemosensitive units
In the case of chemosensitive units the 5-HT3 receptor antagonists MDL
72222, ICS 205-930 and GR38032F all reduced ongoing discharge in
arthritic joints or in normal joints previously exposed to 5-HT (see
table 6.2).. Reductions in activity produced by antagonists lasted for 1
- 3 minutes. The 5-HT2 receptor antagonist ketanserin also markedly
reduced ongoing discharge in arthritic and normal joints (table 6.2).
Analysis of the affects of the 5-HT receptor antagonists on the fast
response to injection of 5-HT was complicated by inconsistency of the
response and its susceptibility to desensitization. However, it was
markedly reduced or abolished following injections of the 5-HT3 receptor
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Fig. 6.6 Effects of ketanserin (100 /igkg"^-, i.a.) on 5-HT-induced slow
excitation of chemosensitive afferent units from normal and arthritic
rats. (A) Bar graph showing the mean peak discharge, expressed as a
percentage of pre-injection control, produced in response to a standard
dose of 5-HT (1 - 100 ng, i.a.) before (open bar) and after (filled bar)
injection of ketanserin (100 /xgkg-1, i.a., n - 14). (B) Bar graph
illustrating the mean duration of the effects shown in A. Error bars






































Table6.2Summaryoftheeff ctsof5-HTant gonistsothespontaneousdis h rgef chemosensitiveuni s MDL72222ICS05-930GR38032Fketanserin n%reductionnXreductionn%reductionreductionindischargendischargedischargendischarge NORMAL4/4533/362/45/963(43-68)(33-100)(64-99(43-8) ARTHRITIC1/41000/-/436.56/958
(13-50)(76-25)
Meanvalueswerec lculatedonlyingr sponsiveunits-figureb cketsshowtra geofeffect. Allantagonistswereinject di.a.td ef100/igkg"1
antagonists MDL 72222 (n=6), ICS 205-930 (n-4) or GR38032F (n-4) (all at
100 /igkg'l, i.a.) (fig. 6.7), but occurred in three recordings following
the administration of ketanserin (100 pgkg'l, i.a.).
The slow response to injection of 5-HT was unaffected by the 5-HT3
receptor antagonists, but was blocked or markedly reduced in fourteen of
fifteen units by the 5-HT2 antagonist ketanserin (100 /igkg'l, i.a.)(Fig.
6.7).
6.2.2 Electrophysiology in vitro
Using the in vitro isolated hind limb preparation the effects of 5-HT
were examined on mechanonociceptors and chemosensitive units with
afferent axons in the PACR. Identified mechanonociceptor units had
afferent fibre conduction velocities in the range 0.4-2 ms'l, and
chemosensitive units had action potential spike shape characteristics
similar to those of identified C fibre units. Only normal joints were
examined in this study.
6.2.2.1 Mechanonociceptor excitation
Six mechanonociceptors were examined for the effects of 5-HT (0.01 - 100
fig, i.a.). Three of these units had a low level of ongoing resting
discharge averaging 0.08 ± 0.02 i.p.s.. Injection of 5-HT excited five
of the six units, which responded with biphasic increase in discharge
similar to that described above for in vivo studies (see fig. 6.8). For
a standard dose of 10 ng the fast response had a mean latency to onset
of 0.5 ± 0.4 seconds and a mean duration of 2.7 ± 0.5 seconds. The peak
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Fig. 6.7 Effects of MDL 72222 (100 /igkg"1, i.a., n - 6), GR38032F (100
Mgkg'l, i.a., n - 4) and ICS 205-930 (100 /igkg'l, i.a., n - 4) on 5-HT-
induced fast excitation in chemosensitive units from both normal and
arthritic rats. Each bar shows the mean peak response as a percentage of
basal discharge to a standard effective dose of 5-HT (5 - 100 ng, i.a.)
before (open bars) and after (filled bars) injection of antagonist.
Error bars represent s.e. mean. Significantly different values are shown
as * when p < 0.05, and ** when p < 0.01 (Wilcoxon).
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discharge over a 15 s time period averaged 0.5 ± 0.1 i.p.s.. Repeated
injections of 5-HT induced a rapid tachyphylaxis of this response and
dose-dependency could not be examined. The delayed excitation had a mean
latency to onset of 44 ± 15 seconds and a mean duration of 526 ± 120
seconds. The peak discharge over a 15 s time period averaged 1.8 ± 0.7
i.p.s.. This response could not be shown to be dose-dependent. A summary
of the units excited by 5-HT is shown in table 6.3.
6.2.2.2 Excitation of chemosensitive units
In this series of experiments six recordings, consisting of between one
and three different action potentials, were obtained from units for
which no mechanosensitive receptive fields could be found. These units
had a mean resting discharge of 0.9 ± 0.2 i.p.s.. Injection of 5-HT
(0.01 - 100 /ig, i.a.) excited all units tested. A biphasic response was
evoked in two recordings, the slow response was seen alone in three, and
in one recording only the fast response was evoked (see table 6.3.). For
a standard dose of 10 ng fast excitation had a mean latency to onset of
1.3 ± 0.3 seconds, and a mean duration of 9 ± 5.5 seconds. The peak
discharge, obtained over a 15 s time period, had a mean value of 1.6 ±
0.8 i.p.s.. Delayed excitation had a mean latency to onset of 58 ± 25
seconds, and a mean duration of 306 ± 96 seconds. The peak discharge
over a 15 s time period averaged 2 ± 0.4 i.p.s.. Fast and slow responses
were prone to tachyphylaxis and dose dependency could not be studied.
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Fig. 6.8 Effects of 10 jig 5-HT on the activity of a mechanonociceptor
from a normal joint in vitro. (A) (i) Neurogram showing the discharge
pattern of fast and slow excitation evoked by the injection of 5-HT at
the arrow, (ii) Shows 30 superimposed triggered oscilloscope sweeps of
the single unit action potential which was counted. (B) Computer-
generated plot of the discharge evoked by the same injection (at arrow)
shown in the neurogram. The time period corresponding to the neurogram
is indicated above the graph.
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Table6.3Summaryofthenu erofmechanonociceptorsandchemosensitivunit excitedby5-HTinvitro. unittypeno.ofno.ofunitsdisplaying unitseachtypeofresponse rapiddelayed mechanonociceptor65(83%)5(83%) chemosensitive63(50%)5(8 %) Thepercentageofunitsrespo dingwiteactypeofresponseisshowinbracket
6.2.2.3 Effects of 5-HT receptor antagonists on 5-HT-evoked excitation
Mechanonociceptors
In two mechanoreceptors with a high level of ongoing activity evoked by
5-HT, injection of the the 5-HT2 receptor antagonist ketanserin (100
pgkg"! equivalent dose for whole rat, i.a.), caused a marked reduction
this activity. This effect had a latency to onset of 60 and 30 seconds
and lasted for over 8 minutes in each case. Ongoing discharge was
reduced by 97% and 100% for the two units. In one of these units
injection of 5-HT evoked a high level of ongoing discharge that was
abolished by injection of the 5-HT3 receptor antagonist ICS 205-930 (100
/xg/kg equivalent dose, i.a.). This effect had a latency to onset of 15
seconds and lasted for over 12 minutes.
The 5-HT3 receptor antagonists could not be studied for their ability
to antagonize.the fast response evoked by 5-HT because it was prone to
tachyphylaxis. In three units the slow response was found to be markedly
reduced or abolished by the 5-HT2 receptor antagonist ketanserin (100
pgkg-1 equivalent dose, i.a.), but in two of these units it was
unaffected by the 5-HT3 receptor antagonist ICS 205-930 (100 pgkg_^
equivalent).
Chemosensitlve units
In one recording with high levels of ongoing activity evoked by 5-HT,
injection of the the 5-HT2 receptor antagonist ketanserin (100 /xgkg"^
equivalent, i.a.), caused a marked reduction in ongoing activity. This
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effect had a latency to onset of 45 seconds and lasted for over 8
minutes. Ongoing discharge was reduced by 65X. In the same recording a
previous injection of 5-HT evoked a high level of ongoing discharge that
was reduced by injection of the 5-HT3 receptor antagonist ICS 205-930
(100 /igkg'l equivalent, i.a.). This effect had a latency to onset of 15
seconds and lasted for over 12 minutes.
The 5-HT antagonists could not be studied for their ability to
antagonize fast or slow responses evoked by 5-HT because of their
susceptibility to tachyphylaxis.
6.3 DISCUSSION
6.3.1 Excitatory and sensitizing effects
This investigation has shown that exogenous 5-HT can both excite and
increase the responsiveness of nociceptive sensory receptors located in
the ankle joint capsular tissues of normal and arthritic joints.
Mechanonociceptors were affected by 5-HT in normal and arthritic joints,
the effect of the amine being greater in the latter. These units
displayed a low level of spontaneous activity in inflamed joints, in
contrast to the general lack of activity in normal joints. Background
discharge in non-mechanosensitive units was present in normal rats, but
was much more common in arthritics. These units were activated by 5-HT,
and responded with two components - transient excitation followed by a
delayed, long lasting increase in activity. The finding that these
responses could also be evoked in vitro suggests that they are not
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mediated via the release of systemic blood-borne mediators or through
spinal reflex mechanisms.
6.3.1.1 Mechanonociceptor sensitization
Single close-arterial bolus injections of 5-HT increased the responses
of mechanonociceptors to a standard mechanical stimulus for as long as
six minutes. This duration of action is similar to that reported for 5-
HT-induced sensitization to the excitatory effects of bradykinin on
high-threshold mechanoreceptors in muscle (Mense, 1981) as well as for
the sensitizing action of 5-HT on slowly adapting type II cutaneous
mechanoreceptors (Fjallbrant & Iggo, 1961). The 5-HT3 receptor
antagonists MDL 72222, ICS 205-930 or GR38032F prevented this action,
but did not otherwise affect the response to mechanical stimuli.
Ketanserin was without effect. These results suggest that the
sensitization demonstrated may involve the action of 5-HT at a 5-HT3
receptor associated with the terminals of articular mechanonociceptors.
The latency (10 -15 s) and the duration of action is consistent with an
action involving second messengers in the sensory nerve terminal.
Activation of the 5-HT3 receptor has yet to be linked with the
production of a particular second messenger, although 5-HT^ like or 5-
HT2 receptor activation has been shown to be associated with production
of the second messengers IP3 or cAMP in a variety of systems (see
Peroutka, 1988). Alternatively the delayed nature of these effects may
be related to a 5-HT3 receptor mediated stimulation of the local




Brief excitation of mechanonociceptors and chemosensitive units occurred
within 10 seconds of the injection of 5-HT both in normal and arthritic
joints. This action was blocked or reduced by the 5-HT3 receptor
antagonists MDL 72222, ICS 205-930 or GR38032F.
Fast depolarizations evoked by 5-HT have been reported in several
isolated neuronal preparations. In rabbit superior cervical ganglion
(SCG) (Wallis & North, 1978), rabbit nodose ganglion (Higashi & Nishi,
1982) and guinea-pig coeliac ganglion (Wallis & Dun, 1988) 5-HT produces
a rapid depolarization. These fast depolarizations show marked
tachyphylaxis and are sensitive to MDL 72222 or ICS 205-930 (Azami et
al., 1985; Round & Wallis, 1985; Round & Wallis, 1986; Wallis & Dun,
1988). 5-HT evoked depolarizations of the rabbit or rat isolated vagus
nerve have also been shown to be sensitive to 5-HT3 antagonists
(Donatsch et al., 1984; Richardson et al., 1985)
6.3.1.3 Delayed Excitation
The most consistent response produced by 5-HT was a dose-dependent
delayed long lasting increase in discharge that was seen in the majority
of the chemosensitive units examined, as well as in mechanonociceptors
recorded both in normal and arthritic joints. The 5-HT3 receptor
antagonists had no effect on the slow response, whereas the 5-HT2
receptor antagonist ketanserin reduced or abolished it. The delayed
nature of this effect suggests that 5-HT may be acting indirectly to
evoke sustained afferent activity. Delayed excitation was consistent and
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dose-dependent in vivo, outlasting the hypotensive effect of 5-HT, thus
reducing the liklihood that these effects were produced secondary to
blood flow changes. In addition there is evidence that blood flow in the
hind-paw of the rat is unaffected by locally administered 5-HT (Owen,
1977). Alternative mechanisms for indirect effects may involve the
release of other algogenic substances such as bradykinin (see Section V)
or the prostanoids (see Section VII) from surrounding tissues by 5-HT.
Evidence for a direct effect of 5-HT on sensory neurones is supplied
by studies on isolated neuronal preparations where a slow response
produced by 5-HT has been reported. In C-type neurones from rabbit
nodose ganglion a long-lasting depolarization was occasionally seen in
response to 5-HT (Higashi & Nishi, 1982). In guinea-pig coeliac ganglion
neurones delayed depolarization induced by 5-HT develops slowly and
lasts for seconds or minutes (Kiraly et al., 1983; Dun et al., 1984).
This response in coeliac ganglion cells is unaffected by MDL 72222 but
is partially blocked by methysergide indicating that a 5-HT3 receptor is
not involved (Wallis & Dun, 1988). In rabbit nodose ganglion cells, 5-
HT-induced inhibition of of a Ca2+-dependent K+ conductance is resistant
to ICS 205-930 but Is antagonized by methysergide (Christian et al.,
1989). This effect has previously been reported to be produced by
forskolin (Weinreich & Wonderlin, 1987), suggesting that inhibition of
the Ca2+-dependent K+ conductance is mediated via cAMP. This finding,
however, does not support a role for 5-HT2 receptors since the second
messenger commonly associated with this receptor type is IP3 (see
Peroutka, 1988).
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6.3.2 Involvement of 5-HT in nociceptor sensitization during
inflammation
The ability of 5-HT to sensitize high threshold C- and A-delta articular
mechanonociceptors suggests that endogenous 5-HT could play a role in
the increased responsiveness of these receptors in inflamed joints. The
results indicate that a 5-HT3 receptor may be involved. However, in
arthritic rats administration of antagonists selective for 5-HT3 or 5-
HT2 receptors did not significantly reduce mechanonociceptor sensitivity
as they should have done if endogenous 5-HT acting at such receptors was
the major factor contributing to their heightened responsiveness. Low
levels of ongoing activity in mechanonociceptor units observed in
arthritic rats were, on the other hand, reduced markedly by the addition
of antagonists for 5-HT3 receptors. This effect lasted only about 5
minutes, a period which is much shorter than the blockade produced by
these antagonists of 5-HT responses which lasted for at least 30 min.
Similar results were obtained for chemosensitive units following
administration of either 5-HT3 or 5-HT2 receptor antagonists. These
observations suggest that endogenous 5-HT may contribute to ongoing
activity seen in inflamed joints, but is by no means the only
contributing factor.
For mechanonociceptors from arthritic joints, where mechanical
sensitivity is enhanced, responsiveness to 5-HT was much greater than
those from normal joints. The minimal effective dose for increased
responsiveness to mechanical stimuli was a fifth of that for normal
joints and responses lasted over four times as long. In arthritic rats
mechanonociceptor units were also excited by doses of 5-HT a hundred
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fold smaller than that required in normal joints. These findings provide
clear evidence that sensitivity to 5-HT is increased for receptors in
inflamed joints, and indicate that the acute release of endogenous 5-HT
could further boost sensitivity.
Finally, a role for 5-HT in the development of acute inflammatory pain
has been suggested by Eschalier et al. (1989) who have shown that the
administration of ICS 205-930 inhibits and reverses carrageenan induced
hyperalgesia in rats. It is possible that 5-HT, released from platelets
(Garatinni & Valzelli, 1965; Franzen & Eysell, 1969; Page, 1988), mast
cells (Johnson & Erdos, 1973) or nerve fibres (Dun et al., 1980;
Verhofsted, 1981; Neel & Parsons, 1986) is responsible for development
of sensitization during the acute inflammatory response and becomes less
important for chronic sensitization. However, further acute release of
5-HT may act to increase levels of sensitization over short periods of
time during chronic inflammation.
6.4 CONCLUSIONS
The 5-HT3 receptor mediated sensitization and rapid excitation of
articular mechanonociceptors seen in the present study is consistent
with the observation that pain produced by application of 5-HT to a
blister base is mediated through a 5-HT3 receptor (Donatsch et al.,
1984; Richardson et al., 1985).
A role for 5-HT2 receptors in 5-HT-induced pain has not previously
been described, and further studies into the origins of the delayed
excitation would be of great interest, particularly in view of its
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marked and consistent nature in these experiments. The fact that both 5-
HT2 and 5-HT3 receptor antagonists reduced ongoing activity in arthritic
joints suggests that both types of receptor are involved in activity
evoked by 5-HT during chronic inflammation. However, the short duration
of these effects suggests that 5-HT may not be essential for sustained
discharge in this particular model of arthritis.
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SECTION VII
EFFECTS OF PROSTANOIDS ON ARTICULAR SENSORY RECEPTORS
IN THE RAT ANKLE JOINT
7.1 INTRODUCTION
Prostanoids were first proposed to play a role in inflammation by Willis
(1978), who discovered large amounts of prostaglandin activity in
inflammatory exudates from rat paws injected with carrageenan.
Subsequently various different prostanoids were identified in inflamed
tissues from both animals and man (see Higgs et al., 1984). A number of
studies have reported on the presence of high prostanoid concentrations
in the synovium of arthritic joints (Higgs et al, 1974; Robinson et al.,
1975; Ferreira, 1979). Studies of this type have been directed mainly
towards demonstrating the effects of non-steroidal anti-inflammatory
drugs in reducing the production of inflammatory prosatanoids in vivo
(Higgs et al., 1974; Robinson et al., 1975; Tokunaga et al., 1981).
Prostanoids are thought to contribute significantly to the major signs
of inflammation. PGE^ and PGE2 cause local vasodilatation and increased
vascular permeability when injected into the skin of animals (Horton,
1963; Crunkhorn & Willis, 1971a; Kaley & Weiner, 1971; Peck and
Williams, 1978), and man (Crunkhorn & Willis, 1971b; Kuehl, 1971).
Prostanoids also contribute to the pain of inflammation, an effect which
is generally considered to result from their potentiation of the algesic
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actions of other inflammatory mediators such as bradykinin (Ferreira,
1972; Moncada et al., 1975; Ferreira et al., 1978; Ferreira & Nakamura,
1979a; Tyers & Haywood, 1979; Higgs et al., 1984).
Electrophysiological studies in rats with adjuvant-induced
polyarthritis have shown that capsular high-threshold C-mechanoreceptors
from the ankle joint have an increased sensitivity to mechanical
stimuli, and an enhanced level of ongoing discharge (Guilbaud et al.,
1985). This enhanced sensitivity and ongoing activity was reduced by
lysine-acetylsalicylate (1-AS), suggesting that locally produced
cyclooxygenase metabolites may be responsible, at least in part, for the
sensitized state (Guilbaud & Iggo, 1985). The aim of the present
investigation was to examine the effects of the prostanoids on the
properties of articular mechanonociceptors from the ankle joints both of
normal rats and those with localized adjuvant-induced arthritis. The
effects of 1-AS on the sensitivity of nociceptive sensory receptors, and
the reversibility of these effects by administration of exogenous
prostanoids were studied in rats with localized adjuvant arthritis. The
effects of the prostanoids on articular mechanonociceptors from normal
joints were also examined, and the prostanoid receptors mediating these
effects characterized using a range of naturally occurring prostanoids,





The effects of PGE2, PGI2 and cicaprost were examined in vivo on C and
A-delta high-threshold mechanoreceptors with receptive fields in the
capsular tissue of the tibio tarsal joint. The effects of PGE2 and
cicaprost on responses of these sensory receptors to bradykinin were
also examined. Experiments were carried out in vitro using the rat
isolated hindlimb preparation to examine the effects of PGE2, cicaprost,
PGD2 and PGF2<* both on high-threshold mechanoreceptors and on
'chemosensitive' units for which no mechanoreceptive fields could be
found.
7.2.1.1 Electrophysiology in vivo
In seventeen experiments, the effects of the prostanoids were examined
on the responsiveness of nineteen high-threshold mechanoreceptors to
mechanical stimuli. A further three mechanosensitive units were examined
for only the excitatory effects of the compounds used. Mechanonociceptor
units had afferent fibre conduction velocities in the range 0.4 - 11.5
ms"l. The excitatory and sensitizing effects of the prostanoids on
articular mechanonociceptors are summarized in tables 7.1 - 7.8.
Mechanonociceptor excitation
The excitatory effects of PGE2 were examined on thirteen
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mechanonociceptors. These units had either a low level of ongoing
resting discharge (mean: 0.6 ± 0.2 i.p.s, n-7), or were silent before
drug injection. Injection of PGE2 (0.3 - 3 pg, i.a.) excited only 23% of
the units tested. Table 7.1 shows a summary of the excitatory responses
evoked by PGE2. Excitation had a latency to onset ranging from 0.2 -4
minutes, and was short lived with a duration of 0.2 - 5.8 minutes. The
median minimal effective dose was 0.3 fig, and only those units which
were already spontaneously active were excited by PGE2. Dose-dependency
of was not evident in any of the responsive units. The mean peak unit
discharge, measured over 60 s, was 1.5 ± 0.6 i.p.s.. Pooled data for
maximum responses to PGE2 are shown in figure 7.1.
The effects of PGI2 were examined on five mechanonociceptors. These
units had either a low level of ongoing resting activity (mean: 0.3 ±
0.2 i.p.s, n-4) or were silent. PGI2 (0.01 - 0.1 fig, i.a.) excited 80X
of units. Figure 7.2 illustrates the pattern of excitation evoked by
PGI2 on a single articular mechanonociceptor. A summary of excitatory
responses is shown in table 7.1. There was a latency ranging from 0.5 -
4 minutes before excitation, and the response had a duration ranging
from 1-24 minutes. The minimal effective dose was 0.1 fig for all four
units. Three of the responsive units had a resting discharge before
exposure to PGI2, while the fourth was silent_ Dose-dependency of the
response was seen in the two units which were examined in this way. The
mean peak unit discharge, measured over 60 s, was 0.6 ± 0.3 i.p.s..
Pooled data for maximum responses to PGI2 are shown in figure 7.1.
Twelve mechanonociceptor units were examined for the excitatory
effects of cicaprost. These units had either a low resting discharge




















Fig. 7.1 Pooled maximal responses for mechanoreceptor excitation evoked
by PGE2, PGI2 or cicaprost. (A) Bar graph showing the mean (+ s.e.m.)
maximal integrated response (delta Zx) for units excited by injections
of PGE2 (median dose: 3 pg, i.a., n-3), PGI2 (median dose: 0.1 /ig, i.a.,
n-4) and cicaprost (median dose: 0.5 pg, i.a., n-10). (B) Mean durations
of the same responses shown above in A. PGE2 excited only three of
thirteen units (23%), PGI2 four of five units (80%) and cicaprost eleven
of twelve units (92%). The durations of the effects caused by PGI2 and
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Fig. 7.2 Computer-generated plot illustrating the excitatory and
sensitizing effects of PGI2 on a single articular mechanoreceptor with
an afferent fibre conduction velocity of 0.44 ms"l- (A) Neurogram
showing the response of this receptor to a single mechanical indentation
stimulus. (B) thirty superimposed triggered oscilloscope sweeps of the
single action potential which was counted (C) Mechanical stimuli were
applied for 2 s once every 2 mins (arrowheads) before and after the
injection of PGI2 (0.1 ng, i.a.) at the arrow. Each bar represents a one
second time interval, with the lower trace being a continuation of that
in the upper panel. The number of action potentials evoked per
mechanical stimulus is shown above each response. A long lasting
excitation and sensitization to mechanical stimuli was produced
following the injection of PGI2.
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(0.01 - 5 /xg, i.a.) excited 92% of units. Table 7.1 shows a summary of
the excitatory responses evoked by cicaprost. There was a latency to
onset ranging from 0.1 - 5.7 minutes, and the response had a duration
ranging from 0.3 - 23 minutes. The median minimal effective dose was 0.1
/xg. Seven of the responsive units had a resting discharge before
exposure to cicaprost, while the remaining four were silent. Dose-
dependency of the response was seen in six of seven units tested in this
way. The mean peak discharge, measured over 60 s, was 1.7 ± 0.4 i.p.s..
A summary of maximum unit responses is shown in figure 7.1.
Comparison of units tested with more than one prostanoid agonist
revealed that two units excited by PGI2 were also excited by cicaprost,
and two units not excited by PGE2 were excited by cicaprost.
Mechanonociceptor responsiveness
The effects of PGE2 (0.03 - 3 pg, i.a.) were examined on thirteen
mechanonociceptors. Their responsiveness to mechanical stimuli, applied
once every two minutes, was increased significantly (sensitization) in
46% of units. The time course for the onset, time to peak and duration
of the response varied between units. A summary of the sensitizing
effects of PGE2 on mechanical responsiveness is shown in table 7.2. The
minimal effective dose had a median value of 3 pg. The peak unit
response, calculated from values taken at different time points
following the injectionn of PGE2, had a mean value of 174% of the pre-
injection control. Figure 7.3 illustrates pooled data for the maximal
increase in responsiveness caused by PGE2.
In five units (38%) the highest dose used (3 pg), caused a marked
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Fig. 7.3 Poooled maximal responses for mechanical sensitization evoked
by PGE2, PGl£ or cicaprost. The bars represent mean responses of
mechanoreceptors to mechanical stimuli, applied once evey two minutes,
expressed as a percentage of the pre-injection control response (-100%).
PGE2 (median dose: 0.3 pg, i.a.,) sensitized six of thirteen units
(43%), PGI2 (median dose: 0.1 ng, i.a.,) four of five units (80%), and
cicaprost (median dose: 0.1 pg, i.a.) seven of eight units (88%). The
time at which the injection was made is indicated by the arrow and the
vertical dashed line. Values significantly greater than those obtained
following injection of saline vehicle are shown as * when p< 0.05
(Wilcoxon). Responses to PGI2 were particularly marked and of long
duration.
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reduction in responsiveness to mechanical stimuli. In two of these units
lower doses of PGE2 (0.03 -0.3 fig, i.a.) had caused a sensitization to
mechanical stimuli. Reduced responsiveness had a latency to onset of
0.25 minutes, and lasted for over 10 minutes in all five units. The mean
minimal unit response, calculated from values taken at different time
points following the injection, was 63% of pre-injection control. The
pooled maximal reduction in responsiveness obtained following injection
of PGE2 is illustrated in figure 7.4. The three units described above
that were sensitized to mechanical stimuli were also excited by PGE2.
The effects of PGI2 (0.01 - 1 pg, i.a.) were examined on five
mechanonociceptors. Their responsiveness to mechanical stimuli, applied
once every two minutes, responsiveness was increased significantly in
80% of these units. An example of the sensitizing effect of PGI2 is
illustrated in figure 7.2. Mechanical sensitization had a duration much
longer than that caused by PGE2. A summary of the sensitizing effects of
PGE2 is shown in table 7.2. The minimal effective dose was 0.1 /ig,
thirty times less than the minimal effective dose for PGI2. Dose-
dependency of the response was tested in two units, both of which gave
larger responses with increasing dose. The mean peak response,
calculated from values taken at differet times after injection, was 228%
of the pre-injection control, nearly twice that caused by PGE2 at higher
doses. Figure 7.3 illustrates the pooled maximal responses obtained
following injection of PGI2. The one unit that was not sensitized to
mechanical stimuli by PGI2 was also not excited.
The effects of cicaprost (0.05 - 5 /ug, i.a.) were examined on eight
mechanonociceptors. Their responsiveness to mechanical stimuli, applied
once every two minutes, was increased significantly for seven (88%).
228
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Fig. 7.4 Pooled data showing the maximal reduction in mechanical
responsiveness evoked by PGE2. Bars represent mean responses of the five
mechanoreceptors to mechanical stimuli, applied once every two minutes,
expressed as a percentage of the pre-injection control response.
Injection of PGE2 (3 pg, i.a.) evoked a reduction in the mechanical
responsiveness of these five units. The arrow and vertical dashed line
show the time point at which the injection was made. Values
significantly lower than those obtained following injection of saline
vehicle are shown as * when p < 0.05 (Wilcoxon).
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Increased responsiveness was seen after a variable delay and had a
duration intermediate to sensitization caused by PGE2 and PGI2. A
summary of the mechanical sensitization caused by PGI2 is shown in table
7.2. The minimal effective dose was of the same order of magnitude as
for PGI2, and had a median value of 0.1 fig. Dose-dependency was tested
in three units, all of which gave larger responses with increasing dose.
The mean peak response, caculated from values at different time points
following injection, was 164% of the pre-injection control, less than
that caused by PGI2. Figure 7.3 illustrates the pooled maximal responses
obtained following injection of cicaprost. One unit sensitized to
mechanical stimuli was not excited by cicaprost.
Comparison of units tested with more than one prostanoid agonist
revealed that two units sensitized to mechanical stimuli by PGI2 were
also sensitized by cicaprost, and from four units tested with PGE2 and
cicaprost two units not sensitized by PGE2 were sensitized by cicaprost.
Combined effects of prostanoids and bradykinin: mechanonociceptor
excitation
The effects of combined injections of threshold or subthreshold
excitatory doses of bradykinin (0.1 - 10 /ig, i.a.) and PGE2 (0.03 - 3
fig, i.a.) were studied in nine mechanonociceptors. These units had
either a low level of ongoing resting discharge (mean: 0.5 ± 0.1 i.p.s.,
n-6), or were silent before the injection of any drugs. The excitatory
responses evoked by the prostanoids, bradykinin and combined injections
are summarized in tables 7.3 - 7.5. Injection of PGE2 evoked an
irregular discharge in only one (11%) of the nine units. The mean peak
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discharge, determined over a 60 s recording period, was 0.9 ± 0.2
i.p.s.. Injection of bradykinin excited 33% of the units. Excitation had
a latency to onset ranging from 1.2 - 3.2 minutes, and a duration
ranging from 3.3 - 5 minutes. The mean peak discharge, measured over a
one minute period, was 0.9 ± 0.2 i.p.s.. Combined injections of
bradykinin and PGE2 evoked excitation greater than that produced by
either drug alone in 55% of units. These effects were greater than
additive in all cases. Responses had a latency to onset ranging from
0.67 - 4.8 minutes, and a duration ranging from 1.7 - 10.8 minutes. The
mean peak discharge, measured over 60 s, was 0.8 ± 0.2 i.p.s. Figure 7.5
shows a summary of the responses evoked by each drug alone and by
combined injections.
The effects of combined injections of threshold or subthreshold doses
of bradykinin (10 fig, i.a.) and PGI2 (0.01 - 0.1 fig, i.a.) were examined
in five mechanonociceptors. These units had either a low level of
ongoing resting discharge (0.3 ± 0.2 i.p.s., n-4), or were silent before
the injection of any drugs. Injection of PGI2 excited 80% of units.
Excitation had a latency to onset ranging from 0.5 - 4 minutes and a
duration ranging from 7-24 minutes. The mean peak discharge,
determined over 60 s, was 0.6 ± 0.2 i.p.s.. Injection of bradykinin
excited 80% of the units. Excitation had a latency to onset ranging from
0.1 - 5.3 minutes, and a duration ranging from 2-8 minutes. The mean
peak discharge, measured over 60 s, was 0.7 ± 0.3 i.p.s.. Combined
injections of bradykinin and PGI2 evoked excitation greater than that
produced by either drug alone in only 40% of units. These effects were
greater than additive. In the remaining three units PGI2 evoked a high

























Fig. 7.5 Summary of the excitatory effects of coiibined injections of
threshold and sub-threshold doses of bradykinin and PGE2 on articular
mechanonociceptors. Each point on the scatter diagram represents the
integrated response (delta Ex) of a single unit to the injection of
either bradykinin, PGE2, or combined injections of the same doses of
each drug. The horizontal bars represent the mean evoked response, and
the crosses indicate units for which combined injections evoked a
response greater than that caused by either drug alone. Although these
effects were greater than additive in all five units the mean response
for combined injections was not significantly greater than the sum of
the mean responses to each drug alone (p < 0.05, Wilcoxon).
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had a latency to onset ranging from 0.1-6 minutes, and lasted for 4 -
16.6 minutes. The mean peak discharge, measured over 60 s was 0.9 ± 0.4
i.p.s. Figure 7.6 summarizes the responses evoked by each drug alone and
by combined injections.
The effects of combined injections of threshold or subthreshold doses
of bradykinin (1 - 10 fig, i.a.) and cicaprost (0.05 - 0.1 fig, i.a.) were
studied in seven mechanosensitive units. These units had either a low
level of ongoing resting discharge (0.5 ± 0.3 i.p.s., n-4), or were
silent before the injection of any drugs. Injection of cicaprost excited
one (14%) of the seven units. Excitation had a latency to onset of 120
seconds and lasted for 8 minutes. The peak discharge, determined over a
one minute recording period, was 0.3 i.p.s.. Injection of bradykinin
also excited one (14%) unit. Excitation had a latency to onset of 3
seconds, a duration of 30 seconds, and evoked a peak discharge, measured
over a one minute period, of 0.1 i.p.s.. Combination injections of
bradykinin and cicaprost evoked excitation greater than that produced by
either drug alone in six (86%) of the seven units. These effects were
greater than additive in all cases. The response had a latency to onset
ranging from 0.25 - 2.7 minutes, and lasted for 5-9.2 minutes. The
mean peak unit discharge, measured over 60 s, was 2.6 ± 1.2 i.p.s..
Figure 7.7 summarizes the responses evoked by each drug alone and by
combined injections. An example of the effect of cicaprost or bradykinin






















Fig. 7.6 Summary of the excitatory effects of combined injections of
threshold and sub-threshold doses of bradykinin and PGI2 on articular
mechanonociceptors. Each point on the scatter diagram represents the
integrated response (delta Zx) of a single unit to the injection of
either bradykinin, PGI2, or combined injections of the same doses of
each drug. The horizontal bars represent the mean evoked response, and
the crosses indicate units for which combined injections evoked
responses greater that that caused by either drug alone. Although these
effects were greater than additive in all five units the mean response
for combined injections was not significantly greater than the sum of


























Fig. 7.7 Summary of the excitatory effects of combination injections of
threshold and sub-threshold doses of bradykinin and cicaprost on
articular mechanoreceptors. Each point on the scatter diagram represents
the integrated response (delta Ex) of a single unit to the injection of
either bradykinin, cicaprost, or combined injections of the same doses
of each drug. The horizontal bars represent the mean evoked response,
and the crosses indicate units for which combined injections evoked a
response greater that that caused by either drug alone. These effects
were considerably greater than additive in all six units, the mean
response evoked by combined injections being significantly (* p < 0.05,
Wilcoxon) greater than the sum of the mean responses evoked by each drug
alone.
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Fig. 7.8 Computer-generated plot illustrating the excitatory and
sensitizing effects of injections of cicaprost or bradykinin alone and a
combined injection on a single articular mechanonociceptor with an
afferent fibre conduction velocity of 0.44 ms'V (A) (i) Neurogram
showing the response of this unit to a mechanical indentation stimulus
(waveform shown below neurogram) (ii) Thirty superimposed triggered
oscilloscope sweeps of the action single potential that was counted.
The bars in each of the graphs represent a 1 s time interval, with
consecutively labelled graphs being a continuation of the one above.
Mechanical stimuli of 2 s duration were applied once every two minutes
(arrowheads) before and after the injection of (B) bradykinin (10 fig,
i.a.), (C) cicaprost (1 fig, i.a.) and (D) the combination of the two
doses. Injections are indicated by the arrows below each trace. The
number of impulses evoked by mechanical stimuli is shown above each
response. The graphs show that bradykinin alone had little effect,
cicaprost alone evoked a transient increase in mechanical responsiveness
and a delayed (6 mins) excitation, and a combined injection evoked long






















































Combined effects of prostanoids and bradykinin: mechanical
responsiveness
The sensitizing effects of the prostanoids, bradykinin and combined
injections are summarized in tables 7.6 - 7.8. The effects of combined
injections of threshold or subthreshold doses of bradykinin (0.5 - 10
fig, i.a.) and PGE2 (1 - 3 fig, i.a.) on responsiveness to mechanical
stimuli were studied in nine units. Injection of PGE2 caused increased
responsiveness in only one (11%) of the nine units. The peak response
obtained following the injection was 117% of the pre-injection control.
In five units (56%) PGE2 caused a reduction in responsiveness to
mechanical stimuli. This response had a delay to onset of 15 seconds,
and lasted for 2-8 stimuli. Injection of bradykinin caused increased
responsiveness in 56% of units. The mean response at the peak of the
effect, calculated from values taken at different times following
injection, was 126% of pre-injection control. Combined injections of
bradykinin and PGE2 caused greater sensitization than that produced by
either drug alone in (89%) of units. These effects were greater than
additive in all cases. The mean response at the peak of the effect was
164% of pre-injection control. Figure 7.9 shows pooled data for the
sensitization to mechanical stimuli caused by each drug alone and in
combination.
The effects of combined injections of subthreshold or threshold doses
of bradykinin (10 fig, i.a.) and PGI2 (0.01 - 0.1 fig, i.a.) on
responsiveness to mechanical stimuli were studied in five units.
Injection of PGI2 caused increased responsiveness in 80% of these units.
The mean peak response, calculated from values taken at different times
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Fig. 7.9 Pooled data showing changes in mechanical responsiveness
evoked by threshold and subthreshold doses of bradykinin or PGE2 alone
and combined injections on eight articular mechanonociceptors. Bars
represent the mean responses of the eight units to mechanical stimuli of
2 s duration applied once every 2 mins. The time at which the injections
were made is shown by the arrow and the vertical dashed line. Although
injections of PGE2 alone caused a depression of mechanical
responsiveness, this same dose markedly potentiated the sensitization
evoked by bradykinin. Although effects were greater than additive for
individual units, mean values at each time point for sensitization
evoked by combined injections were not significantly greater than the
sum of the sensitization evoked by each drug alone (p < 0.05, Wilcoxon).
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following injection, was 216% of the pre-injection control. Injection of
bradykinin caused increased responsiveness in 80% of units. The mean
peak response was 120% of pre-injection control. Combination injections
of bradykinin and PGI2 caused greater sensitization than that produced
by either drug alone in four (80%) of the five units. These effects were
greater than additive in all four cases. The mean peak response obtained
was 185% of the pre-injection control response. In the remaining unit
PGI2 alone produced a marked and sustained sensitization. Figure 7.10
shows pooled data for the sensitization to mechanical stimuli caused by
each drug alone and combination.
The affects of combined injections of subthreshold or threshold doses
of bradykinin (1 - 10 fig, i.a.) and cicaprost (0.1 - 1 ng, i.a.) on
responsiveness to mechanical stimuli were examined in five units.
Injection of cicaprost caused increased responsiveness in 60% of units.
The mean peak response obtained following the injection was 147% of the
pre-injection control. Injection of bradykinin caused increased
responsiveness in 80% of units. The mean peak response was 126% of pre-
injection control. Combined injections of bradykinin and cicaprost
caused greater sensitization than that produced by either drug alone in
four (80%) of the five units. These effects were greater than additive
in all cases. The mean peak response obtained folloing combined
injections was 158% of control. Figure 7.11 summarizes the sensitization
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Fig. 7.10 Pooled data showing changes in mechanical responsiveness
evoked by injections of threshold and sub-threshold doses of bradykinin
or PGI2 alone and combined injections on five articular
mechanonociceptors. Bars represent the mean responses of the five units
to mechanical stimuli of 2 s duration applied once every 2 mins. The
time of at which injections were made is shown by the arrow and the
vertical dashed line. Sensitization to mechanical stimuli evoked by
bradykinin was potentiated by PGI2, although PGI2 alone caused a
sensitization. Mean values significantly different from additive are
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Fig. 7.11 Pooled data showing changes in mechanical responsiveness
caused by injections of threshold and sub-threshold doses of bradykinin
or cicaprost alone or combined injections on four articular
mechanoreceptors. Bars represent the mean responses of four units to
mechanical stimuli of 2 s duration applied once every 2 mins. The time
at which injections were made is indicated by the arrow and the vertical
dashed line. Combined injections of the two agents evoked greater than
additive effects on mechanical responsiveness. Although effects were
greater than additive for individual units, mean values at each time
point for sensitization evoked by combined injections were not
significantly greater than the sum of the sensitization evoked by each
drug alone (p < 0.05, Wilcoxon).
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7.2.1.2 Electrophysiology in vitro
Using the rat isolated hindlimb preparation the excitatory effects of
the prostanoids PGE2, PGD2, PGF2a and the PGI2 analogue cicaprost were
examined in thirteen experiments. Mechanical stimuli were not used in
these experiments. Both mechanonociceptors and chemosensitive units were
studied. In the same experiments the affects of these prostanoid
agonists on responses to bradykinin were also investigated. All units
examined had afferent fibre conduction velocities in the C fibre range
(0.4 - 2 ms'l), or had action potential spike shape characteristics of
identified C or fine A-delta afferent units (see Section III).
Mechanonociceptor excitation
The effects of PGE2, PGD2 and PGF2Ct were examined in eight, three and
two experiments respectively. A summary of the excitatory effects of the
prostanoids on articular mechanonociceptors is shown in table 7.9. From
six mechanosensitive units that were excited by capsaicin or 5-HT (see
Section IV), injection of PGE2 (0.01 - 10 fig, i.a.) did not evoke
excitation of any of these units. Injections of PGD2 (0.1 - 10 fig, i.a.)
or PGF2a (0.1 - 1 fig, i.a.) failed to excite three mechanoreceptors that
were excited by 5-HT or capsaicin (see Section IV).
In eight experiments, cicaprost (0.01 - 1 fig, i.a.) excited six of six
units that were excited by capsaicin or 5-HT. The response had a latency
to onset ranging from 0.2 - 9 minutes, and had a duration of 3.7 - 27
minutes. The median minimal effective dose was 0.1 fig. Two of the
responsive units had a resting discharge (mean: 0.6 ± 0.1 i.p.s.) before
249
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Fig. 7.12 Computer-generated plot illustrating dose-dependent
excitation evoked by cicaprost on an articular mechanonociceptor in
vitro. The upper trace shows the response to i.a. injection of 0.1 /*g
cicaprost (at arrow) and the lower trace the response of the same unit
to a subsequent i.a. injection of 1.0 pg cicaprost (at arrow). A period
of 15 mins elapsed between the injections. Each bar represents a 1 s
time interval. The inset trace shows thirty superimposed oscilloscope
sweeps triggered by the single action potential that was counted.
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exposure to cicaprost. Dose-dependency of the response was seen in the
two units which were examined for this relationship. An example of the
dose dependent excitation caused by cicaprost is illustrated in figure
7.12. The mean discharge at the peak of the response, measured over 60
s, was 1.3 ± 0.5 i.p.s., and the mean maximum number of evoked action
potentials above basal discharge (delta Ex) was 240 ± 118 impulses (mean
duration: 13.8 ± 7.2 mins).
Excitation of chemosensitive units
The effects of PGE2, PGD2 and PGF2a were examined in eight, three and
two experiments respectively. A summary of the excitatory effects of the
prostanoids on chemosensitive units is shown in table 7.10. From six
recordings, consisting of between one and three different unit action
potentials, injection of PGE2 (0.01 - 10 fig, i.a.) caused excitation in
all cases (table 7.10). The response had a latency to onset ranging from
0.3-4 minutes, and response had a duration of 1.5 - 9 minutes. The
median minimal effective dose was 0.1 fig. Responsive units had a mean
resting discharge of 0.6 ± 0.2 i.p.s. before exposure to PGE2. Dose-
dependency of the response was seen in three of the six recordings. The
mean discharge at the peak of the response, measured over 60 s, was 2.2
± 0.6 i.p.s.. Pooled data of the maximal responses evoked by PGE2 is
shown in figure 7.13. Injections of PGD2 (0.1 - 10 fig, i.a.) or PGF2<*
(0.1 - 1 fig, i.a.) did not evoke an excitation in any of the recordings.
In eight experiments, cicaprost (0.01 - 1 fig, i.a.) caused excitation
in six of six recordings in which activity was evoked by capsaicin
(table 7.10). The response had a latency to onset ranging from 0.2 - 5
252
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Fig. 7.13 Pooled maximal responses for excitation of chemosensitive
units evoked by PGE2 or cicaprost in vitro. (A) Bar graph showing the
mean maximal integrated response (delta Ex) for units excited by
injections of PGE2 (shaded bar) (median dose: 0.1 ng, i.a., n-6), and
cicaprost (open bar) (median dose: 0.1 \ig, i.a., n-6). (B) Bar graph
showing the mean durations of the same responses shown above in A.
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minutes), and had a duration of 1 - 27 minutes, approximately twice the
duration of the mean PGE2 response. The median minimal effective dose
was 0.1 fig. Responsive units had a mean resting discharge of 0.6 ± 0.2
i.p.s. before exposure to cicaprost. Dose-dependency of the response was
seen in two of the six recordings. The mean peak discharge, measured
over 60 s, was 3.1 ± 0.6 i.p.s.. Pooled data from maximal responses
evoked by cicaprost is shown in figure 7.13.
Combined effects of prostanoids and bradykinin: mechanonociceptors
The effects of PGE2, PGD2 and PGF2a on mechanoreceptor responses to
bradykinin were examined in eight, three and two experiments
respectively. Bradykinin (10 fig, i.a.) excited only one
mechanonociceptor from nine. From six tested with PGE2 (0.01 - 10 fig,
i.a.), and three tested with PGD2 (0.1 - 10 fig, i.a.) or PGF2a (0.1 - 1
fig, i.a.), responses to bradykinin were unaffected in all cases.
From the six mechanoreceptors tested with cicaprost responses to
combined injections of threshold or subthreshold doses of bradykinin (1
- 10 fig, i.a.) and cicaprost (0.1 - 1 fig, i.a.) were larger than those
evoked by either drug alone in four units. Effects were greater than
additive in all cases. An example of the effect of bradykinin or
cicaprost alone and combined injection is illustrated in.figure 7.14.
Respones evoked by combined injections had a mean latency to onset of
2.9 ± 2.6 minutes (range: 0.02 - 16 minutes. The effect had a mean
duration of 10.2 ± 3.1 minutes (range: 4.2 - 25 mins), and the mean peak
discharge, measured over 60 s, was 2.3 ± 1 i.p.s.. Figure 7.15








Fig. 7.14 Computer-generated plot illustrating the excitatory effect of
cicaprost alone or in combination with bradykinin on an articular
mechanonociceptor. Each bar represents a one second time interval (A)
Response to i.a. injection of 0.1 fig cicaprost (at arrow). (B) Response
to a combined i.a. injection of 0.1 fig cicaprost and a previously
innefective dose of 1.0 fig bradykinin (at arrow). The inset trace shows
thirty superimposed oscilloscope sweeps triggered by the single action

































Fig. 7.15 Summary of the excitatory effects of injections of threshold
and sub-threshold doses of bradykinin or cicaprost alone and combined
injections on articular mechanonociceptors and chemosensitive receptors
in vitro. Each point on the scatter diagram represents the integrated
response (delta Ex) of a single unit to the injection of either
bradykinin, cicaprost, or combined injections of the same doses of each
drug. Open circles represent mechanonociceptors, and closed circles
represent chemosensitive units. The horizontal bars represent the mean
evoked response, and the crosses indicate units for which combined
injections evoked a response much greater that that caused by either
drug alone. These effects were greater than additive in all seven units.
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or cicaprost alone, and combined injections of the two drugs.
Combined effects of prostanoids and bradykinin: chemosensitive units
Injections of PGD2 (0.1 - 10 /xg, i.a.) or PGF20 (0.1 - 1 /xg, i.a.) did
not cause any change in bradykinin evoked excitation in any of the
recordings. From six recordings, combined injections of PGE2 (0.1 - 10
/xg, i.a.) and bradykinin (0.1 - 10 /xg, i.a.) caused excitation greater
than that produced by either drug alone in three cases. This effect was
not any greater than additive. Excitation evoked by combined injections
had a mean latency to onset of 0.7 ± 0.3 minutes (range: 0.03 - 2 mins),
and the response had a mean duration of 6.6 ± 1.4 minutes (range: 4 -
11.7 mins). The mean peak discharge, measured over 60 s, was 2.2 ± 0.9
i.p.s.. Figure 7.16 shows a summary of responses to threshold or
subthreshold doses of bradykinin or PGE2 alone, and combined injections
of the two drugs.
From five recordings, combined injections of cicaprost (0.01 - 0.1 /xg,
i.a.) and bradykinin (0.1 - 10 /xg, i.a.) caused excitation greater than
that produced by either drug alone in three cases. This effect was
greater than additive in all cases as illustrated in figure 7.15. In the
remaining two units cicaprost (0.1 /xg, i.a.) evoked a large excitation
when given alone. Excitation caused by combined injections had a mean
latency to onset of 1.9 ± 1.1 minutes (range: 0.2-6 mins), and the
response had a mean duration of 9.4 ± 3.9 minutes (range: 1.2 - 24
mins). The mean peak discharge, measured over 60 s, was 2.8 ± 0.5


























Fig. 7.16 Summary of the excitatory effects of injections of threshold
and sub-threshold doses of bradykinin or PGE2 alone or combined
injections on chemosensitive receptors in vitro. Each point on the
scatter diagram represents the integrated response (delta Sx) of a
single unit to the injection of either bradykinin, PGE2 or combination
injections of the same doses of each drug. The horizontal bars represent
the mean evoked response, and the crosses indicate units for which
combined injections evoked a response greater that that caused by either
drug alone. These effects were only marginally greater than additive.
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7.2.2 Arthritic joints
The effects of PGE2, or the highly selective IP-receptor agonist
cicaprost, were examined in vivo on C and A-delta articular
mechanonociceptor in arthritic joints following the administration of
lysine acetylsalicylate (1-AS) to supress endogenous prostanoid
production. The effects of 1-AS on these receptors were also examined in
arthritic joints in vitro using the rat isolated hindlimb preparation.
7.2.2.1 Electrophysiology in vivo
Studies on the effects of administration of 1-AS, PGE2 or cicaprost were
performed in nine experiments, from which sixteen articular
mechanonociceptors were identified and studied. Mechanonociceptor units
had afferent fibre conduction velocities in the C or fine A-delta range
(0.5 - 4.6 i.p.s), and had a mean resting discharge of 2 ± 0.7 i.p.s
(n-12).
Effects of 1-AS on resting discharge
Injection of 1-AS (100 mgkg*^-, equivalent to 50 mgkg"! acetylsalicylic
acid (ASA), i.v.), caused a reduction in resting activity in all twelve
units examined. Afferent unit discharge began to decline 2-12 minutes
after administration, and reached a minimum level after a delay of 4 -
16 minutes (mean: 10 ± 1.5 mins). The mean minimum discharge level
attained, measured at different time points following injection, was 36X
of pre-injection control. Recovery to higher levels of resting discharge
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was not seen for observation periods of up to 40 minutes. Figure 7.17
illustrates a summary of the responses of the twelve units to 1-AS.
Effects of prostanoids on resting discharge following 1-AS
The effects of PGE2 were examined on ten mechanonociceptors whose
resting activity had been reduced by 1-AS. Injection of PGE2 (0.03 - 30
Hg, i.a.), transiently increased afferent discharge to levels
approaching those seen before administration of 1-AS in six (60%) of
these units. This effect had a mean latency to onset of 2 ± 0.4 minutes,
and was generally short lived, with a mean duration of 3.4 ± 0.8 minutes
(range: 1-11 mins). Dose dependency of the response was seen in all
five of the units examined for this relationship, results from which are
shown in figure 7.18. The maximum dose used in the majority of units was
3 ng, and pooled data from responses to this dose is shown in figure
7.19. In one unit tested with 30 ng PGE2, a large (peak discharge: 219X
of pre-l-AS control) and sustained (11 mins) increase in resting
activity was evoked.
The effects of cicaprost were examined on eight mechanoreceptors whose
activity had been reduced by 1-AS. Injection of cicaprost (0.1 - 1 fig,
i.a), evoked a large and sustained afferent discharge in seven (88Z) of
these units. This effect had a relatively short latency to onset (mean :
0.8 ± 0.1 mins), and had a mean duration of 12.5 ± 2.6 minutes (range 3
- 40 mins). Dose dependency of the response was seen in all four units
examined for this relationship, results from which are shown in figure
7.20. The maximum dose used in all units was 1 ng, and pooled data of
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Fig. 7.17 Pooled data showing the depressant effects of l-AS on
spontaneous discharge of articular mechanonociceptors in arthritic
joints. Each point on the graph represents the mean of the average unit
discharge recorded over a 60 s period, and is expressed as a percentage
of the pre-injection control (-100%). The arrow and vertical dotted line
indicate the time at which injections were made. The effects of i.v. 1-
AS (50 mgkg'l, ASA equivalent) and i.v. saline are shown. Mean values
are significantly (p < 0.05, Wilcoxon) lower than corresponding values
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Fig. 7.18 Excitatory effects of increasing doses of PGE2 on the
discharge of articular five mechanonociceptors following treatment with
1-AS. Each point represents the mean of the average unit discharge
recorded over a one minute time period. Values are expressed as a
percentage of the pre-l-AS control discharge (-100%). The arrow and
dashed vertical line indicate the time at which injections of PGE2 were
made. Dose-dependency is seen for doses between 0.03 pg and 0.3 pg, but
responses to 3 pg PGE2 are delayed in onset and on average reduced.
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PGE2 n=6 oca n=7
Fig. 7.19 Pooled data showing the maximal excitatory response evoked by
PGE2 or cicaprost following treatment with 1-AS. Each point represents
the mean discharge recorded over a 60 s period. Values are expressed as
a percentage of the pre-l-AS control discharge (-1002). The arrow and
dashed vertical line indicate the time at which injections were made.
PGE2 (3 /ig, i.a.) caused an increase in afferent discharge in 602 of
units, whereas cicaprost (1 ng, i.a.) excited 882. Only those values for
responsive units are shown. The mean maximum response to cicaprost was
of greater amplitude and of longer duration than that caused by a higher
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Fig. 7.20 Dose-dependent excitatory effects of cicaprost on the resting
discharge of four articular mechanonociceptors following treatment with
1-AS. Each point represents the mean unit discharge recorded over a 60 s
period. Values are expressed as a percentage of the pre-1-AS control
discharge (-100%). The arrow and dashed vertical indicate the time at
which the injections were made. Long lasting increases in resting
discharge well above those seen before the administration of 1-AS were
evoked by injection of 1 pg cicaprost.
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Examination of units tested both with PGE2 and cicaprost revealed that
four units excited only weakly by PGE2 were excited strongly by
cicaprost. A further two units were excited by cicaprost, while PGE2 had
no effect.
Effects of 1-AS on mechanical responsiveness
Injection of 1-AS (50 mgkg'l, i.v.), caused a reduction in
responsiveness to mechanical stimuli, repeated once every two minutes,
in all eleven units examined. Responsiveness began to decline 2-26
minutes after administration, and reached a minimum level after 8-34
minutes (mean: 21 ± 3.2 mins). The mean minimum discharge per stimulus
attained, calculated from values taken at different times following
injection, was 50% of pre-injection control. Recovery to higher levels
of responsiveness was not seen for observation periods of up to 40
minutes. Figure 7.21 shows pooled data from the responses of the eleven
units to 1-AS.
Effects of prostanoids on mechanical responsiveness following 1-AS
The effects of PGE2 were examined on seven mechanonociceptors whose
mechanical responsiveness had been reduced by 1-AS. Injection of PGE2
(0.03 - 30 pg, i.a.), caused a small increase in responsiveness towards
levels seen before administration of 1-AS in four (57%) of these units.
There was a mean latency to onset of 2.9 ± 0.7 minutes, and the effect
was generally short lived, with a duration of 1 - 8 stimuli (mean: 4 ±
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Fig. 7.21 Pooled data showing the depressant effects of l-AS on
mechanically evoked discharge from articular mechanonociceptors.
Each bar represents the mean response to mechanical stimuli of 2 s
duration applied once every 2 mins before and after i.v. injection of 1-
AS (50 mgkg-1, ASA equivalent). Responses before and after injection of
saline are also shown. The arrow and dashed vertical line show the time
at which injections of l-AS were made. Mean values are significantly (p
< 0.05, Wilcoxon) lower than corresponding values following saline
injection, from 2 mins after injection of l-AS.
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four units examined for this relationship. Maximum responses were
obtained with doses ranging from 0.03 - 3 /ig. Pooled data from maximum
responses are shown in figure 7.22.
The effects of cicaprost were examined on seven mechanonociceptors
whose responsiveness had been reduced by 1-AS. Injection of cicaprost
(0.1 - 1 /ig, i.a), caused a large and sustained increase in mechanical
responsiveness in six (86%) of these units. This effect had a latency to
onset of 3 i 0.4 minutes, and a duration of 1 - 24 stimuli (mean: 19 ±
4.4 mins). Dose dependency of the response was seen in all four units
examined for this relationship, as shown in figure 7.23. Maximum
responses were obtained with doses ranging from 0.1 - 1 /ig, and pooled
data from these responses are shown in figure 7.23.
Consideration of units tested with both PGE2 and cicaprost revealed
that one unit, affected only weakly by PGE2, displayed a marked increase
in responsiveness following cicaprost. A further two units gave a large
response to cicaprost, while being unaffected by PGE2.
2.2.2.2 Electrophysiology in vitro
Examination of the effects of 1-AS were carried out in three
experiments, from which three mechanonociceptors were identified. Two
units were further examined for the effects of cicaprost following 1-AS.
Mechanosensitive units had action potential spike shape characteristics
similar to those of identified C fibre units. An an irregular ongoing
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Fig. 7.22 Pooled data showing the maximum sensitizing effect of PGE2 or
cicaprost on the mechanically evoked discharge from articular
mechanonociceptors following treatment with 1-AS. Each bar represents
the mean response to mechanical stimuli of 2 s duration applied once
every 2 mins before and after injection of PGE2 (0.03 - 3 /ig, i.a.) or
cicaprost (0.1 - 1 /xg, i.a.). Values are expressed as a percentage of
pre-l-AS control. PGE2 caused a sensitization to mechanical stimuli in
only 57X of units, whereas cicaprost sensitized 86X. Only those values
for responsive units are shown. The arrow and dashed vertical line show
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Fig. 7.23 Dose-dependent sensitizing effects of cicaprost on
mechanically evoked discharge from three articular mechanonociceptors
following treatment with 1-AS. Each bar represents the mean response to
mechanical stimuli of 2 s duration applied once every 2 mins before and
after injection of cicaprost. Values are expressed as a percentage of
pre-l-AS control (-100%). The arrow and dashed vertical line indicate
the time at which injections of cicaprost were made. Increasing the dose
of cicaprost from 0.1 pg to 1 pg increased both the duration and
amplitude of the response.
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Effects of 1-AS on resting discharge
Combined perfusion and superfusion of 1-AS (Krebs solution containing
100 mgl'l, 1-AS, equivalent to 50 mgl'l ASA) caused a reduction in
resting discharge in both of the units examined. A reduction in the
occurrence of irregular bursting activity was the most obvious effect.
Afferent discharge began to decline at 1 and 5 minutes after the start
of the infusion, and reached a minimum level after a delay of 12 and 23
minutes. The mean minimum discharge level attained was 10Z of pre-l-AS
control. Recovery to higher levels of resting discharge was not seen for
recording periods of 40 minutes. Figure 7.24 illustrates a summary of
the responses of the two units to 1-AS.
Effects of cicaprost on resting discharge following 1-AS
The effects of cicaprost were examined on two mechanoreceptors whose
resting activity had been reduced by 1-AS. Injection of cicaprost (0.01
- 1 /ig, i.a.) evoked an afferent discharge in both of the units tested.
This effect had a latency to onset of 1 - 5 minutes, and lasted for 3 -
9 minutes. Figure 7.25 illustrates the dose-dependent effect of
cicaprost on the one unit tested in this way.
Effects of 1-AS on mechanical responsiveness
Addition of 1-AS (50 mgl'l, ASA equivalent) to the Krebs medium
perfusing and superfusion the tissues, reduced mechanically evoked
discharge (stimuli applied once every two minutes) in all three units
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Fig. 7.24 Pooled data showing the depressant effects of l-AS on the
resting discharge of articular mechanonociceptors in vitro. Each point
on the graph represents the mean discharge recorded over a 60 s period,
and is expressed as a percentage of the pre-injection control (-100X).
The arrow and vertical dotted line indicate the time at which l-AS was
administered. Shown are the effects of l-AS (50 mgl'l, ASA equivalent),
or standard Krebs medium on afferent discharge. Mechanonociceptors from
arthritic joints displayed a high level of bursting activity, which is
reflected in the variability in the discharge obtained when perfusing
with standard Krebs medium. The main action of l-AS was to reduce the
bursting activity of mechanonociceptors seen in these joints.
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Fig. 7.25 Dose-dependent excitatory effects of cicaprost on the
spontaneous discharge of articular mechanonociceptors following
treatment with 1-AS in vitro. Each point on the graph represents the
mean discharge recorded over a 60s period, and is expressed as a
percentage of the pre-l-AS control (-100Z). The arrow and vertical
dotted line indicate the time at which injections were made.examined.
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Responsiveness began to decline 2-18 minutes after the addition of 1-
AS, and reached a minimum level after a delay of 10 - 32 minutes (mean:
24.7 ± 7.'3 mins). The mean minumum discharge attained per stimulus,
calculated from values taken at different times following administration
of 1-AS, was 7X of pre-1-AS control. Recovery to higher levels of
responsiveness was not seen for observation periods of 40 minutes.
Figure 7.26 illustrates a summary of the responses of the three units to
1-AS.
Effect of cicaprost on mechanical responsiveness following 1-AS
The effects of cicaprost were examined on two units whose mechanical
responsiveness had been reduced by 1-AS. Injection of cicaprost (0.01 -
1 ng, i.a.)t caused an increase in responsiveness towards levels seen
before administration of 1-AS in the one unit on which the highest dose
of 1 ng was tested. Figure 7.27 illustrates the dose-dependent effect of
cicaprost on this unit.
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Fig. 7.26 Pooled data showing the depressant effects of 1-AS on
mechanically evoked activity of articular mechanonociceptors in vitro.
Each bar represents the mean response to mechanical stimuli of 2 s
duration applied once every 2 mins before and after addition of l-AS (50
mgl'l ASA equivalent) to the Krebs medium. Values are expressed as a
percentage of the pre-l-AS control response (-100X). Mechanically evoked
responses before and after injection of saline are also shown. The arrow
and dashed vertical line show the time at which l-AS was administered.
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Fig. 7.27 Dose-dependent effects of cicaprost mechanically evoked
discharge of an articular mechanonociceptor following treatment with 1-
AS in vitro. Each bar represents the mean unit response to mechanical
stimuli of 2 s duration applied once every 2 mins before and after i.a.
injection of cicaprost. The arrow and dashed vertical line show the time
at which injections were made. Only the highest dose (1 /*g) evoked an
increased responsiveness to mechanical stimuli.
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7.3 DISCUSSION
The results obtained in the present study show that the prostanoids PGE2
and PGI2 have several actions on articular nociceptors. These include
excitation, and sensitization to mechanical and chemical stimuli. Both
PGI2 and cicaprost, the highly selective IP-receptor agonist, were more
potent than PGE2 in all of these actions.
7.3.1 Normal joints
7.3.1.1 Receptor excitation
Prostanoid-induced sensitization of articular nociceptors both to
mechanical and chemical stimuli described above is consistent with
previous findings showing the hyperalgesic and sensitizing properties of
the prostanoids in other systems (Ferreira, 1972; Moncada et al., 1975;
Handwerker, 1976a,b; Chahl & Iggo, 1977; Tyers & Haywood, 1979; Higgs et
al., 1979; Mense, 1981; Petromichelakis & Rood, 1982; Martin et al.,
1987). However, the prostanoids have only rarley been shown to produce
excitation of nociceptive sensory receptors when given alone. In the
skin of the rat, injections of PGE^ evoked a long lasting (up to 20
mins) discharge in 80% of recordings of afferent activity from the
saphenous nerve (Chahl & Iggo. 1977). In cat muscle, PGE2 (i.a.) evoked
a weak, irregular discharge in 46% of C-fibre afferent units (Mense,
1981). Finally, in the cat knee joint, PGE2 excited approximately 60% of
all A-delta and C fibre afferent units (Schaible & Schmidt, 1988b).
These effects of PGE2 in the cat had a latency to onset of 10 - 30
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seconds, were of long duration (generally at least 3 mins), and were
dose-dependent in the majority of units. In the present study,
injections of PGE2 in vitro evoked weak excitation in less than a
quarter of mechanonociceptors, and in vitro affected none of the
mechanonociceptors examined. In contrast to the small numbers of units
responding to PGE2, injection of relatively low doses of PGI2, in vivo
excited 80% of the units under study. PGI2-evoked activity was of long
duration, generally lasting for well over 10 minutes. Similar results
were obtained in vivo and in vitro for the highly selective IP-receptor
agonist cicaprost. In the present study, the high potency of PGI2 and
cicaprost, the low potency of PGE2, and the lack of effect with PGF2<* or
PGD2 suggests that, in the rat, prostanoid-induced excitation of
articular nociceptors is mediated by IP-receptors. The relatively potent
excitatory effects of PGE2 reported by Schaible & Schmidt (1988b) in the
cat knee joint may reflect a species difference in the populations of
IP- or EP-receptors or present on articular sensory nerves. However, it
is difficult to draw any conclusions from this study in the cat as only
PGE2 was used, and no comparison with the effects of other prostanoids
can be made. Excitatory effects of PGE^ reported in rat skin by Chahl &
Iggo (1977), may have been mediated by IP-receptors, EP-receptors or
both, since this prostanoid has potent agonist effects at both receptor
types (see Jones et al., 1984). Studies on the depolarizing effects of
the prostanoids on the rabbit or rat isolated vagus nerve (see Section
VIII), suggest that populations of EP-receptors present on C fibre
sensory nerves differ in these two species.
Examination of the excitatory effects of prostanoids on chemosensitive
articular receptors in vitro revealed a similar rank order of potency to
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that seen for mechanonociceptors. PGF2a and PGD2 had no effect, while
PGE2 and cicaprost caused excitation, with cicaprost being the more
effective. These results support the idea that excitatory prostanoid
receptors on rat chemosensitive sensory receptors are mainly of the IP
type, but does not exclude the involvement of an EP-receptor in
prostanoid-evoked excitation of these units.
In support of the idea that prostanoids may cause pain when given
alone are various studies on animals and man. Intra-arterial,
intravenous or intramuscular injections of the E-series prostanoids
(Bergstrom et al., 1965; Carlson, 1968; Bevergard and Oro, 1969; Karim,
1971; Collier et al. 1972; Gillespie, 1972), PGI2 (Fitzgerald et al.
1979; O'Grady et al., 1980; Szceklick et al., 1980) or its stable
analogue, iloprost (Kaukinen et al., 1984) have been reported to cause
pain and headache in man. In the dog intra-arterial injections of PGE2
into the spleen evokes pseudoaffective response (Moncada et al., 1974),
and when injected into the knee joint PGE2 or PGE^ cause an
incapacitation (Rosenthale et al., 1972). Additionally, intraperitoneal
injection of PGE2 or PGE^ evokes a writhing response in mice (Collier &
Schneider, 1972).
A dissociation between the hyperalgesic effects of low dose PGE^, and
the pain-producing effects of high dose PGE^ was demonstrated by
Ferreira (1972), who injected the prostanoid intra-dermally in man.
These effects may reflect an action of PGE^ at two different prostanoid
receptors, or may be related to an increase in the activation of the
same system at higher doses.
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7.3.1.2 Mechanical sensitization
Prostanoid-induced sensitization of sensory receptors to mechanical
stimuli has been reported previously in rat skin for PGE2 on A-delta and
C fibre nociceptors (Martin et al. , 1987), and for PGE^ on moderate
pressure A-delta mechanoreceptors (Pateromichelakis & Rood, 1982). In
the cat knee joint, sensitization to joint movement has also been
reported for PGE2 on articular sensory receptors with A-delta and, to a
lesser extent, C fibre afferents (Schaible & Schmidt, 1988b). In the
present study, PGI2 and cicaprost both sensitized nearly double the
number of units affected by PGE2. In contrast to the long duration
effects of PGI2 or cicaprost, PGE2-induced sensitization was generally
short-lived and showed no dose-dependency. These results suggest that
these effects are predominantly mediated by IP-receptors.
Of further interest is the finding that PGE2-induced effects on the
mechanical responsiveness of the units under study had two components:
at low doses sensitization occurred in just under half the units,
whereas at higher doses a marked reduction in mechanical sensitivity was
seen. This observation suggests that PGE2 may be acting at two different
prostanoid receptors to produce these effects. The presence of an EP-
receptor mediating mechanical sensitization is supported by the finding
that PGI2-induced effects were of greater amplitude and longer duration
than those of cicaprost. PGE2-induced depression of mechanical
responsiveness may be mediated by an EP-receptor subtype or perhaps by a
receptor for a different endogenous prostanoid.
Hyperalgesia to mechanical stimuli has been reported by other workers
for PGE^, PGE2 or PGI2 in the paw of the rat (Willis & Cornelsen, 1973;
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Ferreira et al., 1978; Tyers & Haywood, 1979). Following their injection
into the knee joint of the dog, both PGE2 and PGI2 cause incapacitation
(Ferreira et. al., 1978). Ferriera (1972) stated that the hyperalgesic
effects of PGI2 were more rapid in onset and of shorter duration than
than those of PGE2, which took up to thirty minutes to develop, and
lasted for several hours. It is difficult to compare this finding with
those of the present study since the method of administration and
assessment of effects was somewhat different. Since injection into the
paw results in the localization of the drug in that area, the known
pharmacokinetics of these prostanoids may explain why the effects of
PGI2, which is hydrolysed very rapidly to 6-keto-PGF]/* at physiological
pH (Cho & Allen, 1978), are of short duration, whereas those of the
relatively stable PGE2 (Ferreira, 1979) are prolonged. The long latency
to onset of PGE2-induced hyperalgesia may be related to the time taken
for the drug to diffuse throughout the tissues, and to reach
sufficiently high concentrations to affect a significant number of
nociceptors.
7.3.1.3 Interactions with bradykinin
The sensitizing properties of the prostanoids on bradykinin-induced
excitation of sensory receptors has been demonstrated previously in the
skin of the rat for PGE^ (Chahl & Iggo, 1977) or PGE2 (Handwerker,
1976), in cat muscle for PGE2 (Mense, 1981), in canine testicular
tissues for PGE2 or PGI2 (Kumazawa et al, 1987), and in the cat knee
joint for PGE2 (Schaible & Schmidt, 1988b). In the present study, both
in vivo and in vitro, the most significant potentiation of bradykinin-
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induced excitation was seen with cicaprost. PGE2 generally caused only a
weak enhancement of responses to bradykinin. PGI2 evoked a sustained
increase in discharge from most units when given alone at the lowest
dose used in vivo. These results suggest that prostanoid-induced
potentiation of bradykinin-evoked excitation is mediated by an IP-
receptor. Comparison of the potentiating effects of PGE2 and PGI2 on the
response of canine testicular C-polymodal nociceptors to bradykinin,
also showed PGI2 to be more effective, there being a ten fold difference
in the potency of the two prostanoids (Kumazawa et al., 1987).
Bradykinin-induced sensitization to mechanical stimuli was also found
to be markedly potentiated by PGE2 or PGI2, and by cicaprost. In this
respect the effects of PGE2 are particularly interesting since an
effective dose of this prostanoid, which on its own caused a depression
of mechanical responsiveness, evoked a sensitization when combined with
bradykinin. These effects may be mediated by two different prostanoid
receptors, one causing depression and the other sensitization wj.th the
combined sensitizing effects of PGE2 and bradykinin overcoming the
depressant effect of high dose PGE2-
The ability of prostanoids to potentiate the algesic effects of
bradykinin have been demonstrated in a number of different models.
Injection of bradykinin into the spleen of the dog or cat induced a
pseudoaffective response which was potentiated by PGE2 or PGEi
(Ferreira, 1972; Tyers and Haywood, 1979), with PGE^ being over a
thousand times more potent than PGE2 (Tyers and Haywood, 1979). In the
rabbit isolated ear preparation, the reflex fall in arterial blood
pressure induced by bradykinin was potentiated by PGE2, PGE^ or PGI2
(Lembeck et al., 1976; Juan, 1979). In this model PGI2 and PGE^ were
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approximately thirty times more potent than PGE2 (Juan, 1979). These
findings are in agreement with those of the present study, and support
the involvement of IP-receptors in prostanoid-induced potentiation
responses to bradykinin.
PGF2a-induced depression of the potentiating effects of PGE^ on
responses to bradykinin by been reported in the rabbit isolated ear
preparation (Juan & Lembeck, 1977). These results suggest that in the
present study the depressant effects of PGE2 on responsiveness to
mechanical stimuli may be mediated via the same receptor type as that
mediating the effects of PGF2C* in the rabbit ear. In the present study
the effects of PGF2Q: on the responsiveness of articular
mechanonociceptors to mechanical stimuli was not examined, and 5
should probably be considered in future investigations. .
7.3.2 Arthritic joints
7.3.2.1 Effects of lysine acetylsalicylate (1-AS)
The results described above confirm those obtained by Guilbaud et al.
(1985) in rats with adjuvant polyarthritis, and establish that 1-AS
causes a reversible depression of mechanical responsiveness and ongoing
discharge in articular mechanonociceptors from chronically inflamed rat
ankle joints. It was previously shown that 1-AS has no effect on
similar, although less sensitive, mechanoreceptors in normal joints
(Guilbaud et al., 1985). The time course of the depressant effect seen
here is similar to that reported for the effect of ASA on the excitation
of muscle nociceptive afferents by bradykinin in the cat (Mense, 1982),
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and also with that described for the effects of ASA or indomethacin on
articular nociceptors from the acutely inflamed cat knee joint
(Heppelman et al., 1986). These findings suggest that these drugs
operate via a peripheral site of action.
The doses of 1-AS used here are in the same range as those commonly
used in studies to evaluate the analgesic action of ASA (Hirata M.,
1966; Blane, 1967; Abe et al., 1971; O'Dea, 1975; Deraedt et al., 1976;
Gouret et al., 1976; Vinegar, 1976; Inoki, 1977), and the onset and
duration of the depressant effect is similar to that of analgesia
produced by ASA in the dog (O'Dea et al., 1975), and in man (Kantor et
al., 1966; Mehlisch, 1983).
7.3.2.2 Effects of the prostanoids after treatment with 1-AS
It has been established both in vitro (Vane, 1971; Ferreira & Vane,
1974; Roth et.al., 1975; Sturge et al., 1978; Van der Ouderas et al.,
1980; Salmon et al., 1983), and in vivo (Ferreira and Vane, 1974;
Moncada et al., 1975; Fitzpatrick & Wynalda, 1976), that
acetylsalicylate inhibits prostanoid synthesis, and is generally
considered to exert its analgesic effects via the resulting reduction in
tissue prostanoid content (Collier et al., 1972; Ferreira and Vane,
1974; Moncada et al., 1975). From the time constants for the effects of
1-AS on the responsiveness of articular receptors Guilbaud et al. (1985)
concluded that a cyclooxygenase metabolite with a half life comparable
to that of PGI2 was responsible for the sensitization of
mechanoreceptors in arthritic joints. However, several enzymes other
than prostanoid cyclooxygenase may be affected by aspirin-like drugs
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(Lembeck & Juan, 1974; Tolman & Partride, 1975; Kuehl and Egan, 1980;
Brune, 1982; 1983), and salicylate has been found to have direct actions
on neuronal membranes (Levitan & Barker, 1972a,b,c; Neto & Narahashi,
1976; Neto, 1980).
In the present study it was demonstrated that following depression of
afferent discharge by 1-AS exogenously administered PGE2 or cicaprost
could evoke increases in activity towards those levels seen before
treatment with 1-AS, suggesting that these effects of 1-AS are mediated
via the inhibition of endogenous prostanoid production. Cicaprost was
considerably more effective than PGE2 both for mechanical responsiveness
and ongoing discharge, supporting the idea that PGI2 is the major
endogenous prostanoid responsible for nociceptor sensitization during
inflammation.
In the acutely inflamed knee joint of the cat, the depressant effects
of ASA or indomethacin, were partially reversed by PGE2 in all units for
ongoing discharge, and in 67% of units for sensitivity to movement
(Heppelmann et al., 1986). These effects were of longer duration than
those seen in the present study for PGE2. Although species differences
may account for the long lasting effects of PGE2 in the cat, without a
comparison with other prostanoids it is impossible to determine whether
or not these are EP-receptor mediated effects.
Following treatment with 1-AS in arthritic joints, responses to
cicaprost lasted on average for over twice as long as those seen in
normals. Increased sensitivity to cicaprost seen in arthritic joints may
be produced as a result of the actions of other inflammatory mediators
such as bradykinin, 5-HT (see Sections V and VI), or lypoxygenase
metabolites of arachidonic acid. LTB4, for example, has been shown to
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sensitize mechanonociceptors in the rat skin, probably via the release
of 8(R),15(S) dihydroxyeicosatetraenoic acid (8(R),15(S)diHETE) from
polymorphonuclear leukocytes (Martin et al., 1987).
The reduction both in mechanonociceptor responsiveness and in resting
discharge caused by 1-AS in vitro was much greater than that seen in
vivo. This result suggests that factors not present in vitro may be
responsible for the residual mechanoreceptor sensitization and ongoing
activity seen following 1-AS in vivo. These additional factors may be
blood borne or may have been washed out of the tissues as a result of
the perfusion process. The short-lived response evoked by cicaprost in
vitro following 1-AS also suggest that components present in vivo may be
potentiating the effects of cicaprost in the arthritic joint. Mediators
likely to be involved include 5-HT and bradykinin (see Sections V and VI
respectively).
7.3.2 Mechanisms of action
Since all the effects of the prostanoids which were seen in vivo could
also be demonstrated in vitro, these are probably directly mediated
effects and do not involve the release of secondary blood borne
mediators or spinal reflex activity. Support for a direct action
mediated by prostanoid receptors associated with sensory nerves is
provided by studies showing effects on isolated neurones in vitro. On
rat sensory neurones in culture application of PGE2 causes these cells
to fire action potentials (Baccaglini & Hogan, 1983). In rabbit C-type
nodose ganglion neurones PGE^, PGE2 and PGD2 inhibit a slow after-
hyperpolarization via the blockade of a Ca2+-dependent K+ conductance
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(Fowler et al, 1985a,b; Weinreich & Wonderlin, 1987). This effect of the
prostanoids was mimicked by forskolin suggesting that inhibition of the
Ca^+-depedent K+ conductance is mediated via cAMP (Weinreich & Wonderin,
1987). Prostanoid-induced depolarization of the rabbit isolated vagus
nerve in vitro (see Section IV) could be mimicked by forskolin, and also
by 8-bromo cAMP, suggesting that depolarization is mediated via cAMP.
These findings support the idea that prostanoids affect the excitability
of nociceptive sensory neurones via prostanoid receptors located on
these neurones.
7.4 CONCLUSIONS
The results described above provide strong evidence for the involvement
of IP-receptors in the excitatory and sensitizing effects of exogenously
administered prostanoids. There is also some support for the existence
EP-receptor mediated sensitizing effects, and further studies using
selective EP receptor agonists (see Section XIII) would be of use in
determining which EP-receptor subtype(s) may be involved. Results from
arthritic joints suggest that PGI2 is the major endogenous prostanoid
responsible for the sensitization of articular mechanonociceptors from
chronically inflamed ankle joints in the rat. In support of a role for
PGI2 in human joint disease, an extensive study examining the prostanoid
content of synovial fluid from inflamed joints found that the stable
hydration product of PGI2, 6-oxo-PGF^a, was in greater abundance than
any of the other prostanoids (Brodie et al., 1980). As detailed above,
administration of 1-AS did not result in the complete suppression of
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ongoing activity and mechanical responsiveness in arthritic joints, and
it is likely that inflammatory mediators other than the prostanoids are
involved in maintained nociceptor sensitization in these joints.
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SECTION VIII
PROSTANOID-INDUCED DEPOLARIZATION OF SENSORY
AND MOTOR NERVES FROM THE RABBIT AND RAT
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SECTION VIII
PROSTANOID-INDUCED DEPOLARIZATION OF SENSORY
AND MOTOR NERVES FROM THE RABBIT AND RAT
8.1 INTRODUCTION
The hyperalgesia actions of the prostanoids, particularly those of the
E-series, are well documented (Ferreira, 1972; Moncada et al., 1975;
Ferreira et al., 1978; Ferreira & Nakamura, 1979a; Tyers & Haywood,
1979; Higgs et al., 1981; Higgs & Moncada, 1983), and PGE2, PGE^ and
PGI2 have been shown to sensitize nociceptive sensory receptors to a
range of mechanical (Martin et al., 1987), and chemical (Handwerker,
1976; Chahl & Iggo, 1977; Mense, 1981; Yanigasawa et al., 1986; Kumazawa
et al., 1987; Schaible and Schmidt, 1988b) stimuli. Furthermore, the
prostanoids have been demonstrated to have direct effects on isolated
sensory neurones, including the induction of action potential generation
in rat sensory neurones in culture (Baccaglini & Hogan, 1983), and the
blockade of a Ca^+-dependent after-hyperpolarization in neurones of the
rabbit nodose ganglion (Fowler et al., 1985a,b; Weinreich & Wonderlin,
1987).
It has recently been shown that prostanoids can cause dose-related
depolarization of the rat isolated vagus nerve in vitro (Poll et al.,
personal communication). Using the naturally occurring prostanoids, the
selective IP-receptor agonists, cicaprost and iloprost, and the
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selective TXA2 agonist, U46619, the following rank order of potency was
obtained
cicaprost > iloprost > PGI2 > PGE^ > PGE2 > PGF2cr > U46619 > PGD2
These results indicate that in this preparation prostanoid-induced
depolarization is mediated predominantly by IP-receptors.
In the present study I have examined prostanoid-induced effects on the
rat isolated saphenous and sciatic nerves in order to determine which
prostanoid receptors are present on these predominantly sensory and
motor nerves of the rat. A mixed nerve, the tibial nerve, was also used
in this study. Additionally, a separate series of experiments, using the
rabbit isolated vagus nerve, were carried out to compare prostanoid-
induced effects on sensory nerves across species. The role played by
cAMP in prostanoid-induced effects were also examined in this
preparation using the non-hydrolysable analogue of cAMP, 8-bromo cAMP,
the adenylate cyclase stimulant forskolin, and the phosphodiesterase
inhibitor IBMX.
8.2 RESULTS
The rat and rabbit isolated nerve preparations used in these experiments
are described in Section II. Application of the naturally occurring
prostanoids and their synthetic mimetics caused a depolarization in all
the isolated nerve preparations used. The rabbit isolated vagus nerve
was depolarized most consistently, responses showing clear
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concentration-dependency. In contrast, although depolarizations were
obtained with the rat isolated nerve preparations, they were weak and
inconsistent.
8.2.1 Rabbit vagus nerve
8.2.1.1 Naturally occurring prostanoids
PGE2 (n-10), PGE^ (n-6) and PGI2 (n-10) all evoked depolarization of the
rabbit isolated vagus nerve in a concentration-dependent manner in the
concentration range 1 x 10'^ - 3 x 10*^ M (fig. 8.1). Neither PGD2 (n—5)
or PGF2<* (n-3) produced significant effects in concentrations up to 3 x
10"^ M. Construction of log concentration-effect curves (figs. 8.2 -
8.4), revealed that PGE2 and PGI2 were of similar potency. A summary of
the EC50 values for individual experiments is illustrated in figure 8.8.
Table 8.1 shows the EC50 values for each of the prostanoids tested.
Mean values were calculated from individual experiments as described in
Section II. The most potent natural prostanoid was PGEi, with an EC50
value of 16 ± 3 nM. Thus, the following rank order of potency was
obtained
PGE^ > PGI2 > PGE2 » PGD2 - PGF2a - 0
The mean log concentration-effect curves for PGE^ and PGI2 were
approximately parallel, however, that for PGE2 was notably shallower
(fig. 8.7).
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Figure 8.1 Rabbit isolated vagus nerve. Discontinuous record of the
effects of (A) PGI2, (B) PGEi and (C) PGE2 on individual vagus nerve
preparations. Upwards direction indicates depolarization: the solid bar
under each response shows the appropriate duration of the agonist














Figure 8.2 Rabbit isolated vagus nerve. Log concentration-effect curve
for PGE2-evoked depolarization. Each point represents the mean ± s.e.m.
depolarization evoked by a given concentration of PGE2 for 10
determinations. Drugs were applied for a period of 3 mins, and tissues

















l 1 1 1 1 1 1 i 1 1
0-001 0-01 01 l-o 10
concentration (pM)
Figure 8.3 Rabbit isolated vagus nerve. Log concentration-effect curve
for PGl2-evoked depolarization. Each point represents the mean ± s.e.m.
depolarization evoked by a given concentration of PGI2 for 10
determinations. Drugs were applied for a period of 3 mins, and tissues























Figure 8.4 Rabbit isolated vagus nerve. Log concentration-effect curve
for PGE^-evoked depolarization. Each point represents the mean ± s.e.m.
depolarization evoked by a given concentration of PGE^ for 6
determinations. Drugs were applied for a period of 3 mins, and tissues
were allowed to repolarize fully between applications.
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Figure 8.5 Rabbit isolated vagus nerve. Log concentration-effect curve
for iloprost-evoked depolarization. Each point represents the mean ±
s.e.m. depolarization evoked by a given concentration of iloprost for 3
determinations. Drugs were applied for a period of 3 mins, and tissues
were allowed to repolarize fully between applications.
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Figure 8.6 Rabbit isolated vagus nerve. Log concentration-effect curve
for cicaprost-evoked depolarization. Each point represents the mean ±
s.e.m. depolarization evoked by a given concentration of cicaprost for 9
determinations. Drugs were applied for a period of 3 mins, and tissues
were allowed to repolarize fully between applications.
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Figure 8.7 Rabbit isolated vagus nerve. Comparison of the effects of a
range of prostanoids. Each point represents the mean
depolarization evoked by a given concentration of PGE2 (•, n-10), PGI2
(■, n-10), PGEi (O, n-6), iloprost (a, n-3) and cicaprost (□, n-9).
Drugs were applied for a period of 3 mins, and tissues were allowed to
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Figure 8.8 Rabbit isolated vagus nerve. Scatter plots illustrating the
individual (•) and mean (horizantal bars) EC50 values for a range of
prostanoid agonists. (A) Comparison between PGE2, PGE^ and PGI2.
(B) Comparison between PGI2, cicaprost and iloprost. Values are given in
/iM. Mean values which are significantly different to that for PGI2 are
shown as *, when p < 0.05 (Wilcoxon).
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Table 8.1 Rabbit isolated vagus nerve. Summary of the EC50 and Emax
values for prostanoid-induced depolarization of the rabbit vagus.
prostanoid ec50 Emax n
agonist (nM) </*V)
pge2 79 496 ± 100 10
pgei 16 * 524 ± 90 6
pgi2 49 632 ± 89 10
PGF2o > 10 000 98 ± 16 3
pgd2 > 10 000 55 ± 16 5
cicaprost 15 * 357 ± 55 9
iloprost 127 609 ± 123 3
u46619 > 10 000 63 ± 30 3
ici81008 > 10 000 140 ± 29 3
sulprostone - 0 2
rioprostil - 0 3
ah13205 _ 0 3
EC50 values expressed as the geometric mean
Emax values expressed as the arthmetic mean ± s.e.m.




The selective IP-receptor agonists, cicaprost (n-9) and iloprost (n-3)
at concentrations from 1 x 10'^ - 3 x 10"' " evoked concentration-
dependent depolarization of the rabbit isolated vagus nerve (figs. 8.5 -
8.6). The synthetic PGF2<* mimetic, ICI81008 (n-3), the stable TXA2
mimetic, U46619 (n-3), the selective EP2-receptor agonist AH13205 (n-3),
the EP2* and EP3*receptor agonist rioprostil (n-3), and the EP^- and
EP3-receptor agonist sulprostone (n-2) at concentrations up to 1 x 10""*
M did not produce significant effects on the rabbit isolated vagus (see
table 8.1). Thus, the following rank order of potency was obtained
cicaprost > iloprost » ICI81008 - U46619
- sulprostone - rioprostil — AH13205 — 0
A summary of the concentration effect curves obtained for
naturally occurring prostanoids and synthetic agonists is
figure 8.7.
8.2.1.3 Desensitization experiments
To examine the possibility that desensitization of responses to the
prostanoids developed, sequential log concentration-effect curves were
constructed using graded low to high concentrations or high to low
concentrations of drug (see Section II). Log concentration-effect curves
were constructed for PGE2 (n-3), PGE^ (n-3), PGI2 (n-3) and cicaprost




PGEi, PGI2 and Iloprost, calculated using values from individual
experiments, are shown in table 8.2. EC50 values obtained for PGE]^
PGI2, and cicaprost were not significantly different (Students T-Test)
when high to low concentration protocols were used rather than the
standard low to high concentration protocols. Analysis of EC50 values
for PGE2 showed a significant (Students t-test, p < 0.05) shift of the
curve to the right when the high to low concentration protocol was
adopted. As can be seen from figure 8.8, although not significantly
different, maximal responses for PGI2 and PGE^ for experiments using
high to low protocol are noticably greater than those obtained for the
low to high protocol.
8.2.1.4 Effects of drugs influencing neuronal cAMP
Superfusion with forskolin (1 x 10"? • 3 x 10"^ M, n-4) or 8-Bromo cAMP
(1 x 10"^ - 1 x lO"^ M, n-5) evoked concentration-dependent
depolarization of the rabbit isolated vagus nerve that mimicked that
produced by the active prostanoid agonists. Depolarization evoked by
other compounds such as carbachol are of a much shorter duration than
those produced by prostaglandins (see fig.8.9). Examples of the
responses evoked by forskolin and cAMP are shown in figure 8.10.
Application of the phosphodiesterase inhibitor, IBMX (1 x 10'^ - 1 x
10"\ n-3), also caused concentration-dependent depolarization as shown
in figure 8.11.
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Table 8.2 Rabbit isolated vagus nerve. Summary of EC50 and Emax values
for low to high (L-H) and high to low (H-L) concentration protocols.
L-H H-L
prostanoid EC50 Emax n EC50 Emax n
agonist (nM) (A'V) (nM) (pV)
pge2 79 * 489 ± 211 3 317 282 ± 41 4
pgex 19 513 ± 266 3 129 578 ± 230 4
pgi2 83 600 ± 60 3 84 607 ± 205 3
cicaprost 16 413 ± 124 4 27 840 ± 219 4
EC50 values are expressed as the geometric mean
Emax values are expressed as the arithmetic mean ± s.e.m.
* EC50 value for L-H protocol significantly different to that for H-L
protocol (p <,0.05, Students T-test).
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Figure 8.9 Rabbit isolalated vagus nerve. Mean log concentration-
effect curves using low to high (•) or high to low (o) concentration
protocols for (A) PGE2, (B) PGI2, (C) PGE^ and (D) cicaprost. Mean
values from n (see table 8.2) determinations are expressed as a
percentage of the response evoked by a supramaximal concentration of
PGI2. Also shown in the lower panel is a discontinuous record of the
effects of PGE2 on two individual vagus nerve preparations. Both low to
high and high to low protocols are shown. Standard concentrations of 0.1




Figure 8.10 Rabbit isolated vagus nerve. Discontinuous records showing
the effects of (A) forskolin and (B) cAMP on individual vagus verve
preparations. Upwards deflection indicates depolarization; the solid bar
under each response shows the duration of the drug application
(forskolin - 3 mins, cAMP - 15 mins). Concentrations of drug applied are
given in /xM below each bar.
307
Figure 8.11 Rabbit isolated vagus nerve. Discontinuous record showing
the effects of IBMX on am individual vagus nerve preparation. Upward
deflection indicates depolarization; the solid bar under each response
shows the duration (15 mins) of application. Concentrations of drug
applied are given in pM below each bar.
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8.2.2 Rat peripheral nerves
8.2.2.1 Tibial nerve
Results obtained using the tibial nerve were the most consistent of
those experiments using the various peripheral nerves of the rat. PGE2,
PGEi, PGI2, cicaprost and iloprost evoked small, concentration-dependent
depolarizations as shown in figure 8.12. At concentrations up to 10
PGF2C*, PGD2 and the TXA2 mimetic, U46619, had no effect. Results are
summarized in table 8.3.
8.2.2.2 Saphenous nerve
Once desheathed the saphenous nerve was finer in appearance than the
deep tissue nerves such as the vagus, and was depolarized only weakly by
PGE2, PGI2 and cicaprost (fig. 8.13). PGF2a, ICI81008, PGD2 or U46619
had no effect at concentrations of up to 10 /iM. Results are summarized
in table 8.4.
8.2.2.3 Sciatic nerve
A motor branch of the sciatic nerve innervating the gastrocnemius muscle
was used in these experiments. The nerve was depolarized weakly by the
natural prostanoids PGE2, PGI2 and PGF2<* (fig. 8.14). One preparation
responded to PGD2. The synthetic prostanoid mimetic compounds ICI81008
and U46619 also evoked depolarization of this preparation (fig. 8.14).
Results are summarized in table 8.5.
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Figure 8.12 Rat isolated tibial nerve. Records illustrating the effects
of (A) 0.3 - 10 uM PGI^, (B) two applications of 10 pM PGE^ followed by
10 pM PGI^* On a separate tibial nerve preparation (C) shows the effect of
0.1 - 10 pM PGE^ followed by 10 pM PGE^, and (D) the effect of 10 pM
cicaprost. Upwards deflection indicates depolarization; the solid bar under
each response shows the duration of application (3 mins). Concentrations
of drug applied are given in pM below each bar.
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Table 8.3 Rat tibial nerve. Summary of prostanoid-induced
depolarization. PGE2, PGE^, cicaprost and iloprost gave he most
consistent responses following application at concentrations of up to
10/xM.


















Figure 8.13 Rat isolated saphenous nerve. Records illustrating the
effects of 10 /xM (A) cicaprost and (B) PGE2 on an idividual saphenous
nerve preparation. Upward deflections indicate depolarization; the solid
bar under each response indicates the duration of application (3 mins).
Concentrations of drug applied are given in /xM below each bar.
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Table 8.4 Rat isolated saphenous nerve. Summary of prostanoid-induced
depolarizations. PGE2, PGE^ and PGI2 gave the most consistent responses
following application at concentrations of 10/iM.








The figures given were taken from experiments on a total of four
preparations.
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Figure 8.14 Rat isolated sciatic nerve. Record illustrating the effect
of (A) 10 /xM PGF2<* follwed by (B) IOjxM U46619 on an individual sciatic
nerve. On a separate preparation (C) shows the effect of IOjxM PGF2a
followed by (D) 10/xM PGI2. (E) Illustrates the effect of 10 /xM PGI2 on
an individual preparation. Upwards deflections indicate depolarization;
the solid bar under each response shows the duration of application (3
mins). Concentrations of drug applied are given in /xM below each bar.
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Table 8.5 Rat isolated sciatic nerve. Summary of prostanoid-induced
depolarizations. PGF2a and ICI81008 gave the most consistent responses,
with PGE2, PGEi, PGI2 and U46619 producing relatively consistent
depolarizations following application of concentrations up to 10/jM.












8.3.1 Rabbit vagus nerve
The potent depolarizing effects of PGE2, PGE^, PGI2 and the selective
IP-receptor agonists, cicaprost and iloprost, suggest that populations
of both EP- and IP-receptors may be present on axons of the rabbit vagus
nerve. The relatively high potency of PGE2 on the rabbit vagus compared
with that of PGE^ and PGI2 is in contrast to that seen for the rat vagus
where PGE^ and PGI2 are approximately 100 fold more potent than PGE2
(Poll et al., personal communication). Species differences in EP-
receptor populations between the rat and the rabbit may explain this
differential relative potency on the two preparations.
Results from experiments on rabbit isolated vagus using selective
agonists for EP^-, EP2- and EP3-receptors suggest that the receptor
mediating the depolarizing effect of PGE2 does not belong to any of the
recognised receptor subtypes. The relatively shallow slope of the PGE2
log concentration-effect curve suggests that a selective desensitization
of the preparation to the action of PGE2 may occur. Desensitization to
the depolarizing effects of PGE2 is supported by the finding that using
a high to low concentration protocol caused a significant shift of the
log concentration-effect curve to the right. Other than desensitization,
these effects may have been produced as a result of an action of higher
concentrations of PGE2 at a receptor subtype mediating inhibitory
effects. Inhibitory effects of high doses of PGE2 on nociceptive sensory
receptors has also been described in the present series of
investigations (see Section VII).
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The relatively high potency of PGE^, compared to that of PGE2, on
vagal preparations of both the rabbit and rat suggests that PGE^ is
acting at IP-receptors as well as EP-receptors. Desensitization to PGE^
was not significant in the rabbit vagus, providing evidence of an action
predominantly at IP-receptors. This is particularly clear in the rat
vagus where PGE^ and PGI2 are equipotent, while PGE2 is a 100 fold
weaker (Poll et al., personal communication). It should also be noted
that in the desensitization experiments using high to low concentration
protocols the mean maximal response for PGI2 and PGE^ were noticeably
greater than those for low to high protocols. This may be explained in
terms of a desensitization of responses to PGI2 and PGE^ . Thus, when
low to high concentration protocols are adopted with PGI2 or PGE^ as the
agonist, a slow desensitization of either an IP- or EP-receptor will
occur, resulting in a smaller maximum response and a shallower slope of
the log concentration-effect curve. Further studies using selective
desensitization or selective antagonists may help to clarify whether EP-
, IP- or both receptor types are involved.
The vagus nerve of the rabbit has been shown to be largely composed of
C fibres (Evans & Murray, 1954), a fibre type that is considered to be
involved in afferent transmission of nociceptive stimuli (see Besson &
Chaouch, 1987). It has recently been demonstrated that transport of
receptors for various endogenous substances from cell bodies to
peripheral nerve terminals occurs in the vagus nerve (Young et al.,
1980). Assuming that the prostanoid receptors expressed on axons of the
vagus nerve are the same as those present at sensory terminals, the
present results are in agreement with the existing literature describing
PGEi or PGI2 as the most potent naturally occurring prostanoids acting
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to increase the excitability of nociceptive sensory receptors (Bergstrom
et al., 1959; Gillespie, 1972; Collier & Schneider, 1972; Willis &
Cornelson, 1973; Ferreira et al., 1973; James & Church, 1978; Ferreira
et al., 1978; Tyers & Haywood, 1979; Juan, 1979). Of particular interest
is the finding that prostanoids of the E-series increase the spontaneous
firing rate of single vagal pulmonary and bronchial afferent C fibres
when injected into the right atrium or nebulized into the lungs of
anaesthetized dogs (Coleridge et al., 1976). Since in the present study,
PGEi and PGI2 were more potent than PGE2, and as arachadonic acid is the
major mammalian precursor to prostanoid synthesis, PGI2 and not PGE^ is
the more likely candidate for the role of endogenous mediator. However,
it has been demonstrated indirectly that PGI2 is converted to 6-keto-
PGEi in the platelet (Wong et al., 1980; Griffiths and Moore, 1983), in
the lung (Berry et al., 1986), and the kidney (Griffiths and Moore,
1983). Conversion to 6-keto-PGEi has now also been measured directly for
the kidney (Pieroni et al., 1988). 6-keto-PGE^ shares many actions with
PGI2, including vasodilatation (Quilley et al., 1979), inhibition of
platelet aggregation (Wong et al., 1979; Quilley et al., 1980), and
promotion of renin secretion (Jackson et al., 1981). It is possible that
conversion of PGI2 to 6-keto-PGE^ may provide a mechanism for extending
the actions of PGI2, where the conversion product is a highly potent IP-
receptor agonist. There are obvious implications concerning prostanoid-
induced hyperalgesia, and as such it would be of great interest to
examine the effects of 6-keto-PGE^ on sensory nerves.
In contrast to the depolarizing effect of PGD2 on the rabbit nodose
ganglion neurones (Fowler et al., 1987), This prostanoid was innefective
on the vagus nerves of the rabbit or the rat (Poll et al., personal
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communication). Differential expression and/or transport of receptors
between the cell bodies and peripheral or central axon terminals of
sensory neurones may explain these findings.
The ability of forskolin and 8-bromo cAMP to mimic the depolarizing
effects of the natural prostanoid agonists in the rabbit isolated vagus,
raises the possibility that the prostanoids are acting via cAMP in this
preparation. This is supported by the finding that PGE^ causes a marked
accumulation of cAMP when incubated with sections of desheathed rabbit
vagus nerve (Kalix, 1979). In addition, neuroblastoma cells in culture
react to the presence of low concentrations of PGE^ with increases in
their cAMP content (Gilman et al., 1971). In the present study the
depolarizing action of the phosphodiesterase inhibitor IBMX on the
rabbit vagus indicates that there is a basal turnover of cAMP in the
rabbit isolated vagus. Inhibition of the phosphodiesterase enzyme by
IBMX, unmasks this basal production of cAMP resulting in nerve
depolarization.
Prostanoid-induced hyperalgesia has been postulated by Ferreira &
Nakamura (1979) to be mediated via cAMP. They demonstrated that
hyperalgesia developed following subplantar injection of PGE2, PGI2 or
dibuteryl cAMP into rat paws. The sensitizing effects of these agents
were enhanced by the presence of phosphodiesterase inhibitors, which
inhibit the metabolism of cAMP. Clues to the mechanism by which
prostanoids may cause sensitization of sensory receptors via cAMP are
provided by results from studies on rabbit C-type nodose ganglion
neurones in vitro, where PGE2, PGE^ and PGD2 cause the inhibition of a
slow after-hyperpolarization via the blockade of a Ca^"4"-dependent K"*"
channel (Fowler et al., 1985a; 1985b; Weinreich & Wonderlin, 1987). This
319
effect is mimicked by forskolin, suggesting that inhibition *-s mediated
via cAMP (Weinreich & Wonderlin, 1987). Prostaglandins also increase the
excitability of dorsal root ganglion neurones in culture (Baccaglini &
Hogan, 1983), although the mechanism involved has not yet been
identified.
8.3.2 Rat peripheral nerves
Isolated sensory nerve and mixed nerve preparations used in this study
were weakly depolarized by PGE2, PGE^, PGI2 and its stable analogues
iloprost and cicaprost. PGF2ct, PGD2 or U46619 had no effect on the
resting potential of these nerves. In the isolated motor nerve, all of
these prostanoids and their stable analogues evoked weak
depolarizations, with PGF2a producing the most consistent response.
The small size and inconsistent nature of the responses obtained in
these experiments may be a result of the small number of fibres
responding to applied drugs, and the inability of the recording
equipment used to pick up the resulting depolarizations. Although the
construction of concentration effect curves was not possible, a rough
guide as to which prostanoids may effect the nerves under study has been
produced. Results obtained with the saphenous and tibial nerves are in
agreement with those from the rat isolated vagus (Poll et al., personal
communication), lending further support to the suggestion that IP- and
perhaps EP-receptor populations are present on peripheral sensory nerves
of the rat. The additional presence of FP- and perhaps TP-receptors on
motor nerves is indicated by the depolarizing actions of PGF2C*, the
selective FP-receptor agonist ICI81008, and the stable TXA2 mimetic
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U46619 on the motor branch of the sciatic nerve. Evidence exists that
prostanoids can affect the functions of motor nerves in other systems.
There are reports suggesting that prostaglandin-like substances increase
the release of acetylcholine from guinea pig ileum (Bergami et al.,
1978). Prostanoids of the E-series, PGI2 and to a lesser extent PGF2a,
augment the cholinergically-mediated contractions obtained in response
to electrical field stimulation of the guinea pig ileum longitudinal
muscle-myenteric plexus preparation (Poll et al., 1988). Indomethacin
and phenylbutazone have been reported to increase the frequency of
miniature endplate potentials in frog sartorius muscle (Madden and
Kloot, 1980). Finally, a direct effect of PGE^, to alter amplitude and
conduction velocity of the compound action potential in frog sciatic
nerve has been demonstrated by Horrobin et al. (1977).
8,4 CONCLUSIONS
Both in the rabbit and the rat, prostanoid-induced depolarization of
peripheral sensory nerve axons appear to be mediated by populations of
IP- and perhaps EP-receptors. In addition to these receptor types,
populations of FP and TP-receptors mediating depolarization may also be
associated with motor nerves. The depolarizing actions of the
prostanoids may be mediated via stimulation of intracellular cAMP
production. These findings support those of previous studies showing
that PGI2 and PGE2 as potent hyperalgesic agents, and produce direct
excitation of nociceptive sensory receptors (see Section VII).
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SECTION IX
COMPARISON OF THE EFFECTS OF LYSINE-ACELTYLSALICYLATE.
SODITJM SALICYLATE AND PARACETAMOL ON AFFERENT
DISCHARGE FROM ARTICULAR MECHANONOCICEPTORS
FROM ARTHRITIC ANKLE JOINTS IN THE RAT
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SECTION IX
COMPARISON OF THE EFFECTS OF LYSINE-ACELTYLSALICYIATE,
SODIUM SALICYLATE AND PARACETAMOL ON AFFERENT
DISCHARGE FROM ARTICULAR MECHANONOCICEPTORS
FROM ARTHRITIC ANKLE JOINTS IN THE RAT
9.1 INTRODUCTION
A peripheral site of analgesic action for non-steroidal anti¬
inflammatory drugs (NSAIDS) was originally demonstrated by Lim and
colleagues (Guzman et al., 1964; Lim, 1970) in the dog spleen model of
bradykinin-induced pain. The concept of a peripheral action of analgesic
agents was supported by the observations that certain prostaglandins
potentiate nociceptive responses to mechanical or chemical stimuli
(Ferreira, 1972; Rosenthale et al., 1972; Ferreira et al., 1973; Willis
& Cornelsen, 1973; Lembeck & Juan, 1974; Moncada et al., 1975; Chahl &
Iggo, 1977), and that NSAIDS inhibit the formation of prostanoids in
different tissues (Ferreira et al., 1971; Vane, 1971; Ferreira & Vane,
1974; Moncada et al., 1975; Roth et al., 1975; Ferreira et al, 1978;
Higgs & Salmon, 1979).
More recently it has been shown that aspirin reduces the excitation of
nociceptive sensory afferents evoked by bradykinin in cat muscle (Mense,
1982). Furthermore, the sensitization of articular nociceptive afferents
induced by either chronic arthritis in the rat (Guilbaud & Iggo, 1985)
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or acute joint inflammation in the cat (Heppelmann et al., 1986), has
been demonstrated to be depressed by the administration of aspirin.
These effects on inflamed joints can be at least partially overcome by
the subsequent administration of exogenous prostanoids (Heppelmann et
al. , 1986; see Section VII), suggesting that a reduction in endogenous
prostanoids in the periphery is responsible for the reduction in
nociceptor sensitivity caused by aspirin.
Arguments against a purely peripheral action of NSAIDS have, however,
been made (see Jurna & Brune, 1990), and the actions of agents such as
paracetamol, which display antipyretic and analgesic effects without
significant anti-inflammatory actions, are often considered to have an
exclusively central action (see Goodman & Gilman, 1985; Rang & Dale,
1987). Furthermore, paracetamol only weakly inhibits the formation of
prostaglandins in peripheral tissue (Flower et al., 1972; Brune et al.,
1981), but potently reduces cyclooxygenase activity in brain tissue
(Flower et al., 1972; Flower & Vane, 1972).
In the present series of experiments the effects of paracetamol were
compared with those of lysine acetylsalicylate (1-AS) on the discharge
characteristics of articular mechanonociceptors from arthritic ankle
joints. These experiments were carried out to provide information
regarding whether or not paracetamol has peripheral actions comparable
with those of aspirin. In addition, sodium salicylate was used in order
to determine whether the acetyl group of 1-AS is required for activity.
In a separate study the effects of 1-AS, sodium salicylate or
paracetamol were examined on tissue levels of PGE2 and 6-keto PGFjct, the
stable metabolite of PGI2, in chronically inflamed capsular tissue from
the rat ankle joint.
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9.2 RESULTS
The effects of 1-AS, sodium salicylate and paracetamol were examined in
nineteen experiments, from which twenty three high-threshold slowly
adapting mechanoreceptors were identified and studied.
Mechanonociceptors from arthritic ankle joints had afferent fibre
conduction velocities in the range 0.25 - 2 ms"-'- (mean: 0.8 ± 0.1
ms'l), indicating that these were C fibres. All of the twenty three
units studied had an irregular resting discharge (mean: 1.4 ± 0.4
i.p.s), before the injection of any drugs.
9.2.1 Mechanonociceptor responsiveness
Administration of 1-AS (100 mgkg'l, equivalent to 50 mgkg"! ASA, i.v.),
caused a significant reduction in the discharge evoked by the standard
mechanical stimulus in all eleven units examined (fig. 9.1). The mean
latency to the onset of the effect was 9.8 ± 2.4 minutes (range: 2-28
mins). Mechanoreceptor responsiveness reached a mean minimal value of
51% (range: 0 - 73%) of the pre-injection control following periods
ranging from 8-32 minutes for individual units (mean: 20 ± 2.7 mins).
Sodium salicylate (50 mgkg'l, i.v.) caused a reduction in the response
to mechanical stimuli in two of three units (fig. 9.2). In these two
units the effect had latencies to onset of 4 and 16 minutes. Minimum
mechanonociceptor responsiveness was reached after 34 and 32 minutes,
and had values of 6 and 50% of pre-injection control respectively.
Injection of paracetamol (50 mgkg'l, i.v.), significantly reduced
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Figure 9.1 Summary of the effects of l-AS on mechanonociceptor
responsiveness to mechanical stimuli. Each bar represents the mean
response of n units to a standard mechanical stimulus, applied once
every two minutes, both before and after the i.v. injection of l-AS (50
mgkg-1-, ASA equivalent) or saline vehicle. Values are expressed as a
percentage of the pre-injection control reponse to the mechanical
stimulus. The arrow and vertical dashed line indicate the time of
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Figure 9.2 Summary of the effects of sodium salicylate on
mechanonociceptor responsiveness to mechanical stimuli. Each bar
represents the mean response of n units to a standard mechanical
stimulus, applied once every two minutes, both before and after the i.v.
injection of sodium salicylate (50 mgkg"^-) or saline vehicle. Values are
expressed as a percentage of the pre-injection control reponse to the
mechanical stimulus. The vertical dashed line indicates the point of
injection, the first mechanical stimulus being delivered 15s after this
time.
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seven units examined (fig. 9.3). The mean latency to the onset of the
effect was 6.6 ± 1.9 minutes (range: 4-18 minutes). Mechanonociceptor
responsiveness reached a mean minimal value of 51% (range: 0 - 70%) of
the pre-injection control, following a delay ranging from 4-20 minutes
(mean: 15 ± 2 mins).
A summary of the effects of 1-AS, sodium salicylate and paracetamol is
shown in figure 9.4, and illustrates that the three drugs cause
reductions in mechanoreceptor responsiveness of similar time course and
amplitude. All caused statistically significant reductions when compared
with changes in mechanoreceptor responsiveness following saline
injection. Although in the majority of experiments prostanoids were
injected 30 - 60 minutes after the administration of 1-AS, sodium
salicylate or paracetamol, following depression of mechanoreceptor
responsiveness, recovery to pre-injection levels of responsiveness was
not seen for recording periods of up to 70 minutes.
*
9.2.2 Spontaneous mechanonociceptor discharge
Injection of 1-AS (50 mgkg'l, ASA equivalent, i.v.), caused a
significant reduction in ongoing discharge in all eleven units (100%)
examined (fig. 9.5). The reduction in discharge had a mean latency to
onset of 4.6 ± 1.3 minutes (range: 2-15 mins). Ongoing discharge
reached a mean minimum value of 39% of pre-injection control (range: 0 -
73%), after a delay in the range 3-25 minutes (mean: 10 ± 1*8 mins).
Sodium salicylate (50 mgkg"^-, i.v.), reduced ongoing discharge in
three of three units examined (fig. 9.6). This reduction had a mean
latency to onset of 5.3 ± 2 minutes (range: 2-9 mins), and the minimum
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Figure 9.3 Summary of the effects of paracetamol on mechanonociceptor
responsiveness to mechanical stimuli. Each bar represents the mean
response of n units to a standard mechanical stimulus, applied once
every two minutes, both before and after the i.v. injection of
paracetamol (50 mgkg'1-) or saline vehicle. Values are expressed as a
percentage of the pre-injection control reponse to the mechanical
stimulus. The vertical dashed line indicates the point of injection, the
first mechanical stimulus being delivered 15s after this time.
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Figure 9.4 Comparison of the effects of l-AS, sodium salicylate and
paracetamol on mechanonociceptor responsiveness to mechanical stimuli.
Each bar represents the mean response of n units to mechanical stimuli
both before and after the i.v. injection of l-AS (50mgkg"l, ASA
equivalent), sodium salicylate (50mgkg"^) or paracetamol (50 mgkg"^).
The arrow and vertical dashed line indicate the time point of injection.
Values are expressed as a percentage of the pre-injection control
response, and the vertical lines above each bar represent the s.e.m.
These mean values illustrate that the depressant effects of all three
drugs follow a similar time course. The rate of decline in
mechanoreceptor responsiveness varied between units, this being
reflected in the size of the error bars. Values significantly (p < 0.05)
different from those obtained following injection of saline (shown in
figures 10.1 - 10.3) are indicated as * (Wilcoxon).
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saline n=9 l-AS n=11
Figure 9.5 Summary of the effects of l-AS on spontaneous
mechanonociceptor discharge. Each point represents the mean discharge of
n units, measured over a 1 min period, both before and after the i.v.
injection of l-AS (50 mgkg'l, ASA equivalent) or saline vehicle. Values
are expressed as a percentage of the pre-injection control discharge
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Figure 9.6 Summary of the effects of sodium salicylate on spontaneous
mechanonociceptor discharge. Each point represents the mean discharge of
n units, measured over a 1 min period, both before and after the i.v.
injection of sodium salicylate (50 mgkg"^-, ASA equivalent) or saline
vehicle. Values are expressed as a percentage of the pre-injection
control discharge (0.4 ± 0.1). The arrow and vertical dashed line
indicate the time point of injection. A large variation in levels of
discharge following sodium salicylate injection was seen.
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discharge averaged 29% of the pre-injection control after periods
ranging from 9-23 minutes (mean: 14 ± 4.4 mins).
Injection of paracetamol (50 mgkg'l, i.v.) caused a significant
reduction in ongoing discharge in nine (100%) of nine units examined
(fig. 9.7). A mean delay of 5 ± 0.8 minutes (range 2-10 minutes) was
seen before the onset of the reduction in ongoing discharge. A mean
minimum level of discharge equal to 50% of pre-injection control ( range
0 - 78%) was reached following periods ranging from 8-20 minutes
(mean: 12.6 ± 1.7 mins).
Figure 9.8 summarizes the effects of 1-AS, sodium salicylate and
paracetamol on the ongoing discharge. All drugs had a similar time
course and amplitude of effect, producing statistically significant
reductions in afferent discharge when compared with the effect of saline
injection. Although in the majority of experiments prostanoids were
injected 30 - 60 minutes after the administration of 1-AS, sodium
salicylate or paracetamol recovery to pre-injection levels of discharge
was not seen for observation periods of up to 70 minutes.
9.2.3 Additive effects of paracetamol and 1-AS
Injection of a second dose of 1-AS (50 mgkg"^-, ASA equivalent, i.v.) in
three experiments, or paracetamol (50 mgkg'l, i.v.) in another three
experiments, did not cause any further reduction in either ongoing
activity or mechanonociceptor responsiveness when administered 40 - 60
minutes after the initial dose. In three experiments administration of
1-AS (50 mgkg"^-, ASA equivalent, i.v.) 30 - 50 minutes after an initial
injection of paracetamol (50 mgkg'l, i.v.), caused a further, although
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saline n=9 paracetamol n=9
Figure 9.7 Summary of the effects of paracetamol on spontaneous
mechanonociceptor discharge. Each point represents the mean discharge of
n units, measured over a 1 min period, both before and after the i.v.
injection of paracetamol (50 mgkg"-'-) or saline vehicle. Values are
expressed as a percentage of the pre-injection control discharge (1.2 ±
0.4 i.p.s.). The arrow and vertical dashed line indicate the time point
of injection.
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Figure 9.8 Comparison of the effects of l-AS, sodium salicylate and
paracetamol on spontaneous mechanonociceptor discharge. Each bar
represents the mean discharge of n units before and after the i.v.
injection of l-AS (50mgkg'l (50 mgkg'^-). The arrow and vertical dashed
line indicate the time point of injection. Values are expressed as a
percentage of the pre-injection control discharge, and the vertical
lines above each bar represent the s.e.m. These mean values illustrate
that the depressant effects of all three drugs follow a similar time
course. The depressant effect of sodium salicylate was less consistent
and more variable, this being reflected in the size of the error bars.
Values significantly (p < 0.05) different those obtained following
injection of saline are shown as * (Wilcoxon).
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Figure 9.9 Effect of 1-AS after paracetamol on mechanonociceptor
responsiveness to mechanical stimuli. Each bar represents the response
of a single unit to a standard mechanical stimulus applied once every
two minutes, both before and after the injection of 1-AS (50 mgkg'l, ASA
equivalent, i.v.). The arrow and vertical dashed line indicate the time
point of injection. Values are given as a percentage of the pre-
injection control response.
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Figure 9.10 Effects of 1-AS on spontaneous mechanonociceptor discharge
after paracetamol. Each point represents the mean discharge of 3 units
both before and after the injection of 1-AS (50 mgkg"^ ASA equivalent,
i.v.). Values are given as a percentage of the pre-injection control
discharge, and the vertical bars represent ± s.e.m.. The arrow and
vertical dashed line indicate the time at which 1-AS was injected. A
rapid onset reduction in discharge is clearly evident.
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not statistically significant, reduction both in mechanical
responsiveness and in ongoing discharge (figs. 9.9 - 9.10).
9.2.4 Effects of cicaprost on paracetamol-induced depression of
mechanoreceptor discharge
As described in Section VII of this thesis, following depression by 1-
AS, injection of cicaprost (0.01 - 1 \ig, i.a.), caused an increase both
in mechanonociceptor responsiveness, and in ongoing activity. When
administered 30 - 60 minutes after the injection of paracetamol (50
mgkg'l, i.v.), injection of cicaprost (0.01 - 1 ng, i.a.) caused similar
increases in mechanonociceptor discharge two units. These responses were
dose-dependent, had a short latency to onset of approximately 15
seconds, and had a long duration of over 20 minutes. A summary of the
effects of cicaprost on mechanonociceptor responsiveness is given in
figure 9.11, and an example of its effect on ongoing activity is shown
in figure 9.12. In a separate experiment injection of cicaprost (0.01 -1
Hg, i.a.) also partially reversed the depressant effect of sodium
salicylate (50 mgkg"^-, i.v.) on both mechanical responsiveness and
ongoing discharge (see figs. 9.13 - 9.14).
9.2.5 Plasma concentrations of paracetamol and aspirin
In a further six anaesthetized rats, samples of blood were taken 5, 10,
15, 30 and 45 minutes after a single injection of 1-AS (50 mgkg*^"> A!*A
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Figure 9.11 Effect of cicaprost on mechanonociceptor responsiveness to
mechanical stimuli after paracetamol. Each bar represents the mean
response to a standard mechanical stimulus both before and after
injection of cicaprost (0.1 and 0.5 /ig, i.a. in two separate units).
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Figure 9.12 Effect of cicaprost on spontaneous mechanonociceptor
discharge after reduction by paracetamol. Each point represents the
discharge of a single unit, both before and after injection of cicaprost
(0.5 /xg, i.a.). Values are given as a percentage of the pre-paracetamol
(50 mgkg'l, i.v.) control discharge (0.5 i.p.s).
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Figure 9.13 Effect of cicaprost on mechanonociceptor responsiveness to
mechanical stimuli after sodium salicylate. Each bar represents the
response of a single unit to a standard mechanical stimulus both before
and after injection of cicaprost (1 ng, i.a.). Values are given as a
percentage of the pre-sodium salicylate (50 mgkg'l, i.v.) control
response.
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Figure 9.14 Effect of cicaprost on spontaneous mechanonociceptor
discharge after reduction by sodium salicylate. Each point represents
the discharge of a single unit, both before and after injection of
cicaprost (1 pg, i.a.). Values are given as a percentage of the pre-
sodium salicylate (50 mgkg'l, i.v.) control discharge (0.8 i.p.s.).(50
mgkg'l, i.v.). Levels of total drug found in the plasma of the blood
samples are shown in table 9.1.
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Table 9.1 Plasma salicylate and paracetamol levels following single
i.v. injections of 1-AS (50 mgkg"^-, ASA equvalent) or paracetamol (50
mgkg-1)•
time after plasma salicylate plasama paracetamol
injection (pgml"^) (pgml'l)
(mins) n-3 n-3
5 56.5 ± 11.2 -
10 76 ± 0 -
15 37.2 ± 11.2 -
30 50.1 ± 12.9 -
45 75.9 ± 11.2 16.2 ±
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9.2.6 Effects of 1-AS, sodium salicylate and paracetamol on
prostanoid levels of capsular tissue In arthritic joints
In a separate series of experiments thirty five rats with established
arthritis were randomly distributed into five equal groups. Individual
groups were given twice daily i.p. injections of either 1-AS at 50 or
250 mgkg-lday"! sodium salicylate at 50 or 250 mgkg'^day"^-, paracetamol
at 50 or 250 mgkg'^day"^-, or saline vehicle (control). Drug dosing was
carried out from day 10 post-adjuvant through to day 14. The rats were
sacrificed at the end of day 14 and the chronically inflamed ankle joint
capsular tissues removed for the subsequent extraction and assessment of
tissue prostanoids (see Methods, Section II). Before dosing the
solutions were coded and their identities not revealed until the study
was concluded.
Results from the analysis of tissue prostanoid content are summarized
in figure 9.15. Values from saline control group show that tissue levels
of PGE2 are significantly higher (p < 0.05) than those of the PGI2
measured as its stable hydrolysis product 6-keto PGF^a" an<*
low dosage schedules of 1-AS or paracetamol significantly (p < 0.05)
reduced tissue levels of PGE2, while only the high dosage of sodium
salicylate caused a significant reduction in the levels of this
prostanoid. In the case of 6-keto PGF^a, tissue levels were
significantly reduced by both the low and high doses of 1-AS, but only
by the high doses of sodium salicylate or paracetamol.
Blood samples were taken at the end of day 14 from one rat in each
group, and the plasma salicylate levels were determined. Results are
summarized in table 9.2.
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Figure 9.15 Summary of the effects of l-AS, sodium salicylate or
paracetamol on the prostanoid content of chronically inflamed joint
capsular tissue. Each bar represents the mean PGE2 or 6-keto PGFja
content of ankle joint capsular tissue from arthritic rats given daily
doses of l-AS (50 or 250 mgkg'^day"^-, i.p.), sodium salicylate (50 or
250 mgkg'lday'l, i.p.) or paracetamol (50 or 250 mgkg'^day"^-, i.p.). The
letters L and H denote the low and high doses respectively. The vertical
bars represent the s.e.m.. For each group,'including, the saline control
n-5. Values which are significantly different from those in saline
(control) treated rats are shown as *, when p < 0.05 (Students T-Test).
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Table 9.2 Plasma salicylate levels measured after five days of daily
dosing with 1-AS (50 or 250 mgkg"*- day""! ASA equivalent, i.p.) or
sodium salicylate (50 or 250 mgkg"^ day'l, i.p.).












Results from electrophysiological experiments using 1-AS confirm reports
showing that aspirin reduces both the mechanical sensitivity and the
ongoing discharge of articular mechanonociceptors from chronically
inflamed rat ankle joints (Guilbaud 6c Iggo, 1985). These findings
support the idea, first proposed by Lim et al. (1964), that the
analgesic action of ASA is mediated via a peripheral site. Furthermore,
in the present study, the depressant action of 1-AS was shared by sodium
salicylate and paracetamol, suggesting that these drugs also have an
analgesic action mediated via a peripheral site associated with
nociceptive sensory receptors in the joint tissues.
ASA has been shown to inhibit prostanoid synthesis both in vitro
(Vane, 1971; Ferreira 6c Vane, 1974; Roth et al., 1975; Sturge et al.
1978; Van der Ouderas et al., 1980; Salmon et al., 1983), and in vivo
(Ferreira 6c Vane, 1974; Moncada et al., 1975; Fitzpatrick 6c Wynalda,
1976), and is considered to exert its analgesic effects via the
resulting reduction in tissue prostanoid content (Collier et al., 1972;
Ferreira 6e Vane, 1974; Moncada et al., 1975). Results detailed in
Section VII of this thesis, showing that the depressant effects of 1-AS
in arthritic joints can be overcome by the administration of exogenous
prostanoids, suggest that these effects are mediated via the inhibition
of endogenous prostanoid production. This effect of exogenous
prostanoids was also seen in the present study following sodium
salicylate-induced depression of mechanonociceptor discharge. Although
sodium salicylate is a poor inhibitor of cyclooxygenase in vitro (Flower
6c Vane, 1972), when administered in vivo salicylates effectively
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decrease the content of prostaglandins in inflammatory exudates (Willis
et al., 1972; Higgs et al., 1976). Because 1-AS or sodium salicylate
reduced the PGE^ an<* 6-keto content of chronically inflamed joint
capsular tissue it is likely that both 1-AS and sodium salicylate are
acting to depress mechanonociceptor discharge via a reduction in
endogenous prostanoids. Furthermore, this reduction in tissue prostanoid
levels was achieved with similar blood plasma concentrations to that
affecting mechanonociceptor discharge.
ASA is known to irreversibly acetylate the active site of
cyclooxygenase (Roth et.al., 1975). However, in vivo acetylsalicylate is
subject to conversion by the liver to salicylate (Cerletti et al.,
1985), and inhibition of cyclooxygenase activity may be explained by the
combination of salicylate with cyclooxygenase. It has been suggested
that NSAID drugs interact with an enzymic receptor (Scherrer, 1974; Gund
& Shen, 1977), and more recently that NSAIDS may interact at two
different sites on the cyclooxygenase enzyme - the catalytic site and
the so called 'supplementary' site (Humes et al, 1981). Thus, it has
been claimed that potent inhibitors interact with both sites, while weak
inhibitors, such as salicylate, act more at the supplementary site.
Sodium salicylate has about the same potency as ASA in anti-pyretic and
anti-inflammatory tests (Collier, 1969), suggesting that at least some
of the actions of ASA are shared by salicylate. Although the evidence
for a mechanism of action of NSAIDS through inhibition of cyclooxygenase
is very strong, it should also be noted that several other enzymes are
affected by these drugs (Lembeck 6c Juan, 1974; Tolman and Partidge,
1975; Kuehl 6c Egan, 1980; Brune, 1982; 1983), and that anti-inflammatory
doses of NSAIDS are known to inhibit neutrophil activation (Abramson,
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1985), providing a possible explanation for their anti-inflammatory
activity.
In the present study the demonstration that paracetamol reduces
mechanonociceptor discharge and mechanical sensitivity in arthritic
joints, together with the finding that this effect can be reversed by
the administration the PGI2 analogue, cicaprost, suggests that this
action is mediated via a reduction in exogenous prostanoids in the
periphery. Further support for this suggestion is provided by results
showing that paracetamol causes a reduction in levels of PGE2 and 6-keto
PGFja in chronically inflamed joint capsular tissue. Paracetamol is also
known to reduce prostanoid levels in inflammatory exudates (Higgs
et.al., 1976), and, furthermore, has been shown to possess anti¬
inflammatory activity in man (McQueen, 1973; Skjelbred et.al., 1977),
and in rats (Vinegar et.al., 1976; Wong & Gardocki, 1983). It has been
shown that paracetamol selectively inhibits nervous tissue
cyclooxygenase with little effect on enzymic preparations from other
tissues (Flower & Vane, 1972; Dembinska-Kiec et.al., 1976). Flower &
Vane (1972) proposed that the analgesic effect of paracetamol was due to
its selective action on nervous tissue prostaglandin synthetase enzymes,
thus indicating a predominantly central site of action. However, studies
by Ferreira et. al. (1978), suggested that paracetamol had both
centrally and peripherally mediated analgesic effects. Based on their
knowledge of its selective action on nervous tissue cyclooxygenase,
Ferreira and colleagues (1978) proposed that this peripheral effect
could be at the nociceptive sensory ending. Recent evidence suggets that
a further peripheral target for a nervous tissue specific cyclooxygenase
inhibitor may be sympathetic postganglionic nerve terminals associated
349
with nociceptive sensory endings (Levine et.al., 1986). However, studies
refuting evidence for heterogeneity, and differential sensitivity of
cyclooxygenase enzymes in the same species have also been reported (Pong
& Levine, 1976). In the present study the additional depressant effects
of 1-AS seen following paracetamol indicate that the two drugs may be
acting by some differing mechanism. This may be explained in terms of an
additional action of 1-AS via the irreversible acetylation of
cyclooxygenase. An additional complication is provided by the finding
that paracetamol only weakly inhibits purified cyclooxygenase when
tested under standard assay conditions, in which the peroxide
concentration may rise to a high level, and paracetamols potency as a
cyclooxygenase inhibitor is increased if the peroxide concentration is
reduced to levels found intracellularly in vivo (see Lands, 1981). High
levels of peroxide seen during inflammation (see Blake et al., 1987) may
explain the generally reported weak anti-inflammatory effect of
paracetamol.
In contrast to the side-effects associated with NSAID drugs
(Lifschitz, 1983; O'Brien 6t Bugby, 1985; Adams et. al.,1986; Goodwin,
1987), paracetamol has few side effects, apart from hepatic cellular
necrosis which mainly occurs during overdosage (Prescott, 1983). A large
number the side effects of NSAIDS have been attributed to inhibition of
prostanoid production in peripheral tissue (Vane, 1971), supporting the
proposal of a selective action of paracetamol on nervous tissue
cyclooxygenase. If this were the case then the reduction in the
prostanoid content of inflammatory exudates (Higgs et.al.1976), and
chronically inflamed tissues caused by paracetamol, would have to be a
result of actions on peripheral nervous tissue. Depression of
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excitability in C fibre afferents may be expected to reduce neurogenic
components of inflammation (see Holzer, 1988) through a reduction in the
peripheral release of neuropeptides such as substance P and CGRP, and as
a consequence of this would cause a reduction in the production of
inflammatory prostanoids. In this way reductions in tissue prostanoid
content seen in the present study could be explained.
9.3 CONCLUSIONS
It has been demonstrated that 1-AS, sodium salicylate and paracetamol
depress the activity of sensitized articular mechanonociceptors from
chronically inflamed ankle joint tissues. These findings support the
idea that these drugs exert their analgesic effects at least partly
through a peripheral site of action. This peripheral analgesic effect
may be mediated via a reduction in endogenous prostanoids as it has also
been shown that (a) these depressant effects can be at least partially
reversed by the administration of exogenous prostanoids, and (b) that
these drugs are capable of reducing tissue prostanoid content in
arthritic joints. Although the particular mechanism of action needs to
be elucidated, the results presented, together with evidence that
paracetamol has anti-inflammatory properties (McQueen, 1973; Vinegar
et.al., 1976; Skjelbred et.al.,1977; Wong & Gardocki, 1983), suggest
that paracetamol may be of use as an adjunct to conventional NSAID
therapy in the treatment of arthritis in man. In addition high doses of
NSAIDS used to increase the level of pain relief have not been found to
show any greater anti-inflammatory effect in rheumatoid arthritis (Orme
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et.al., 1976; Grennan et.al., 1973; Dunagan et.al., 1988; Seideman &
Melander, 1988). The large number of side effects associated with
NSAIDS, and the concept that total blockade of prostanoid production may
in fact increase joint pathology, either by increasing production of
lypoxygenase products of arachidonic acid (Walker & Harvey, 1984) or
reducting in anti-inflammatory prostanoids (Cammarata & Aspinall, 1969;
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SECTION X
GENERAL DISCUSSION AND CONCLUSIONS
The involvement of various endogenous chemical mediators in the
increased nociceptive activity seen in chronically inflamed joints was
investigated using a novel model of localized adjuvant-induced arthritis
in the rat. Results from these studies can be used to define the
relative importance of these mediators in causing the joint pain
associated with arthritis.
Localized adjuvant-induced monoarthritis as a model for the
neuropharmacological study of chronic inflammation in rats
Relatively low doses of F.C.A., injected subdermally around the tibio
tarsal joint, induced an arthritis which was localized to the ankle
region of one hindlimb. The time course of over which tissue swelling
and hyperalgesia developed followed a similar pattern found by Stein et
al. (1988) using a model of adjuvant-induced inflammation of one
hindpaw. The bilateral nature of adjuvant-induced polyarthritis has been
suggested to result at least partly through a contribution from the
nervous system. Basbaum et al. (1988) concluded that several components
of the nervous system contribute to the inflammatory process producing
joint injury in experimental arthritis. These include the peripheral
terminals of both small-diameter peptide containing primary afferents
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and sympathetic efferents, large diameter primary afferents, and
descending brainstem inhibitory control systems. However, in the present
series of studies no evidence of contralateral inflammation was
obtained. Furthermore, results from other investigations using localized
forms of chronic inflammation in the rat have described only unilateral
increases in opioid peptides in the dorsal horn of the spinal cord
(Stein et al., 1987), and increases in levels of CGRP found in primary
afferents (Nahin et al., 1990) or dorsal root ganglia (Smith et al.,
1990). Although the nervous system probably has role in inflammation,
these findings and those from the present study indicate that the
bilateral nature of adjuvant polyarthritis may be due to factors other
than those associated with the nervous system. Antigenic or humoral
factors released during inflammation may be responsible. The low dose of
adjuvant used in the present study, together with the mild nature of the
inflammation probably results in fewer of these factors being released
to affect contralateral limb. Further investigations using higher doses
of adjuvant to determine a threshold for bilateral effects, together
with studies examining alterations in nociceptive sensory systems will
be required to determine the precise role played by the nervous system
in bilateral chronic inflammatory joint disease. These studies should
include examination of the changes in neuropeptide levels taking place
in primary afferents and spinal dorsal horn neurones, and the mechanisms
by which these changes occur. The behaviour of second order neurones in
the spinal cord and the activation of reflex pathways during chronic
inflammation should also be examined.
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The limited nature of the bone and cartilage destruction described
in the present model differs from the severe erosion seen in adjuvant
polyarthritis, and more closely resembles the rheumatoid disease in
humans (see Rainsford, 1982). Adjuvant-induced arthritis appears to be a
particularly useful model, and is considered to be the most appropriate
for the pharmacological study of the pain associated with clinical
arthritis. The development of this new localized model of adjuvant
arthritis provides considerable benefits, both on scientific and ethical
grounds. Studies using the model are not complicated by the severe
systemic changes seen in adjuvant polyarthritis, and furthermore provide
the option of using the contralateral unaffected joint as a within the
same animal control.
Electrophysiological investigations in arthritic joints showed that
there was a large increase in the number of identifiable receptive
fields for articular mechanonociceptors compared to normal joints.
Mechanonociceptors had lower thresholds for mechanical activation, and
generally displayed a resting discharge not seen in normal joints. These
results are in agreement with those of several other workers using
models of both chronic (Guilbaud et al., 1985), or acute (Coggeshall et
al., 1983; Grigg et al., 1986; Schaible and Schmidt, 1985; 1988)
inflammation of the joints. Mechanonociceptors in rat arthritic ankle
joints were also found to be more sensitive to intra-arterial injections
of chemical excitants such as capsaicin or 5-HT. In addition to the
identified mechanonociceptor activity, high levels of ongoing discharge
were seen in afferent units for which no mechanosensitive receptive
fields could be found in the joint tissues. Chemosensitive units were
found to be excited by chemical stimuli including capsaicin, the
356
selective excitant of fine afferent fibres. Selectively chemosensitive
sensory receptors which become active during inflammation have also been
described by other workers (see McMahon & Koltzenburg, 1990). These
findings and those of the present study are extremely important and
provide a means whereby total nociceptive input to the spinal cord and
higher perceptual centres can be greatly increased during arthritis. The
sensory receptors described here do not fit into the classical
definition of a nociceptor, and are perhaps best described as
inflammation receptors (Iggo, 1988), signalling the chemical
microenvironment of peripheral tissue. This hypothesis provides an
explanation for the long unanswered question of why there are
proportionately so many unmyelinated afferents innervating peripheral
tissue.
In the present study identification of the receptive fields and
afferent fibre conduction velocities of chemosensitive units was not
fully investigated. Although no mechanically sensitive receptive fields
could be found for these units by probing on the joint surface, this
does not exclude the possibility that they were not responsive to
mechanical stimuli. Identification of receptive fields for specifically
chemosensitive units has been accomplished by Meyer and Campbell (1988)
in primate skin using a localized electrical stimulus as a probe. This
approach should be considered in future studies on rat ankle joints to
determine if the units described here are in fact selectively
chemosensitive.
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The rat isolated hindlimb preparation
A novel isolated hindlimb preparation was developed for use in
neuropharmacological studies in vitro. Mechanonociceptors from normal
ankle joints displayed similar characteristics to those seen in vivo.
Identified C fibre units had high mechanical activation thresholds,
displayed slowly adapting responses to a mechanical stimulus of constant
amplitude, and were excited and sensitized by chemical stimuli. These
are typical properties of sensory receptors, and thus, do not appear to
be dependent upon blood-borne factors or an intact sympathetic
innervation. Mechanical and chemical responsiveness was observed for
periods of up to eight hours after removal of the limb, suggesting that
the ionic balance and oxygen content of the tissue around the sensory
endings is sufficient to sustain normal receptor function.
Electrophysiological studies on arthritic joints in vitro revealed the
presence of increased numbers of mechanonociceptor receptive fields, as
seen in vivo. Lower thresholds for mechanical activation and higher
levels of resting discharge were also characteristic of arthritic
joints. These findings indicate that the enhanced mechanonociceptor
sensitivity is not dependent on the presence of blood constituents, nor
on CNS influences.
The fact that normal sensory receptor function can be seen over
prolonged periods, together with the increased sensitivity of sensory
receptors in arthritic joints, suggests that the isolated hind limb
preparation could be used in neuropharmacological studies examining the
effects of chronic joint inflammation on nociceptor responsiveness.
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Furthermore, the isolated nature of this preparation makes it ideal for
using two limbs from the same animal in order to examine sensory
receptors in the athritic and contralateral unaffected joints.
A number of other workers have also successfully developed
preparations for the study of sensory receptors in vitro. Carotid body
chemoreceptors (Eyzaguirre & Lewin, 1961), superfused diaphragm-phrenic
nerve (Kieschke & Mense, 1984), canine testis-spermatic nerve (Kumazawa
& Mizumura, 1983), isolated perfused rabbit ear-auricular nerve (King et
al. 1976) and rat skin in vitro (Reeh, 1986) preparations have been
examined. All of these preparations provide the advantage of the
experimenter being able to control the environmental conditions in the
tissue. Concentrations of exogenous chemical can be controlled either
through bath application or by direct application to the receptive
fields of single units. In the present study drugs were injected into
the perfusate, and reached their target sensory receptors via the
vasculature supply of the limb. The possibility of applying drugs more
locally to single receptive fields in the rat isolated hindlimb
preparation has also been suggested. It would be possible to apply
discrete and quantifiable amounts of solution to single receptive fields
within the joint tissue by pressure ejection using a glass micropipette.
This technique was attempted during the course of my work, but
insufficient time was available to produce any meaningful data. Further
studies using this technique of drug administration may provide more




Intra-arterial injections of 5-HT excited and sensitized articular
receptors from normal and arthritic joints. Sensory receptors in
arthritic joints were more sensitive than those from normal joints.
Rapid excitatory events are most likely to result from a direct action
of the amine at 5-HT receptors associated with sensory terminals within
the joint tissues. However, delayed excitation and mechanonociceptor
sensitization may occur secondary to the local release of other
endogenous excitants or sensitizing chemicals such as bradykinin or the
prostanoids. In support of a direct action on 5-HT receptors associated
with sensory terminals are the findings that 5-HT has delayed effects on
isolated sensory neuronal preparations in vitro (Higashi, 1977; 1980;
Simmonds & DeGroat, 1980; Wallis et al., 1982; Christiansen et al.,
1982). These delayed nature of these effects is likely to be due to 5-HT
receptor mediated activation of intracellular second messengers such as
IP3 or cAMP (see Peroutka, 1988). The present findings are in keeping
with existing knowledge on the actions of 5-HT. In neuronal cells 5-HT
activates a wide range of conductances either via receptor gated ion
channels (5-HT3) or through activation of second messenger systems (ie
5-HT2). An individual cell often has more than one response to a single
application of 5-HT, these often being separated by their time course.
This variety of actions is due, at least in part, to the diversity of
receptor subtypes and their coupling to distinct second messenger
systems and ion channnels. Further investigations into the role of
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second messengers in 5-HT mediated effects on sensory receptors will be
required if the excitatory and sensitizing actions of the amine are to
be completely understood.
In arthritic joints administration of 5-HT2 or 5-HT3 receptor
antagonists caused short lasting reductions in resting discharge,
supporting a role for 5-HT in the maintenance of the high levels of
activity seen in these joints. Likely sources of endogenous 5-HT in the
rat are blood platelets (Garratini & Valzelli, 1965; Franzen & Eysell,
1969), mast cells (Johnson & Erdos, 1973), or sympathetic neurones (Dun
et al., 1980; Verhofsted et al., 1981; Neel & Parsons, 1986). Since 5-HT
is not found in human mast cells, it has not generally been considered
to be an important mediator of inflammation in humans. However, blood
platelets may release 5-HT during immune activation or as a result of
tissue damage, and have recently been implicated in the progression of a
number of inflammatory diseases (see Page, 1988). It has also been
suggested that the sympathetic nervous system may have a role in the
development of pain in arthritis (see Fitzgerald, 1989). Thus, over¬
activity of the sympathetic nervous system during inflammation may
result in an increased release of 5-HT from sympathetic terminals.
Although a 5-HT3 receptor has been implicated in 5-HT-induced pain in
the human blister base (Fastier et al., 1959; Donatsch et al, 1984b;
Richardson et al, 1985), the involvement of a 5-HT2 receptor in delayed
nociceptive responses has not been reported previously. Further
investigations into the role of 5-HT2 receptors in the pain associated
with chronic inflammation is warranted in view of the present findings.
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Bradykinin
Intra-arterial injection of bradykinin excited and sensitized articular
mechanonociceptors to mechanical stimuli in both normal and arthritic
joints. Results from this study and those of other workers suggest that
the excitatory effects of bradykinin are at least partially dependent
upon the sensitizing actions of other substances such as 5-HT (Mense,
1981), or the prostanoids (Chahl & Iggo, 1977; Kumazawa & Mizumura,
1980; Mense, 1981; 1982). The excitatory effects of bradykinin on
nociceptive sensory receptors in normal tissues is mediated via a B2
receptor (Mizumura et al., 1990). In further studies characterization of
bradykinin receptors mediating the effects seen in the present study
would be of interest, particularly in arthritic rats, as the B1 receptor
is known to be synthesized during inflammation (Regoli et al., 1978;
Marceau et al., 1980).
Production of bradykinin is markedly increased during inflammation
(see Lewis, 1970; Garcia-Leme, 1978), and a number of pro-inflammatory
responses are triggered by bradykinin (Regoli & Barabe, 1980; Manning et
al., 1982; Marceau et al., 1983; Rozengurt, 1986). However, during
chronic inflammation many actions of bradykinin, including the induction
of pain, are likely to be greatly potentiated by other inflammatory
mediators such as the prostanoids. It has been suggested that the
development of selective bradykinin receptor antagonists may be useful
in the treatment of the pain associated with inflammation. However, it
may be more beneficial block the effects of the potentiating substances
rather than the acute and perhaps protective pro-inflammatory functions
of bradykinin using receptor antagonists.
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Prostanoids
Intra-arterial injection of PGE2, PGI2, or the selective IP-receptor
agonist cicaprost, excited and sensitized articular mechanonociceptors
to mechanical stimuli. These prostanoids also potentiated the effects of
bradykinin on articular sensory receptors. Examination of the effects of
PGE2, PGI2, and cicaprost in vivo. or PGE2, cicaprost, PGD2, and PGF2<*
in vitro. produced the following rank order of potency
PGI2 - cicaprost » PGE2 » PGD2 - PGF2a
A similar order of potency was obtained for prostanoid-induced
depolarization of the rat or rabbit isolated vagus nerve in vitro, with,
in addition, PGE^ being equipotent with PGI2, and the TXA2 mimetic
U46619 being inactive. These results are in agreement with previous
reports showing that PGI2 and PGEi, which has potent agonist activity
both at IP- and EP-receptors (Coleman et al., 1987), are more potent
hyperalgesic agents than PGE2 (Juan, 1979). The present findings
provide evidence for the involvement of IP-, and perhaps EP-receptors,
in the excitatory and sensitizing actions of the prostanoids on
articular nociceptors in the rat. In view of the general concensus that
prostanoids do not cause overt pain when administered alone, the present
finding that i.a. PGI2 or cicaprost excited articular nociceptors is
particularly novel. In humans, prostanoid-induced pain is only reported
when relatively high doses of PGE^ are administered intradermally,
whereas low doses of PGE^ potentiate the pain caused by bradykinin
(Ferreira, 1972). It cannot be discounted that the excitatory action of
PGI2 seen in the present study resulted from IP-receptor mediated
sensitization to an endogenous excitant already present in the joint
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tissues. Indeed excitation of articular nociceptors was caused by the
combined i.a. injection of subthreshold doses of PGI2 and bradykinin.
However, in studies on rat isolated sensory neurones PGE2 causes these
cells to fire action potentials (Baccaglini & Hogan, 1983), suggesting
that the prostanoids can directly excite nociceptive neurones in the
absence of other mediators such as bradykinin.
The use of isolated nerve preparations in order to determine which
prostanoid receptors may be present on sensory terminals has proved to
be successful in the present study. Investigations using isolated nerve
preparations have contributed significantly to the development of
selective antagonists for neuronal 5-HT receptors (see Ireland, 1987;
Ireland and Tyers, 1987; Butler et al., 1988), and should be useful in
further studies on the prostanoids. Prostanoid-induced depolarization of
fine sensory nerves from the rat and rabbit was shown to be mediated
predominantly by IP-receptors. The prostanoid receptor mediating PGE2-
induced depolarization of the rabbit isolated vagus could not be
determined using the standard available selective agonists for the EP^-,
EP2- and EP3-receptors. Further studies will be necessary to determine
if the receptor mediating this response is a novel EP-receptor subtype.
However, the development of new selective agonist and antagonist
compounds for prostanoid receptors will be required before further
advances can be made.
Results obtained in the present study examining the possible
involvement of second messenger systems in prostanoid-induced
depolarization of the rabbit vagus are in agreement with previous
findings showing that in sensory neurones the effects of prostanoids are
mediated via the activation of cAMP (Kalix, 1979; Gilman et al., 1971;
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Fowler et al., 1985a,b; Weinreich and Wonderlin, 1987). Prostanoid-
induced hyperalgesia has also been postulated to be mediated via cAMP
(Ferreira & Nakamura, 1979). Further investigations examining the
effects of non-hydrolysable analogues of cAMP and forkolin on sensory
receptors would be of use in determining whether these second messengers
have sensitizing and excitatory effects similar to those of the
prostanoids. The rat isolated hindlimb preparation would be of most use
in this type of study, since a greater level of control could be
achieved over the environment to which the drugs are added.
Results from the present study examining the effects of 1-AS, PGE2 and
cicaprost support the hypothesis, first proposed by Guilbaud & Iggo
(1985), that PGI2 is the major endogenous prostanoid resposible for
enhancing mechanonociceptor sensitivity in arthritic rat ankle joints.
Determination of whether the effects of 1-AS seen in the present study
is solely due to a supression of PGI2 production awaits the development
of selective IP-receptor antagonists. There is evidence to support a
role for PGI2 in human rheumatoid arthritis, since an extensive study
examining the prostanoid content of synovial fluid from human arthritic
joints found 6-keto-PGF]a, the stable breakdown product of PGI21 to be
present at the highest concentrations (Brodie et al., 1980).
Prostanoids may be produced by a variety of different cell types
during inflammation, including platelets (Willis, 1978), mast cells
(Becker & Henson, 1973; Roberts et al., 1978), neutrophils (Goldstein et
al., 1977; Zurier, 1976), mononuclear phagocytes (Davies & Allinson,
1976) and macrophages (Gordon et al., 1976; Myatt et al., 1976; Humes et
al., 1977). Prostanoids are produced by inflamed tissues ex vivo, such
as cultured human synovium which produces PGE2 (Robinson et al., 1975),
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PGI2 and TXA2 (Salmon et al., 1983). In addition it has recently been
suggested that sympathetic neurones synthesize and release prostanoids
from their postganglionic terminals (Taiwo & Levine, 1988), and that the
contribution made by the sympathetic nervous system to arthritic pain
(see Fitzgerald, 1989) is mediated through the actions of these
prostanoids on nociceptive sensory terminals.
The potential of using selective prostanoid receptor antagonists as
analgesics in human rheumatoid disease may provide considerable
advantages over conventional NSAID analgesic therapy. The blockade of
prostanoid production by NSAIDS is predominantly responsible for the
high incidence of side effects associated with their use in the
treatment of rheumatoid arthritis (Lifschitz, 1983; Goodwin, 1987).
NSAIDS may also potentiate chronic inflammation (Lewis & Barrett, 1986),
and have a harmful effect on cartilage (Palmoski & Brandt, 1985). It has
been suggested that these effects may result from an increased
production of lipoxygenase products of arachidonic acid metabolism
(Walker & Harvey, 1984) or through loss of the known anti-inflammatory
effects of the prostanoids themselves (Aspinall & Cammarata, 1969;
Lichtenstein & DiBernard, 1971; Orange et al., 1971; Zurier & Quagliata,
1972; Glenn & Rohloff, 1972; Zurier et al., 1972; 1974; Bonta et al.,
1978;). By using selective prostanoid antagonists it may be possible to
provide analgesic and anti-inflammatory activity without the adverse
effects caused by the total blockade of prostanoid production.
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Conclusions
Overall the results presented support a role for bradykinin, 5-HT and
the prostanoids PGI2 and PGE2 in the pain associated with chronic joint
inflammation in the rat. More than one mediator is likely to be
responsible for the sensitization of articular nociceptors seen in
arthritic rat ankle joints. As modulators of the responsiveness of
nociceptive sensory receptors to other mediators, and as potent
excitants themselves, the prostanoids, and in particular PGI2, probably
play a major role in sensitizing nociceptors in arthritic joints. The
potent analgesic effects of NSAIDS in man suggests that the prostanoids
are important mediators of pain in human joint disease with the
prostanoids PGE2 and PGI2 likely to be most relevant to humans since
levels of these prostanoids are high in synovial fluid from patients
with rheumatoid arthritis (Brodie et al., 1980). In addition to the
prostanoids, future investigations should consider the actions of other
endogenous chemical mediators on nociceptive sensory nerves. Of
particular interest is the suggested sensitizing action of 8(R),15(S)-
dihydroxyeicosatetraenoic acid (8(R),15(S) diHETE) via a direct effect
on sensory terminals (Taiwo et al., 1987), and the proposed peripherally
mediated analgesic effects of the opioids during inflammation (Ferreira
& Nakamura, 1979; Hargreaves et al., 1988; Stein et al, 1988).
With the recent discovery of a host of putative inflammatory mediators
such as the cytokines, platelet activating factor and various
neuropeptides (see Willougby, 1987), our picture of chronic inflammatory
process is becoming increasingly complex. The mediators involved in the
pain associated with inflammation and their mechanisms of action are
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only now starting to emerge. It is likely to take a considerable amount
of additional time and effort before these processes are fully
understood, and new potent analgesic, anti-inflammatory compounds are
developed.
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Bradykinin, acetate salt Sigma
Capsaicin (8-methyl-n-vanylyl-nonenamide) Sigma
Cicaprost (ZK 96480) Schering, A.G. Berlin
GR38032F (1,2,3,9-tetrahydro-9-methyl-3- Glaxo, UK
[2 -me thy1-1H-imidaxo1-1-y1)me thy1]-4-
carbazol-4-one hydrochloric dihydrate
5-hydroxytryptamine creatinine
sulphate complex, dopamine hydrochloride Sigma
ICI 81008 ICI Pharmaceuticals Division
ICS 205-930 ((3a-tropanyl)-3yl)-lH-indole-
3-carboxylic acid ester) Sandoz, Basel
Iloprost (ZK 36374) Schering, A.G. Berlin
Lysine acetylsalicylate
Ketanserin, tartaric acid salt
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The effects of 5-HT on articular sensory receptors in normal
and arthritic rats
^.J. Birrell, D.S. McQueen, *A. Iggo & *B.D. Grubb
Department of Pharmacology, University of Edinburgh Medical School, 1 George Square, Edinburgh EH8 9JZ and
'Department of Preclinical Veterinary Sciences, R.(D.)S.V.S., University of Edinburgh, Summerhall, Edinburgh EH9 1QH
1 The effects of intra arterial (i.a.) injections of 5-hydroxytryptamine (5-HT, 1-100/tg) on the discharge
of (a) identified articular high threshold mechanoreceptors and (b) unidentified chemosensitive receptors in
the ankle joint have been studied electrophysiologically in anaesthetized normal and arthritic rats.
Recordings were made from a fine branch of the medial plantar nerve.
2 5-HT increased the mechanical responsiveness of high threshold nociceptive mechanoreceptors with C
and AS fibre afferents in both normal and adjuvant-arthritic rats. Receptors in arthritic joints were more
sensitive to 5-HT than were those from normal joints.
3 5-HT produced a complex response from both types of articular receptors following i.a. injection. Two
separate components were identified: (a) a fast transient burst of activity was obtained within 10s of this
injection in 66% of units from normal animals and 45% from arthritics, followed by (b) a delayed slow
longer-lasting excitation seen in 62% of the units examined from normals and 77% of units from arthritic
rats.
4 Increased mechanoreceptor resonsiveness produced by 5-HT was reduced or abolished by the 5-HT3
receptor antagonists studied (MDL 72222, ICS 205-930, or GR 38032F, in single doses of lOO^gkg"
i.a.).
5 Fast excitation showed marked tachyphylaxis and was antagonized by MDL 72222, ICS 205-930 or
GR 38032F. It was unaffected by ketanserin (100/rgkg"*, i.a.). Delayed excitation was reduced or abol¬
ished by ketanserin but was unaffected by the 5-HT3-receptor antagonists.
6 Administration of MDL 72222, ICS 205-930 or GR 38032F caused short lasting (< 5 min) reductions
in background activity from both types of unit recorded in arthritic rats, as well as in normal rats in which
activity had increased following administration of 5-HT. Ketanserin caused similar reductions in back¬
ground activity in chemosensitive units, but had no effect on mechanoreceptors.
7 At least two types of receptor are involved in the actions of 5-HT on articular sensory receptors with
fine afferent fibres. Increased mechano-responsiveness involves a 5-HT3-receptor as does fast excitation.
Delayed excitation probably involves a 5-HT2-receptor. Endogenous 5-HT appears not to play a crucial
role in sensitization of high threshold mechanoreceptors in this model of chronic inflammation and
arthritis, although its local release may potentiate the actions of other inflammatory mediators on sensory
receptors in the ankle joint.
Introduction
Adjuvant-induced polyarthritis in rats has been used exten¬
sively as a model for the study of chronic inflammatory pain
(see Colpaert, 1987). Electrophysiological studies with this
model have shown that high threshold C-fibre mechanorecep¬
tors (putative nociceptors) have lower thresholds in the ankle
joints of these animals in comparison with normal rats
(Guilbaud et al., 1985). These results suggest that the behav¬
ioural changes seen in adjuvant polyarthritis can partly be
accounted for in terms of altered properties of articular
sensory receptors. The enhanced receptor sensitivity can be
reduced by lysine acetylsalicylate, suggesting that locally pro¬
duced cyclo-oxygenase metabolites may be responsible for at
least part of the sensitization (Guilbaud & Iggo, 1985). It is
still uncertain, however, the extent to which other inflamma¬
tory mediators found in tissue exudates may contribute to the
sensitization of peripheral sensory receptor mechanisms.
Keele & Armstrong (1964) demonstrated that 5-
hydroxytryptamine (5-HT) has the ability to cause pain when
applied to a blister base, and 5-HT was later shown to lower
thresholds for chemically-induced pain in man (Sicuteri et al.,
1965) and to enhance pseudoaffective responses to bradykinin
in animals (Nakano & Taira, 1976). Sensory nerve endings
associated with small myelinated and non-myelinated axons
have been found to be activated and sensitized by 5-HT in
1 Author for correspondence.
skin (Fjallbrant & Iggo, 1961; Beck & Handwerker, 1974) and
muscle (Mense, 1981), as are cutaneous SAII mechanorecep¬
tors with rapidly conducting afferent fibres (Fjallbrant & Iggo,
1961).
Although the pain evoked by application of 5-HT to a
blister base has been demonstrated to be antagonized by ICS
205-930, and therefore probably involves a 5-HT3-receptor
(Donatsch et al., 1984; Richardson et al., 1985), in most cases
the pharmacological identity of the 5-HT-receptor associated
with sensory endings has not been established. The present
study was undertaken to examine the effects of 5-HT on
sensory receptors in the rat ankle joint, and to characterize
the 5-HT receptors mediating these effects by the use of selec¬
tive antagonists (Fozard, 1984; Bradley et al., 1986; Brittain et
al., 1987). We also investigated whether 5-HT plays a role in
the sensitization of high threshold mechanoreceptors in
arthritic joints by using a rat model of adjuvant-induced
mono-arthritis in which, the arthritis is mild and confined to
one ankle (Grubb et al., 1988).
Methods
Induction ofarthritis
Male Wistar rats weighing 200-250 g were anaesthetized with
ether during subdermal injection of 0.15 ml of Freund's com¬
plete adjuvant (l.Omgml-1 heat killed Myobacterium tuber¬
culosis in paraffin oil, Sigma) around the left ankle joint.
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Experiments were performed on anaesthetized animals follow¬
ing a period of two to nine weeks, during which time a local¬
ized arthritis consisting of swelling (approx. 50% increase in
circumference of the left ankle joint) and redness of the
injected ankle had developed and was maintained.
Surgical procedures
A total of 10 arthritic and 12 normal male Wistar rats weigh¬
ing between 200 and 300 g was used in these experiments.
Animals were anaesthetized with urethane (25% w/v, 0.6ml
100g"1 body wt. i.p.). The trachea was cannulated and
arterial blood pressure monitored via a cannula in the left
carotid artery. A cannula was also inserted into the right
femoral artery for the injection of drugs into the abdominal
aorta at the level of the iliac bifurcation. Drugs were dissolved
in 0.9% w/v aqueous NaCl solution (saline) and injected in
volumes of 0.1ml followed by a 0.2 ml saline wash. Acces¬
sibility to articular receptors via the vasculature was tested by
use of a single low dose of capsaicin (1 pM i.a.) which caused a
transient increase in neural discharge of all the afferents
studied.
Electrophysiological recording
Neural recordings were made from the primary articulo-
cutaneous ramus (PACR) of the left tibial nerve with
platinum-iridium wire electrodes, by employing techniques
described in detail elsewhere (Guilbaud et al., 1985). Sponta¬
neously active units for which no mechano-sensitive receptor
fields could be found (termed 'chemosensitive' because of their
excitation by 5-HT and capsaicin) and high threshold slowly-
adapting mechanoreceptors with axons in the PACR were
examined. Neural recordings were stored on videotape for
subsequent analysis of individual afferent units by use of a
pulse height voltage discriminator linked to a microcomputer.
Mechanoreceptors were identified by their response to
mechanical stimulation, by use of smooth tipped glass probes
of 0.5-1.0 mm diameter. Thresholds of individual units were
determined with a series of calibrated Von Frey hairs; these
high threshold mechanoreceptors probably function as noci¬
ceptors (Wyke, 1981; Guilbaud et al., 1985). Mechanical
stimuli in any given trial were delivered at fixed intervals by
an electromechanical indentation generator; ramp and
plateau waveforms were used routinely, with indentations of
200-600 ^m and 2 s duration repeated at 60-120 s intervals.
The indentation probe consisted of a sealed metal tube (1 mm
diameter) smoothed over at the tip with epoxy-resin, contain¬
ing a silver wire core, insulated except at the tip, used as the
cathode for localized electrical stimulation when measuring
conduction velocities. Afferent fibre conduction velocity was
measured by localized electrical stimulation, via the probe at
the level of the receptor, and determining the time take for the
action potential to reach the recording electrodes.
Data analysis
Neural discharge (counts per second) was plotted against time
for each test, and the change in frequency from the pre-
injection control period calculated. In order to standardize
results from experiments with different absolute discharge fre¬
quencies, mean values for blocks of 10 s duration were used to
calculate peak response as a percentage of the mean discharge
in the pre-injection 10 s control period. Mechanoreceptor
responses were quantified in counts per mechanical stimulus
and expressed as a percentage of the pre-injection response.
Statistics
Mean values are given + s.e.mean. Statistical analysis of dif¬
ferences between means was carried out by the Wilcoxon two-
sample test (two-tailed) and the null hypothesis rejected if
P < 0.05.
Drugs
The following compounds were used in this study, with con¬
centrations being expressed in terms of the salt: 5-
hydroxytryptamine creatinine sulphate complex, dopamine
hydrochloride (Sigma); MDL 72222 ((laH, 3a, 5aH-tropan-3-
yl) 3,5-dichlorobenzoate methanosulphonate salt, kindly
donated by Merrell Dow Research Institute Strasbourg); ICS
205-930 ((3a-tropanyl)-3yl)-lH-indole-3-carboxylic acid ester,
kindly donated by Sandoz, Basel); GR 38032F (1,2,3,9-
tetrahydro - 9 - methyl - 3 - [(2methyl -1H - imidazol-1 -yl)methyl] -
4H-carbazol-4-one hydrochloride dihydrate, kindly donated
by Glaxo Group Research, Ware); ketanserin, tartaric acid
salt (kindly donated by Janssen Pharmaceuticals, Beerse).
Capsaicin (8-methyl-n-vanylyl-nonenamide, Sigma) was pre¬
pared by diluting a stock solution (lmgrnl"1 in 10% ethanol:
10% Tween 80: 80% saline) in saline.
Results
Two types of sensory activity were investigated: mechano¬
receptors for which receptive fields were found in the joint
capsule (Guilbaud et al., 1985), and 'chemosensitive' units, pre¬
viously described by Grubb et al. (1988), which were excited
by 5-HT and capsaicin but for which no receptor fields for
mechanical stimuli were found (Table 1). Both mechano-
sensitive and chemosensitive units were excited by capsaicin
(1-10/rg, i.a.) in all experiments. Low threshold, rapidly adapt¬
ing mechanoreceptors with receptive fields in the tissues adjac¬
ent to the joint capsule were not considered in these studies.
Normal rats - mechanoreceptors
Mechanoreceptors with afferent fibres in the PACR and with
receptive fields in the ankle joint tissues of normal rats had
high mechanical threshold, were slowly adapting with punc¬
tate receptive fields of approximately 1 mm diameter and were
therefore similar to those described by Guilband et al., (1985).
Units had mean von Frey thresholds of 81 ± 6.8 mN, and the
conduction velocities of their afferents (2.1-10.5 ms-1) indi¬
cated that they were C or A<5 fine afferent fibres. Only one
mechanosensitive unit showed any background (spontaneous)
discharge (0.2 i.p.s.) before the addition of 5-HT - the number
of these high threshold units found in individual animals was
small, and their lack of resting discharge and high mechanical
Table 1 Summary of the number ofmechanosensitive and chemosensitive units responding to 5-hydroxytryptamine (5-HT) and the
minimal effective doses for these effects in normal and arthritic rats
No. of units displaying
each type of response
Rapid Delayed Minimal effective
Units n excitation response dose (jrg)
Normals Mechanosensitive 6 4 3 100
Chemosensitive 16 12 12 1
Arthritic Mechanosensitive 10 3 5 1
Chemosensitive 12 7 12 1
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thresholds made them difficult to find. A summary of all units
responding to 5-HT is given in Table 1.
Effects of 5-HT on responsiveness to mechanical
stimulation In the six units examined 5-HT (1-100 pg)
evoked a dose-dependent increase in responsiveness to the
standard mechanical stimulus (illustrated for 100 pg in Figure
1). The minimal effective dose which gave reproducible
responses in all four of the units tested in this way was found
to be 5 pg. As illustrated in Figure 2 a mean peak increase of
56% (n = 4) in response to subsequent mechanical stimuli was
observed following injection of 5 pg 5-HT, and this effect
lasted for 38 ± 34 s. Larger doses of 5-HT had a more pro¬
longed action, as can be seen in Figure 1 where the response
to a mechanical stimulus was still elevated three minutes after
the injection of 100 pg 5-HT. Repeated injections of 5-HT pro¬
duced a sensitization to the drug in four mechanosensitive
units.
Excitatory effects of 5-HT on spontaneous activity of mechano¬
sensitive units Close arterial injection of 1-100//g 5-HT
evoked a discharge in three previously silent mechanorecep-
tors and enhanced the discharge of one unit from a very low
initial level of discharge. The effect was reproducible in two of
these units at the highest dose used (100 pg 5-HT). A biphasic
response observed following injection of 5-HT consisted of a
transient burst of activity (hereafter called a 'fast' response)
with rapid onset (<10s), followed by a delayed (>20s),
longer-lasting increase in discharge, hereafter called a 'slow'
response (see Figure 3).
Normal rats - chemosensitive afferents
In the 12 normal animals examined in this study 16 recordings
consisting of between one and three different action potential
spikes were obtained from units with a low level of activity
before the addition of 5-HT. Their action potential spike char¬
acteristics were similar to those of identified C-fibre afferents,
and their mean rate of discharge was 1.4 + 0.3i.p.s.
Excitatory effects of 5-HT on chemosensitive units All the
units with an ongoing discharge were excited by an initial or









Figure 1 Effects of 100 pg 5-hydroxytryptamine (5-HT) on the activ¬
ity of a high threshold mechanoreceptor with afferent fibre conduction
velocity of 4ms"1 from a normal animal. The graph (bin width 1 s)
illustrates afferent discharge and shows fast and slow excitation.
Mechanical stimuli (arrowheads) were repeated once every minute
and neural responsiveness was increased following an injection of
5-HT (arrow). The inset shows 100 superimposed oscilloscope sweeps












Figure 2 Effects of 5-hydroxytryptamine (5-HT) on mechanorecep¬
tor responsiveness in both normal and arthritic rats, (a) The mean
peak increase in mechanoreceptor responsiveness is shown as a per¬
centage of preinjected control produced by 5 pg 5-HT (i.a.) in four
normal rats (open column) and by 1 pg 5-HT (i.a.) in six arthritic rats
(solid column), (b) Illustrates mean duration of increased responsive¬
ness produced by the same injections of 5-HT (normal rats, open
column; arthritics, solid column). Bars represent s.e. mean.
** P < 0.01 (Wilcoxon, two-tailed).
units became spontaneously active following the drug admin¬
istration.
Two main components could be recognised in the response
to 5-HT. An early, brief burst of activity, which was seen in
75% of active units, followed by a slow sustained increase in
discharge in 75% of units. Responses in individual units were
either monophasic or biphasic; fast responses occurred within
10 s following injection of 5-HT and lasted for a maximum of
30 s. Tachyphylaxis developed to repeated injections of 5-HT
(20-100pg at lOmin intervals; data not illustrated). However,
with lower doses (1—10 /rg) and a 15min interval between
injections, a relatively consistent response was obtained in
four recordings. The slow response generally took longer than
15 s to develop and lasted for over 4min in some cases.
Depression of activity following the initial excitation was also
seen in a small number of units when background activity was
elevated.
Arthritic rats - mechanoreceptors
A characteristic feature of arthritic preparations, as previously
described (Guilbaud et al., 1985), was the large number of
mechanoreceptors found in the joint. On average approx¬
imately three times as many mechanoreceptors were found in
the ankle joint tissues of arthritic rats in comparison with
control animals. These units had lower thresholds than
normal for activation with von Frey hairs (52.7 + 4.6 mN,
P < 0.05) and generally had overlapping receptive fields; their
conduction velocities (0.5-7.8ms"1) indicated that they were
C/Ad fibres. In contrast to the lack of spontaneous mechano¬
receptor activity in normal rats, nine of the 10 mechano¬
sensitive units studied showed spontaneous discharge,




















Figure 3 Comparison of 5-hydroxytryptamine (5-HT)-induced slow
excitation of mechanosensitive units in normal and arthritic rats, (a)
Shows the peak increase in discharge produced by 100 pg 5-HT (i.a.)
in two responding units of six tested from normal rats (open column)
and the mean peak increase produced by 1 pg 5-HT in four out of five
units from arthritics (solid column). The mean basal rate of discharge
in arthritic rats was 1.1 ± 0.8i.p.s., whereas in control rats no activity
was present before the injection of 5-HT. (b) Shows the duration of
effects for the same injections as in (a). Open column, represents data
from the two individual units which were excited by 5-HT in normal
rats. Solid column represents mean of four units from arthritic rats.
Bars show s.e.mean.
Effects of 5-HT on responsiveness to mechanical
stimulation In all 10 units examined a dose-dependent
increase in responsiveness to the standard mechanical stimu¬
lus was obtained following the injection of 5-HT (1-100 pg). In
seven units the effective threshold dose for production of con¬
sistent responses was found to be 1 pg. A mean increase of
75% (n = 6) in response to subsequent mechanical stimuli was
produced following injection of the threshold dose. This effect
lasted for 240 ± 48 s, a duration which is significantly greater
(P < 0.01) than that produced by 5pg 5-HT in normal rats
(Figure 2). Sensitization of mechanoreceptor responses to
5-HT was observed in two units.
Excitatory effects of 5-HT on activity of mechanosensitive units
Increases in spontaneous activity of six mechanosensitive
units was seen following injection of 5-HT (1-100^g). The bip-
hasic response seen in normal animals was much less con¬
spicuous, being obtained in only one recording. One unit gave
a fast and slow response, and another unit displayed only the
fast response. Three units responded with only a slow increase
in spontaneous activity. In four of the units the slow response
consisted of a mean peak increase of 1.6 ± 0.6i.p.s. above
basal discharge (1.1 ±0.7i.p.s.) which lasted for 185 ± 34 s.
This effect of 5-HT contrasts markedly with the small
response obtained following injection of 100^g 5-HT in the
normal rat (Figure 3). Spontaneous activity in a seventh unit
was depressed following 5-HT administration.
Figure 4 Effects of 5-hydroxytryptamine3 (5-HT3)-antagonists GR
38032F (100/igkg"1, i.a.), MDL 72222 (lOO^gkg-1, i.a.) and ICS
205-930 (100/^gkg-1 i.a.) on 5-HT-induced enhancement of mechano¬
receptor responsiveness in both normal and arthritic rats, (a) Shows a
shift to the right of the log dose-response curve caused by ICS
205-930 (100/igkg-1 i.a.) in a high threshold mechanoreceptor with
afferent fibre conduction velocity of 2.7 ms-1 from an arthritic rat.
(O) and (•) responses before and after addition of antagonist, respec¬
tively. The dose of 5-HT is shown in pg with the peak response
obtained given as a percentage of the preinjection control, (b) Illus¬
trates the effect of GR 38032F (n = 5) and MDL 72222 (n = 5) on the
mean peak increase in mechanoreceptor responsiveness produced by
an effective standard dose of 5-HT (1-100 pg i.a.). Columns represent
peak responses before (open) and after (solid) injection of antagonist,
(c) The duration of response obtained for the same injections as in (a).
Bars represent s.e.mean. Significantly different mean values are shown
as: *P <0.05 and **P< 0.01.
Arthritic rats - chemosensitive units
Chemosensitive units Spontaneously active units lacking any
identifiable mechanosensitive receptive fields were more
numerous in arthritic rats than in controls. In experiments on
10 animals the effects of 5-HT on spontaneous discharge were
examined in 12 recordings consisting of between one and
three different units with action potentials characteristic of
identified C-fibre afferents. Their mean rate of spontaneous
discharge before the administration of 5-HT was
1.4 + 0.2i.p.s.
Excitatory effects of 5-HT on chemosensitive units All the
units examined were responsive to injections of 5-HT (1-
100/rg). A biphasic response was seen, as in normal rats. A fast
excitatory response was seen in 58% of units, followed in all
the units studied by a slow long lasting increase in discharge.
Effects of5-HT-receptor antagonists in normal and in
arthritic rats
The 5-HT receptor antagonists, MDL 72222, ICS 205-930 and
ketanserin, were administered at lOO^gkg-1 i.a., doses pre¬
viously found to be active in abolishing chemoreceptor
responses to 5-HT in the cat (Kirby & McQueen, 1984). In the
present experiments the 5-HT3-receptor antagonists selectively
blocked the 5-HT3-receptor-mediated Bezold-Jarisch-like
reflex evoked by 5-HT, and ketanserin selectively antagonized
5-HT-induced hypotension.
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Table 2 Summary of the effects of 5-hydroxytryptamine (5-HT)-receptor antagonists on spontaneous discharge of chemosensitive units
MDL 72222
1
00M00=3.8 ICS 205-930 (100ggkg"1) GR 38032F (100//gkg"1) Ketanserin (100ggkg 1
% reduction % reduction % reduction % reduction
n in discharge n in discharge n in discharge n in discharge
Normals 4/4 53 3/3 62 4/4 53 5/9 63
(43-68) (33-100) (64-99) (43-86)
Arthritic 1/4 100 4/4 36.5 6/9 58
(13-50) (76-25)
Mean values are given - figures in parentheses show range of effect.
n = number of units.
Mechanoreceptor responsiveness
The 5-HT3-receptor antagonists, MDL 72222, ICS 205-930
and GR 38032F, administered intra-arterially, each antago¬










MDL 72222 ICS 205-930 GR 38032F
Figure 5 Effects of MDL 72222 (100gg kg-1 i.a., n = 6), GR 38032F
(100/igkg"1 i.a., n = 4) and ICS 205-930) (100/igkg-1 i.a., n = 4) on
5-hydroxytryptamine (5-HT)-induced fast excitation in chemosensitive
units from both normal and arthritic rats. Each column shows the
mean peak response as a percentage of basal discharge to a standard
effective dose of 5-HT (5-100/ig i.a.) before (open) and after (solid)




















Figure 6 Effects of ketanserin (100/igkg-1 i.a.) on 5-
hydroxytryptamine (5-HT)-induced slow excitation of chemosensitive
afferent units from normal and arthritic rats, (a) The mean peak dis¬
charge expressed as a percentage of preinjection control produced in
response to a standard dose of 5-HT (1-100//g i.a.) before (open
column) and after (solid column) injection of ketanserin (100 gg kg"1,
i.a., n = 14). (b) The mean duration of the effects shown in (a). Bars
represent s.e.mean. ** P < 0.01.
mechanical stimuli in both normal and arthritic rats. In five
units, treatment with MDL 72222 (100/rgkg-1) markedly
reduced the increased responsiveness produced by 5-HT;
injection of ICS 205-930 (100/tgkg-1) produced a clear right-
ward shift in the 5-HT dose-response curve in one unit. In
studies on five units, GR 38032F (100/rgkg-1) abolished the
response in one unit and produced a marked reduction in the
response in the other four units (see Figure 4).
The 5-HT2-receptor antagonist, ketanserin (100/rgkg-1),
did not affect the 5-HT-evoked increase in mechanoreceptor
responsiveness, either in normal or in arthritic rats when
tested in six units.
Spontaneous activity of mechanosensitive units
In spontaneously active mechanosensitive units from arthritic
rats, MDL 72222 (100/igkg"1, n = 1) or GR 38032F
(100//gkg~l, n = 2) caused reductions in ongoing activity of
70% and 65% respectively when injected on their own.
Reductions of activity lasted for no longer than 5 min in each
case. In two mechanosensitive units, ketanserin (100/rgkg-1)
had no effect on spontaneous activity.
An examination of the effects of the various 5-HT receptor
antagonists on the fast and slow components of 5-HT-induced
increases in spontaneous activity was complicated by the
inconsistent nature of the fast response and its marked suscep¬
tibility to tachyphylaxis. The slow response, however, was
consistently observed in all cases, and in arthritic animals
neither MDL 72222 (lOO/rgkg-1, n= 1), ICS 205-903
(100 fig kg-1, n = 1) nor GR 38032F (100/rgkg-1, n = 1) had
any affect on it. In only one out of two units did ketanserin
cause a shift to the right of the 5-HT dose-response curve.
Chemosensitive units
In the case of spontaneously active chemosensitive units,
MDL 7222, ICS 205-930 and GR 38032F all reduced ongoing
discharge in arthritic rats as well as in normal animals pre¬
viously exposed to 5-HT (see Table 2). Reductions in activity
produced by antagonists lasted for 1-3 min. Ketanserin also
markedly reduced ongoing discharge in arthritic and normal
rats (Table 2).
Analysis of the effects of 5-HT-receptor antagonists on the
fast response to injection of 5-HT were complicated by incon¬
sistency of the response and its susceptibility to tachyphylaxis.
However, it was markedly reduced or abolished following
injections of the 5-HT3-receptor antagonists MDL 72222
(n = 6), ICS 205-930 (n = 4) and GR 38032F (n = 4) (see
Figure 5).
The slow response to injection of 5-HT was unaffected by
the 5-HT3-receptor antagonists, but in 14 out of 15 recordings
was blocked or markedly reduced by ketanserin (100ggkg""1)
(see Figure 6).
Discussion
This investigation has shown that exogenous 5-HT can both
excite and increase the responsiveness of sensory receptors
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with fine (C, possibly some A<5) afferents located in the ankle
joint tissues of normal and arthritic rats. High threshold noci¬
ceptive mechanoreceptors were affected by 5-HT in both
normal and arthritic animals, the effect of the amine on
arthritic joints being more marked. The units recorded from
arthritic joints had spontaneous activity, in contrast with the
general lack of activity in units from normal joints. These
findings are in good agreement with those obtained previously
for the inflamed ankle joint (Guilbaud et al., 1985). Further¬
more, background discharge originating from chemosensitive
units for which no mechanosensitive receptive fields could be
found was greater in arthritic rats. These units were activated
by 5-HT or capsaicin and responded to 5-HT with two com¬
ponents - fast brief excitation followed by a slow prolonged
increase in activity. The effects of exogenous 5-HT on joint
sensory receptors are quire similar to those on cat carotid che-
mosensors, where fast and slow excitatory effects involving
5-HT3- and 5-HT2-receptors, respectively, have been obtained
(Kirby & McQueen, 1984).
Action of5-HT on mechanoreceptors
Single close-arterial bolus injections of 5-HT increased the
responses of high threshold mechanoreceptors to a standard
mechanical stimulus for as long as six minutes. This duration
of action is similar to that obtained for 5-HT-induced sensiti¬
zation of high threshold mechanoreceptors in muscle to exci¬
tation induced by bradykinin (Mense, 1981), as well as for the
action of 5-HT on SAII cutaneous mechanoreceptors
(Fjallbrant & Iggo, 1961). MDL 72222, ICS 205-930 or GR
38032F prevented this action, but did not otherwise affect the
response to mechanical stimuli. Ketanserin was without effect.
These results suggest that the sensitization demonstrated may
involve the action of 5-HT at a 5-HT3-receptor located on the
mechanoreceptor terminals within the joint tissues.
Fast excitation
Brief excitation of mechanosensitive units and chemosensitive
units occurred within 10 s of the injection of 5-HT in both
normal and arthritic joints. This action was blocked or
reduced by the 5-HT3-receptor antagonists. Fast depolar¬
ization evoked by 5-HT has been observed in several isolated
neuronal preparations. For example, in cat and rabbit
superior cervical ganglion (Haefely, 1974; Wallis & North,
1978), rabbit nodose ganglion (Higashi & Nishi, 1982) and
guinea-pig coeliac ganglion (Wallis & Dun, 1988) 5-HT pro¬
duced a rapid depolarization which was prone to tachy¬
phylaxis and was sensitive to MDL 72222 or ICS 205-950
(Azami et al., 1985; Round & Wallis, 1986; 1987; Wallis &
Dun, 1988).
Slow excitation
The most consistent response to 5-HT was a slow dose-
dependent long-lasting increase in discharge that was seen in
the majority of the chemosensitive units examined, as well as
in mechanosensitive units from normal and arthritic rats. The
5-HT3-receptor antagonists had no effect on this slow excita¬
tion, whereas in the case of chemosensitive units ketanserin
reduced or abolished it. The delayed nature of this effect could
mean that 5-HT is acting indirectly to increase afferent activ¬
ity. In our preparation, slow excitation was dose-dependent
and outlasted the hypotensive effect of 5-HT, thus making it
unlikely to be secondary to changes in blood pressure. Alter¬
native mechanisms could include the involvement of a second
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Abstract
Neural recordings were made from sensory fibres in a nerve supplying the ankle joint in normal rats and
in rats with a novel monoarticular arthritis. The responses of mechanically and chemically sensitive units
to intra-arterial injections of 5-HT were measured. In most cases the mechanosensitivity of sensory
receptors in the ankle joint was not altered by 5-HT. However, 5-HT produced an increase in afferent
activity in units which were identified as C-fibres on the basis of action potential amplitude and duration.
The receptive fields of these chemosensitive units were not located. The responses of these units to 5-HT
were dose dependent and were abolished by the 5-HT2-antogonist, ketanserin, but not by the
5-HT3-receptor antagonist, MDL 72222. The responses of chemosensitive units to injections of 5-HT
were similar in normal and arthritic rats although the response was slightly prolonged in arthritic
animals.
Introduction
The mechanical sensitivity of C- and A<5-fibre joint
afferents is increased in animals with inflamed
joints (Guilbaud etal., 1985; Grigg etal., 1986)
and this sensitisation can be reversed by adminis¬
tration of lysine acetylsalicylate (Guilbaud and
Iggo, 1985) indicating that at least one group of
the inflammatory mediators, the prostanoids, can
sensitise afferent nerves or their receptors. Anoth¬
er agent released during tissue inflammation is
5-hydroxytryptamine (5-HT). In this study we
have examined the effect of 5-HT on the discharge
of afferent nerve fibres in normal and arthritic rat
ankle joints.
Methods
1. Induction of arthritis. Rats were anaesthetised
briefly with ether and an injection of 0.15 ml of
Freund's complete adjuvant (Sigma Chem. Co.
Ltd) was made into the tissues overlying the left
ankle joint and the development of arthritis was
followed over the next 4 weeks. Injections made in
this way resulted in a localised arthritic lesion
which predominantly involved the left ankle joint.
2. Neurophysiological recordings. Animals were
anaesthetised with urethane (25%, 0.6 ml/100 g
body weight) and the trachea and left carotid ar¬
tery were catheterised. Blood pressure and respira¬
tion were monitored continuously. An additional
catheter, used for injecting drugs, was inserted into
the right femoral artery until the end was situated
at the iliac bifurcation.
Neural recordings were made from the primary
articulo-cutaneous ramus (PACR) using the tech¬
niques employed by Guilbaud et al. (1985). The
responses of all units to injections of 5-HT (May
and Baker Ltd) into the iliac bifurcation were ob-
Agents and Actions, vol. 25, 3/4 (1988)
served. All injections were made in a volume of
0.1 ml followed by a 0.2 ml saline wash. All num¬
bers given are mean ± s.e.m. Data was analysed by
playing recorded tapes through a CED interface
(Cambridge Electronic Design Ltd) linked to a mi¬
crocomputer. Most nerve strands contained be¬
tween 1 and 4 active units and individual units
were separated using a spike amplitude discrimi¬
nator.
Results
/. General observations. Successful experiments
were made on 9 rats, 5 arthritic (2-4 weeks post
injection) and 4 controls and the physiological
properties of control and inflamed joints were
compared. Two major differences were observed.
Firstly, the number of receptors which could be
excited by mechanical stimulation was increased in
inflamed joints compared to control joints indicat¬
ing a lowering of the mechanical threshold of some
of the mechanosensitive units. Secondly, spontane¬
ously active units were present in 3 of 5 arthritic
animals with an average of 3 active units in each
case (mean discharge frequency = 0.6 + 0.2 Hz) but
were not recorded in control animals.
2. Injections of5-HT. Following injections of 5-HT
only two mechanosensitive units showed an in¬
creased response to graded mechanical stimu¬
lation. It was observed, however, that a population
of afferent fibres which had previously been inac¬
tive responded 'to injections of 5-HT; it was not
possible to identify their receptive fields by me¬
chanical probing. The number of units responding
to 5-HT was the same in control and arthritic
animals. The majority of the action potentials
recorded following an injection of 5-HT were ex¬
tremely small and of long duration (2.6 + 0.1 msecs)
which is consistent with the activation of C-fibres
by 5-HT in this preparation. The responses of
these units to 5-HT were dose dependent with a
threshold of 2-10nmoles. A prolonged tachy¬
phylaxis was observed if large doses (100 nmoles)
were used.
There did not appear to be any difference in the
sensitivity of the afferent units to 5-HT when nor¬
mal and inflamed joints were compared and the
mean latency of the responses to injections of
5-HT was similar (29.8 + 8.3 sees). There was some
evidence that the duration of the response to 5-HT





The effect of intra-arterial injection of 5-HT on the combined
discharge frequency of 3 units in the PACR on a normal rat.
• = control injections of 5-HT, a = injections of 5-HT following
administration of 200 gg/kg MDL 72222, o = injections of 5-HT
following administration of 100 gg/kg ketanserin. MDL 72222
had no appreciable effect, whereas ketanserin, a 5-HT2-receptor
antagonist markedly reduced the 5-HT induced nerve activity.
3. Characterisation of the 5-HT-receptor. 5-HT is a
potent algogen when applied to the blister base in
man and it has been demonstrated that this effect
is mediated through a 5-HT3-receptor (Richard¬
son etal., 1985). Following the identification of
5-HT sensitive units in each animal 100 pg/kg
MDL 72222 (a 5-HT3-receptor antagonist, Mer-
rell Dow, Strasbourg) was given intra-arterially.
MDL 7222 reduced the responses to 5-HT in only
1 of 4 control rats, and had no effect in 5 arthritic
rats. Since MDL 72222 was generally ineffective in
reducing the stimulation produced by 5-HT,
100 pg/kg ketanserin (a 5-HT2-receptor antago¬
nist), was given intra-arterially to each animal. In
3 of 4 control animals and in 4 of 5 arthritic
animals the excitatory effects of 5-HT were mark¬




An important issue in these experiments was
whether it was appropriate to use this new model
of arthritis for neurophysiological and neurophar-
macological studies of inflamed joints. A compar¬
ison of the neurophysiological characteristics of
sensory receptors in rats with fully developed ar¬
thritis (Guilbaud et al., 1985) and in rats with this
new mild form of arthritis shows that they are
almost identical.
In these experiments 5-HT was an excitatory agent
for nerve fibres in the rat ankle joint, and its effects
were predominantly mediated through a 5-HT2-
receptor. This finding is in contrast with the excita¬
tory effects of 5-HT on the human blister base
where 5-HT acts through the 5-HT3-receptor to
cause pain.
One major concern was that the excitatory effects
of 5-HT might be secondary to drug-related
changes in the local blood flow. This seems unlike¬
ly since vasoactive agents such as PGE2 cause a
systemic vasodilatation yet have no effect on sen¬
sory receptor discharge; also, there is evidence that
blood flow in the hind-paw of the rat is unaffected
by locally administered 5-HT (Owen, 1977).
A problem with these experiments is that the iden¬
tity of the afferent units excited by 5-HT is uncer¬
tain since we were unable to locate their receptive
fields by mechanical probing. However, it seems
likely from analysis of spike width and spike height
that they were C-fibres and could be involved in
signalling noxious stimuli.
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In summary, two important findings have arisen
from these experiments. Firstly, it is possible using
a low dose of F.C.A. to induce a localised inflam¬
matory condition which appears, using neurophy¬
siological criteria to induce a similar type of recep¬
tor sensitisation to that seen in rats with full
polyarthritis. Secondly, 5-HT excites afferent fi¬
bres when injected into the ankle joint and this
effect appears mainly to involve 5-HT2-receptors.
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THE EFFECT OF PROSTAGLANDIN E2 AND BRADYKININ ON THE
DISCHARGE OF ARTICULAR MECHANORECPTORS IN NORMAL RATS.
B.D. Grubb, A. Iggo, *D.S. McQueen and *G.J. Birrell.
Department of Preclinical Veterinary Sciences and
"Department of Pharmacology, University of Edinburgh,
Edinburgh, U.K.
Afferent C-mechanoreceptors in the joint capsule of
the rat ankle are sensitized in adjuvant induced
polyarthritis (Guilbaud et al, Exp Brain Res 1985,
<58:29)* The responses of these receptors to graded
jmechanical stimuli are reduced in polyarthritic rats by
the intravenous administration of lysine aspirin
suggesting that prostaglandins are involved in the
sensitization process (Guilbaud and Iggo, Exp Brain Res
i 1985, 6 1: 16A) .
! We have examined the effect of close arterial
;injections of PGE2 (0.03-3 jig) on the responses of
identified joint mechanoreceptors to graded mechanical
stimuli in normal rats. In five anaesthetised rats,
none of six units (2 A-delta and A C-fibre) was excited
by PGE2 and two units showed a significant depression
(to 36% and 32% of control) at the highest dose (3 jig).
In the same experiments intra-arterial injections of
threshold doses of the algogen bradykinin (0.01-10 jig)
alone or in combination with PGE2 (0.3-3.0 jig) were
made. In 5/5 units the peak excitation elicited by the
combination was larger than the response obtained with
bradykinin alone. These results suggest that PGE2
sensitises Joint mechanoreceptors to bradykinin.
[From the Proceedings of the Physiological Society, 22-23 September 198!)
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Sensitization of joint capsule C- and AS high-threshold mechanoreceptors
by 5-hydroxytryptamine (5-HT) in anaesthetized normal and arthritic rats
By G. J. Birrell, B. D. Grubb*, A. Iggo* and I). S. McQueen. Department of
Pharmacology, University of Edinburgh Medical School, 1 George Square, Edinburgh
EIJ8 9JZ, and * Department of Preclinical Veterinary Sciences. R(D)SVS, Summerhall,
Edinburgh EH9 1QH
Electrophysiological studies in rats with adjuvant-induced arthritis have shown
that there is an increased sensitivity of joint capsule high threshold mechanoreceptors
in the ankle joints of these animals compared with normal rats (Guilbaud et a,I. 1985).
Investigations in our laboratory have shown that 5-HT produces excitation of C- and
AS afferent fibres innervating rat ankle joint capsule receptors (Grubb et al. 1988).
We now report further studies examining the effects of 5-HT on the responses of high
threshold mechanoreceptors in the ankle joints of normal rats and those with
unilateral adjuvant-induced chronic inflammation.
Male Wistar rats (200-300 g) were anaesthetized with urethane (25%, 0-6 ml
100 g_1, i.p.). C- and AS fibre afferent discharge was recorded from the ankle joint
in response to a standard mechanical stimulus, repeated every 1 or 2 min, using
techniques described previously (Guilbaud et al. 1985).
Injection of 5-HT (1-100 pg, i.a.) produced a dose-dependent increase in response
to the standard stimulus. In four recordings from normal animals, a mean increase
of 116% (range: 17-333%, n = 7) in response to subsequent stimuli was observed
following injection 5/tg 5-HT. Sensitization lasted for 69 7 ±35-4 s (mean + s.e.m.). In
arthritic animals, six units displayed a mean increase of 71T% (range: 15-180%,
n = 8) in' response to subsequent mechanical stimuli following injection of a
correspondingly effective dose of 1 pg 5-HT. Sensitization lasted for 285+ 33 8 s.
Our results indicate that 5-HT sensitizes joint capsule C- and AS high threshold
mechanoreceptors. In arthritic rats joint capsule receptors, which have an enhanced
mechanical sensitivity, show greater than normal sensitivity to 5-HT.
This work was supported by an ARC project grant. G.J.B. holds a SERC CASE award with
Glaxo Group Research.
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Actions of PGE2 and cicaprost on the sensitivity of high-threshold mechano-
receptors in normal and inflamed ankle joints of the anaesthetized rat
By G. J. Birrell*, B. D. Grubb, A. Iggo and D. S. McQueen*. Department of
Preclinical Veterinary Sciences, Il(D)SVS, Summerhall, Edinburgh EH9 1QH and
* Department ofPharmacoloqy. University ofEdinburqh Medical School, 1 George Square,
Edinburgh EH8 9JZ
Lysine acetvlsalicylate is able to reverse the sensitization of articular C-
mechanoreceptors produced by chronic joint inflammation (Guilbaud et al. 1985;
Guilbaud & Iggo, 1985). These experiments suggest that prostanoids may be
involved in the sensitization of mechanoreceptors in inflamed joints. We have
examined the action of PGE2 and the stable PGI2 analogue, cicaprost, on
responsiveness of joint mechanoreceptors to mechanical stimuli in normal rats and
in rats with modified adjuvant arthritis (Grubb et al. 1988).
Male Wistar rats were anaesthetized with urethane (25% w/v solution, 0 6 ml
100 g_1 body weight, i.p.) and the medial aspect of the left ankle joint was exposed.
Nerve fibres isolated from the primary articulo-cutaneous ramus or tibial nerve were
characterized by conduction velocity and a repeated graded mechanical stimulus was
applied to the receptive field. Bolus injections of PGE2 (0-03-30-0 fig) and cicaprost
(0 01-2 0 fig) in normal saline were made through a femoral arterial cannula and
lysine acetylsalicylate (50-100 mg kg"1) was administered through a femoral
venous cannula.
A total of 32 units were studied in 24 animals, 14 from arthritic and 18 from control
animals. The responses of C- and AS high threshold mechanoreceptors to mechanical
indentation of inflamed joints were measured before and after administration of
salicylate, PGE2 and cicaprost. In all units salicylate reduced the response to
mechanical indentation. In 57% of units PGE2 caused a partial reversal of the
salicylate effect and in 43% there was no effect. Cicaprost caused a similar increase
to PGE2 in 83% of units and there was no effect in 17%. In normal animals PGE2
caused excitation in 15%, had no effect in 54% and caused a depression in 31 % of
units. In contrast, cicaprost excited 54% of units and had no effect in 46%.
These results suggest that PGE2 and cicaprost may act differentially to sensitize
joint mechanoreceptors. This suggestion is supported by the observation that
cicaprost and not PGE2 induced spontaneous activity in units from both control and
inflamed joints.
Supported by the Arthritis and Rheumatism Council.
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Effects of aspirin and paracetamol on high-threshold tarsal joint mechano-
receptors in anaesthetized rats with adjuvant-induced arthritis
By D. S. McQueen, A. Iggo*, G. J. Birrell and B. D. Grubb*. Department of
Pharmacology, University of Edinburgh Medical School, Edinburgh EH8 9JZ and
*Preclinical Veterinary Sciences, K(D)SVS, Summerhall, Edinburgh EH9 1QH
In rats with adjuvant-induced polyarthritis the mechanical sensitivity of high-
threshold slowly adapting mechanoreceptors (recorded from sensory nerve fibres
innervating the tarsal joint) is reduced by lysine acetylsalicylate (Guilbaud & Iggo,
1985). The present experiments were undertaken to show whether aspirin has similar
effects on these receptors in a model of adjuvant arthritis where the lesion is confined
to one tarsal joint (Grubb et al. 1988). We also studied the effects of paracetamol so
as to clarify the action of this drug on peripheral sensors.
Male Wistar rats were used ; 015 mg Freund's complete adjuvant was injected,
under halothane (2%) anaesthesia, around one tarsal (ankle) joint. Between 12 and
30 days later the animals were anaesthetized with urethane (25 %, 0-6 ml 100 g-1 i.p.)
and neural discharge from tarsal joint mechanoreceptors recorded (Grubb et al.
1988). The effects of i.v. lysine acetylsalicylate (in a dose equivalent to 50 mg kg-1
aspirin) or paracetamol (50 mg kg-1) were studied on 'spontaneous' and on
mechanically evoked discharge (400 /tm indent, 2 s duration every 2 min - see
Guilbaud & lggo, 1985) and the conduction velocity measured. Results are shown in
Table 1.
Table 1. Effects of aspirin and paracetamol (50 mg kg"1 i.v.) on activity ('spontaneous' and
mechanically evoked) of tarsal joint mechanoreceptors in n arthritic rats
Pre-drug Minimum
discharge discharge Time (min)
n (100%) (%) to minimum
Mean value ±s.e.m.
Aspirin (l-ASA) Spont. (ct/s) 4 2-5 ±1-5 52 ±8 16
Mechn. (ct) 5 25 + 4 65 ±8 30
Paracetamol Spont. (et/s) 8 1-3 ±0-4 66 ±12 22
Mechn. (ct) 4 35 ±5 63 ±24 18
Aspirin has similar effects in this preparation to those obtained by Guilbaud &
Iggo (1985) - background and mechanically evoked discharge from mechano¬
receptors, the majority of which had C fibre afferents, were both reduced by the
salicylate. The effects of paracetamol on the receptors were not significantly different
from those of aspirin (P > 0-05; Wilcoxon signed-ranks test).
These results support the proposal that prostanoids sensitize joint capsule
mechanoreceptors in arthritis (Guilbaud & Iggo, 1985); they also provide direct
evidence that paracetamol acts in the periphery to reduce input from these presumed
nociceptors in adjuvant arthritis. Aspirin and paracetamol may act by a common
mechanism, probably involving inhibition of cyclo-oxygenase.
Supported by a grant from the Arthritis Council. G.J.B. is an SERC-CASE scholar.
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COMPARISON OF THE EFFECTS OF PGE2 AND CICAPROST ON THE RESPONSES OF RAT
ANKLE JOINT MECHANORECEPOTORS TO BRADYKININ. G.J. Birrell*1 , D.S.
McQueen*1, A. Iggo2 and B.D. Grubb*2, department of Pharmacology






AIM OF INVESTIGATION: This study was undertaken to evaluate the effects of PGE2 and
cicaprost, a PGI2 mimetic, on the responses of high threshold articular mechanoreceptors
to bradykinin and mechanical stimuli.
METHODS: Male wistar rats were anaesthetized with urethane and recordings were made of
A-delta and C-fibre afferent discharge from the ankle joint in response to a standard
mechanical stimulus.
RESULTS: Close arterial injections of threshold doses of bradykinin (l-10ug) alone or
in combination with either PGE2 (0.3~3ug) or cicaprost (0.01-1.0ug) excited the receptors
and also increased their responsivness to mechanical stimuli. In 8 of 10 units for PGE2
and 7 of 8 units for cicaprost, the responses elicited by combined injections were were
greater than those to either drug alone. Cicaprost and PGE2 effects differed in that
the former was a particularly potent excitant, producing long lasting periods of sustained
activity in 6 out of 10 units.
CONCLUSIONS: These results, together with other studies, suggest that PG£2 and
cicaprost may act by different mechanisms to produce sensitization of joint
mechanoreceptors to the actions of bradykinin.
Proceedings of Satellite Meeting to the Vlth World Congress on Pain: The
Neurobiology of Nociception, Kauai. 1990.
COMPARISON OF THE EFFECTS OF PGE2 AND CICAPROST ON THE RESPONSES OF
RAT ANKLE JOINT SENSORY RECEPTORS TO BRADYKININ IN VITRO. G.J.
Birrell*1, D.S. McQueen*1, A. Iggo2, department of Pharmacology and
^Department of Preclinical Veterinary Sciences, University of
Edinburgh, Edinburgh, UK.
AIM OF INVESTIGATION: This study was undertaken to evaluate the effects of PGE2 and
cicaprost, a PGI2 mimetic, on the responsiveness of articular sensory receptors to
bradykinin using a novel in vitro preparation.
METHODS: Male wistar rats were anaesthetized and following cannulation of the femoral
artery for perfusion with oxygenated Krebs solution the left hindlimb was isolated in a
superfusion bath at 30°C. Recordings were made of afferent discharge from the ankle
joint in response to the application of drugs via the arterial perfusate.
RESULTS: Bradykinin (0.1-10ug) produced excitation when given alone or in combination
with either PGE2 (0.1-10ug) or cicaprost (0.01-1ug). In 1 of 8 recordings for PGE2 and
10 of 11 for cicaprost, responses to combined applications were greater than those to
either drug alone. Cicaprost proved to be more potent than PGE2 in this respect and in
contrast to PGE2 was also a potent excitant when administered alone in 13 of 11
recordings. In all cases active units had action potential spike characteristics similar
to those for identified A-delta and C-fibre afferents.
CONCLUSIONS: These results suggest that PGI2 may be more effective than PGE2 in
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Effects of cicaprost and PGE2 on the responses of rat ankle joint sensory
receptors to bradykinin in vitro
By G. J. Birrell, D. S. McQueen and A. Iggo*. Department of Pharmacology,
University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ and *Department of
Preclinical Veterinary Sciences, University of Edinburgh, Summerhall, Edinburgh
EH9 1QH
Recent studies on joint capsule sensory receptors have shown that the i.a.
administration in vivo of cicaprost, a stable PGI2 mimetic, and of PGE2 can increase
the responsiveness of these sensors to mechanical stimuli (Birrell el al. 1990). We now
report the effects of cicaprost and PGE2 on the receptors' responses to bradykinin
(BK), using a novel in vitro preparation of the rat ankle (tibio-tarsal) joint.
Male Wistar rats (200-350 g) were anaesthetized with urcthane (0-6 ml 25% w/v
solution 100 g-1, i.p.). The left femoral artery was cannulated to allow perfusion
(2 ml min-1) of the limb with Krebs solution (mm: NaCl, 118-4; KCL, 4-7;
MgS04.7H20, 1-2; KH2P04, 1-2; NaHC03, 25; CaC1.2H20, 2-5; glucose 11 1)
equilibrated with 95% 02 and 5% C02 at 32 °C, after heparinized saline
(500 U kg-1 heparin) was flushed through the limb. Following surgical isolation of
the limb, the paw was secured in a Perspex superfusion bath and the skin removed
from the leg. Neural recordings were made as described previously (Guilbaud et al.
1985) from the desheathed nerve placed in a small side chamber filled with liquid
paraffin. Drugs were injected into the perfusate.
For 14 high-threshold mechanoreceptors (nociceptors) tested, BK (0-1-10 pg)
caused dose-dependent excitation in 9 instances (64%). Cicaprost (0-01-1 pg) evoked
dose-dependent excitation in 11 of 12 (92 %) recordings that was sustained for 10 min
or more. PGE2 (0-01-10 pg) only weakly and transiently excited 7 of 8 units (88%).
Combined injections of threshold or subthreshold doses of cicaprost (0-01-1 pg and
BK (0-01-10 pg) were more effective than either drug alone in 7 of 11 (64%) units.
Combined injections of BK (01-10 pg) with PGE2 (0 01-10 pg) produced enhanced
excitation in only 3 of 7 (43%) recordings. These results provide further evidence to
suggest that protanoids, and in particular PGI2, increase the excitability of articular
nociceptive sensory endings by a direct action in the periphery and also interact with
BK. Furthermore, cicaprost on its own excited these receptors, suggesting that
endogenous PGI2 may directly activate articular nociceptors.
Supported by the Nuffield Foundation (Oliver Bird Fund for Research into Rheumatism).
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Neuropeptide content of dorsal root ganglia cells in the arthritic rat
By G.D.Smith, A. F. Bowden*, G. J. Birrell*, D. S. McQueen* and A.,J.
Harmar. MRC Brain Metabolism Unit, Department of Pharmacology and *Department
of Pharmacology, 1 George Square, Edinburgh EH8 9JZ
It has been shown that the levels of certain neuropeptides in dorsal root ganglia
(DRGs) and spinal cord are altered in experimental models of arthritis (I'anerai et al.
1987; Kuraishi et al. 1989). The present study was undertaken to measure the
neuropeptide content of DRGs at the C2 to T6 level of the spinal cord in rats with
an adjuvant-induced monoarticular arthritis of the carpal joint.
Male Wistar rats (200-250 g) were divided into two groups of five. Under
halothane anaesthesia, one group received an injection of 0T ml Freund's Complete
Adjuvant (FCA, Sigma, 1 mg/ml) subdermally around the left carpal joint on Day
0, where as the other group was untreated and served as the control. There was an
initial swelling of the joint in the FCA group which peaked at day 3 (47-7 + 4-8%
increase in circumference compared to contralateral joint, P < 0-01, Wilcoxon two
sample test), followed by a chronic phase which peaked by day 15 (26-0 + 4-3%
compared to contralateral joint, P < 0-01).
Rats were killed by decapitation on Day 15 and Substance P (SP), calcitonin gene-
related peptide (CGRP) and somatostatin (SST) content of DRGs from left and right
sides in the regions C2 to T6 were measured by radioimmunoassay. Peptide levels
were elevated the most at the C6 to C7 level, and are shown in Table 1.
Table 1. Levels of peptides in DRGs at the C6 to C7 level (pg/ganglion)
Control FCA
Left Right Left Right
CGRP 2914-2 + 596-6 2748-3 + 336-4 7831-2*+106-4 2374-4 + 254-7
SP 59-4 + 5-9 55-9 + 4-7 730 + 7-2 47-2 + 7-2
SST 46-8 + 7-3 43-6 + 3-6 49-2 + 3 1 39-5 + 30
Data shown as mean + s.e.m. *P < 001, compared to DRG on the right side.
In conclusion, CGRP content of DRGs from the area C6 to C7 were significantly
elevated on the side ipsilateral to the arthritic carpal joint, whereas there was no
significant difference in SST and SP content. This evidence suggests that CGRP in
sensory neurons may be involved in the pathology of chronic inflammatory disease.
We acknowledge financial support from the Oliver Bird Fund. G.J.B. and A.F. B. are CASE
award students.
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